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ABSTRACT 
Age-related macular degeneration (AMD) is the leading cause of irreversible 
blindness in people over the age of 50. As many as 50 million people are affected by 
AMD worldwide and prevalence is expected to continue to rise due to an aging 
population. There are two forms of the disease, dry (geographic atrophy) and wet 
(choroidal neovascularization), both of which result in retinal degeneration and central 
vision loss. Although anti-vascular endothelial growth factor therapies are moderately 
successful at treating the wet form, there are no treatments currently available for the 
more common dry form. Pharmacological therapies have been extensively explored for 
the treatment of dry AMD, but have achieved little success because the pathogenesis 
underlying AMD is unknown and likely varies among patients. Recently, tissue 
engineering has emerged as a promising approach to restore function by replacing 
diseased retinal tissue with healthy retinal pigment epithelium (RPE). While AMD-
associated vision loss occurs when photoreceptors degenerate, this process arises as a 
consequence of earlier RPE dysfunction. In the healthy retina, the RPE acts as a critical 
VI 
regulator of the microenvironment for both photoreceptors and the nearby vasculature. 
However in AMD, the RPE no longer performs these essential homeostatic functions 
leading to photoreceptor apoptosis and vision loss. 
This dissertation describes the development and in vitro characterization of a 
tissue engineering scaffold for RPE delivery as potential treatment for dry AMD. First, a 
novel microfabrication-based method termed "pore casting" was developed to produce 
thin scaffolds with highly controlled pore size, shape, and spacing. Next, human RPE 
were cultured on pore-cast poly(c-caprolactone) (PCL) scaffolds and compared to cells 
on track-etched polyester, the standard RPE culture substrate. RPE on porous PCL 
demonstrated enhanced maturation and function compared to track-etched polyester 
including improved pigmentation, barrier formation, gene expression, growth factor 
secretion, and phagocytic degradation. Lastly, this study established a patient-specific 
method for predicting AMD progression using retinal oxygen concentration. This 
approach differs from current diagnosis techniques because it uses physiologically-
relevant mechanisms rather than generalized clinical associations which have little, if 
any, prognostic value. 
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1. INTRODUCTION AND SPECIFIC AIMS 
Age-related macular degeneration (AMD) is the leading cause of irreversible 
blindness in people over the age of 50 [1 ,2]. AMD is divided into two distinct types. dry 
(geographic atrophy) and wet (choroidal neovascularization), which have the same end 
result, central vision loss . Fortunately, early AMD can be diagnosed by the presence of 
large and/or numerous drusen beneath the retina well before substantial vision loss has 
occurred. However, despite early diagnosis, this information is minimally useful as there 
is no treatment cunently available for this stage of the disease as the FDA-approved 
interven twnal treatments are only effective for treating the later wet form of AMD [3]. 
This research develops a tissue engineering strategy for the treatment of dry AMD prior 
to irreversible vision loss. Because AMD first affects Bruch's membrane (BrM) and 
retinal pigment epithelium (RPE), this approach aims to replace these diseased tissues 
with healthy RPE on a biomaterial scaffold. 
The mechanisms underlying dry AMD progression are poorly understood. In fact, 
AMD is likely not just one or two diseases, but a collection of diseases with the same 
end-stage pathology. As a result, some patients diagnosed with early AMD, a relatively 
innocuous form of the disease, will not advance to the more harmful late-stage disease for 
many years while others may never advance. Unfortunately, current diagnosis methods 
are unable to distinguish rapidly progressing patients from non-progressing patients and 
have little, if any, predictive value at the individual patient level [ 4]. Though improved 
prognosis is already desirable to distinguish these two groups of patients, it will be 
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especially important when intervention is available in order to avoid unnecessary surgery. 
Herein we also aim to develop a hypoxia-based method for patient-specific AMD 
prognosis. In summary, the aims of this research were to ( 1) fabricate and characterize a 
tissue engineering scaffold appropriate for RPE delivery to the sub-retinal space, (2) 
evaluate the in vitro behavior of RPE on the scaffold, and (3) develop a method to 
determine at-risk patients who could benefit from RPE transplantation. 
Aim 1: Develop and characterize a tissue engineering scaffold suitable for RPE 
delivery. 
The RPE is adherent to a sheet of extracellular matrix termed BrM. In early 
AMD, cellular debris (drusen) accumulates in or on BrM leading to dysfunction of the 
adjacent RPE. RPE replacement has been identified as an opportunity to stop the 
progression of AMD before major vision loss and without the added complexity of neural 
integration. However, early attempts to transplant RPE without a support or attached to 
aged/diseased BrM have not achieved functional success [5-9]. Consequently, many 
groups have now turned their focus to synthetic scaffolds for RPE delivery with the goal 
of mimicking key characteristics of healthy native BrM. 
This research aimed to fabricate a thin, biocompatible RPE scaffold with well-
defined pores and surface architecture. As with any biomaterial, biocompatibility is 
essential for proper in vivo function. We have chosen to use poly(G-caprolactone) (PCL) 
which has previously demonstrated sub-retinal biocompatibility in animal models when 
other materials commonly accepted as biocompatible were harmful to retinal tissue 
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[10,11). The next most important criteria for an RPE scaffold is selective permeability as 
native BrM acts as both a path for nutrient/waste exchange and barrier to cell migration. 
A majority of metabolites used in the outer retina cross BrM from the choroidal 
vasculature to highly-active photoreceptors [12]. At the same time, BrM must prevent 
cell migration as loss of barrier function can permit vascular invasion resulting in wet 
AMD, the most aggressive and harmful form of the disease. To eliminate the possibility 
of undesirable cell migration through the scaffold, we used microfabrication techniques 
to create a scaffold with small, fully-deterministic pores. Further, these pores were evenly 
spaced across the scaffold to allow each cell access to multiple pores for transepithelial 
transport. 
Aim 2: Evaluate the behavior of RPE cells on porous PCL scaffolds in vitro. 
The RPE perform numerous functions critical for maintaining the adjacent 
photoreceptor and vascular microenvironments. These functions include light absorption, 
protein and ion management, recycling of visual cycle components, phagocytosis of 
photoreceptor outer segments, and polarized growth factor secretion [12). In AMD, 
unhealthy RPE are unable to meet the demands of surrounding tissue leading to RPE 
apoptosis, vascular dropout, and eventual photoreceptor degeneration. Further, because 
RPE are quiescent in the adult, an external cell source is likely required to restore the full 
diversity of functions. 
This research aimed to assess the in vitro behavior of RPE on porous PCL 
compared to track-etched (porous) polyester transwells, the current standard in the RPE 
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field. RPE on transwells already display improved markers of maturation compared to 
traditional tissue culture polystyrene plates, but still lack many functional attributes of in 
vivo RPE. Additionally, in their current formulation, these films are inappropriate for 
RPE transplantation due to their rigidity and pore heterogeneity. In this study, the 
behavior of RPE on porous PCL was compared to transwells in long-term culture with 
the goal of delivering a tissue engineered construct with a mature RPE monolayer at the 
time of surgical implantation. In vitro assays for morphology, pigmentation (light 
absorption), barrier function, gene expression, growth factor secretion, and phagocytosis 
were critical in determining the function of RPE on porous PCL relative to transwells. 
Aim 3: Develop a method to assess patient risk of advancing to late AMD. 
Although dry AMD is highly prevalent, not all patients progress to the late form 
of the disease that initiates severe vision loss. In fact, while current AMD diagnosis 
standards developed by the Age Related Eye Disease Study (AREDS) are somewhat 
correlated with advancing disease, less than half of the patients in the highest risk group 
advance to late AMD within 5 years [ 13] . In addition, while these diagnostic metrics 
yield important population data, their inability to provide an individual patient with an 
accurate prognosis limits the value of this approach. Therefore, better methods for 
predicting disease progression are needed to identify patients at risk for progression and 
in need of intervention once available. 
This aim explored a new, patient-specific approach for AMD prognosis based on 
physiological mechanisms. The end-stage pathological mechanism proposed here is 
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retinal hypoxia induced by pathological changes to the microenvironment, namely 
drusen. While several groups have generally proposed hypoxia as the mechanism of 
degeneration in AMD, we are the first group to study this idea for prospective disease 
prognosis. We created a semi-automated method for modeling the intraretinal oxygen 
profile at steady state using patient-specific geometry. Areas of the retina predicted to be 
hypoxic were then compared to subsequent retinal degeneration using data from a follow-
up patient visit. 
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2. BACKGROUND 
2.1 The Eye 
2.1.1 Ocular Structure & Function 
The eye is a complex organ that converts light from the surrounding environment 
into an electrochemical signal that is interpreted by the brain to produce vision. Photons 
entering the eye pass through the optically transparent cornea, crystalline lens, and 
vitreous before reaching the light-sensitive retina located at the back of the eye. The 
cornea is the forward-most tissue of the eye which serves as an immunological barrier, 
minimizes the passage of scattered light, and provides a majority of the light focusing 
capacity of the eye [14]. After passing through the cornea and largely inert aqueous 
humor, light passes through the pupil which serves as an aperture to regulate the total 
amount of light entering the eye. It then reaches the lens where, depending on the 
distance of the light source, the surrounding muscles contract or elongate to alter the 
curvature of the lens through a process known as accommodation [15]. This process 
allows the lens to alter its refractive power to focus light from an object at a particular 
distance. From the lens, light travels through the gelatinous vitreous humor and 
ultimately reaches the retina. A diagram of ocular components can be seen in Figure 2.1 . 
2.1.2 Retinal Anatomy & Physiology 
The human retina is a well-organized, thin tissue comprised of eleven layers 
which are (from back/outermost to front/innermost): the RPE, photoreceptor outer 
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segment, photoreceptor inner segment, external limiting membrane, outer nuclear layer 
(ONL), outer plexiform layer (OPL), inner nuclear layer, inner plexiform layer, retinal 
ganglion cell layer, nerve fiber layer, and inner limiting membrane. Light detection 
occurs in the first six layers that constitute the outer retina while visual signal comparison 
and transmission occurs in the latter five layer which comprise the inner retina. 
Photoreceptors of the outer retina detect light focused by the lens and begin an 
electrochemical cascade that travels through bipolar cells, horizontal cells, amacrine 
cells, and ganglion cells to propagate nerve impulses to the brain via the optic nerve 
(Figure 2.2) [16]. The macula is a 3mm region of the retina approximately specialized for 
high acuity central vision. Within the macula, an even smaller region lmm in diameter 
called the fovea possesses the highest acuity vision which is necessary for reading and 
facial recognition [ 17]. 
Cornea---
Anterior----"--
segment 
(contains 
aqueous humor) 
Lens----' 
Posterior segmenl ------/ 
(contains vitreous humor) 
Figure 2.1 Diagram of ocular structure. After Marieb EN, Hoehn K, The special senses 
in Human Anatomy & Physiology, 91h ed, Boston, MA: Pearson Education; 2013: 548. 
Copyright 2013 Pearson Education. 
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Figure 2.2 Retinal architecture. (A) Posterior segment of the eye displaying the locations 
of the neural retina relative to the pigmented layer of retina (RPE), retinal vasculature, 
choroid, and sclera. (B) Rod photoreceptor structure. (C) Cell types found in the retina 
from RPE at the back to the axons of ganglion cells . Light travels through these 
transparent layers before reaching photoreceptors that initiate the phototransduction 
cascade through bipolar and ganglion cells. (D) Histological staining of the retina using 
hematoxylin and eosin. A, C, and D reprinted from Marieb EN, Hoehn K, The special 
senses in Human Anatomy & Physiology, 91h ed, Boston, MA: Pearson Education; 
2013:550. Copyright 2013 Pearson Education. B reprinted by permission from Macmillin 
Publishers Ltd: Nature Reviews Genetics Wright AF, Chakarova CF, AbdEl-Aziz MM, 
Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a 
complex trait, 11:273-84. Copyright 2010. 
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2.1. 3 Photoreceptors 
Photoreceptors are elongated, columnar cells densely packed in parallel that 
interface with RPE on their basal side and form synapses with bipolar or horizontal cells 
in the OPL at their apical end. In between, the cell body contains the nucleus and 
mitochondria and is responsible for producing specialized proteins for phototransduction 
including opsin, a G-protein coupled transmembrane receptor. Once synthesized, opsin is 
localized to membranous discs in the outer segment and covalently linked to the 
chromophore 11-cis retinal (a form of Vitamin A). When stimulated by a photon, 11-cis 
retinal undergoes a conformational change to all-trans retinal which initiates a sequence 
of transducin activation, cyclic guanosine monophosphate ( cGMP) phosphodiesterase 
activation, cGMP degradation, and closure of cGMP-gated cation channels [18]. The 
resulting imbalance of ions causes cell hyperpolarization that stops the release of 
glutamate to bipolar cells at the synaptic terminal. 
Unlike most neuronal cells which are hyperpolarized at rest and become 
depolarized upon stimulation, photoreceptors work in the opposite way. When 
unstimulated in the dark, photoreceptor ion channels are open resulting in a continuous 
inward current that depolarizes the cell and causes neurotransmitter release. Then, when 
stimulated by a photon, ion gates close leading to cell hyperpolarization and a reduced 
rate of neurotransmitter release. The persistent current that occurs when photons do not 
stimulate the photoreceptor is commonly called the dark current. Maintaining the dark 
current is an energy-intensive process and the main reason why photoreceptors are among 
the most metabolically-active cell types in the body [19,20] . Although costly in the 
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respect of energy usage, this strategy has been developed to maximize the signal-to-noise 
ratio of phototransduction [21]. 
Photoreceptors are divided into two sub-classes, rods and cones. Rod 
photoreceptors have single photon threshold to stimulus and are therefore capable of 
scotopic (low-light) vision, but only produce black and white vision. Alternately, cone 
photoreceptors only function for photopic (normal/high light) vision, but have high 
spatial resolution and produce color vision. Rod photoreceptors contain rhodopsin which 
responds to a broad spectrum of light ( 496nm peak) while cone photoreceptors contain S, 
M, or L cone opsin, which have overlapping absorbance in the blue ( 419nm peak), green 
(531nm peak), and red (558nm peak,) spectrums respectively [22]. Although cone 
photoreceptors each contain only one of the three cone opsins, the signals from multiple 
adjacent cones with overlapping spectrums are combined to produce vision with 
substantial color variety. In the human retina, rod photoreceptors are vastly more 
abundant than cone photoreceptors (92 million rods vs. 4.6 million cones) and located 
mainly in the peripheral retina while nearly all cones are located in the fovea conferring 
high acuity color vision to the central visual field [23]. 
2.1.4 The Retinal Pigment Epithelium & Bruch's Membrane 
Named for their dark appearance due to high melanin content, retinal pigment 
epithelium (RPE) cells form a quiescent (non-dividing) monolayer at the back of the 
retina. Although not synaptically connected to the neural retina, each RPE cell is in 
physical contact with approximately 23 photoreceptors [24]. From this location, the RPE 
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performs a variety of functions critical for maintaining retinal homeostasis including light 
adsorption, ion transport, water transport, immunological barrier formation, visual 
product recycling, phagocytosis, and growth factor secretion (Figure 2.3) [ 12,25]. 
Pigmentation allows the RPE to absorb excess light not absorbed by the photoreceptors to 
prevent back-scatter and minimize photo-oxidative stress to underlying tissues. The RPE 
forms the outer blood-retinal barrier, which is analogous to the blood-brain barrier in 
terms of selective transport and immune privilege. RPE cells also phagocytose 
membranous discs shed by the photoreceptor outer segment. Photoreceptors shed 
approximately 10% of their discs each day from the tip of the outer segment [26]. These 
discs, which contain all-trans retinal (the photobleached or "used" form of the 11-cis 
retinal chromophore ), are phagocytosed by RPE and recycled through the process of 
esterification by lecithin retinol acyltransferase, conversion to 11-cis retinol by retinal 
pigment epithelium-specific 65 kDa protein (RPE65), and oxidation to 11-cis retinal 
before being returned to the photoreceptor for reuse [27]. Additionally, RPE secrete 
growth factors trophic to the surrounding cells (photoreceptors and vascular endothelial 
cells), the most important of which are pigment epithelium-derived factor (PEDF) and 
vascular endothelial growth factor (VEGF). Due to the vastly different requirements of 
the neural retina and vascular bed on opposite sides of the RPE, many of these factors are 
preferentially secreted in one direction. PEDF, a neuroprotective and anti-angiogenic 
factor is secreted apically (towards photoreceptors [28,29] while VEGF, a potent 
angiogenic factor is secreted basally to maintain the choriocapillaris, the sub-retinal 
vascular plexus [30]. 
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The RPE is adherent to Bruch's membrane (BrM), a 1-4J..tm thick pentalaminar 
sheet of extracellular matrix (ECM) sheet that serves as the basement membrane to both 
RPE and choriocapillaris (Figure 2.4). Composed largely of type-IV collagen and elastin 
[23], the BrM has five layers: the RPE basement membrane, inner collagenous layer, 
elastic layer, outer collagenous layer, and choriocapillaris basement membrane [31] . The 
three major functions of BrM are (1) regulating molecular transport between the choroid 
and RPE, (2) acting as a barrier to cell migration, and (3) providing a physical support for 
RPE cell adhesion and maturation [31]. Though the RPE is the active mediator of 
molecular transport between photoreceptors and the choriocapillaris, this can only occur 
if BrM also maintains permeability [32]. Interestingly, BrM has been shown to be 
substantially thinner and more porous beneath the macula compared to the periphery-
perhaps evolved as a strategy to promote transport in an area with especially high 
metabolic requirements [33]. 
The choriocapillaris is a fenestrated vascular plexus located beneath BrM. This 
vascular complex supplies approximately 90% of the metabolites required by the outer 
retina while the remaining 10% are provided by the deep retinal vasculature [33]. A 
constant supply oxygen, glucose, and other metabolites is required to meet the high 
metabolic demands of photoreceptors and ensure proper visual function [34]. In addition 
to delivering essential metabolic components, the choriocapillaris also serves as a 
clearance system that removes waste products produced by photoreceptors and RPE 
during the visual and retinoid cycles [35]. 
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Figure 2.3 The retinal pigment epithelium performs numerous functions to maintain the 
homeostatic status of both photoreceptors and the choriocapillaris including light 
absorption, protein/ion management, recycling of visual cycle components, phagocytosis 
of photoreceptor outer segments, and polarized growth factor secretion. Reprinted with 
permission from Strauss 0 . The retinal pigment epithelium in visual function. 
Physiological Reviews 2005;85:845-81. http: //physrev.physiology.org/content/85/3/845 
Copyright 2005 the American Physiological Society. 
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Figure 2.4 (A&B) Surface morphology of human Bruch's membrane (BrM) imaged 
using scanning electron microscopy and (C) cross-section of mouse BrM imaged using 
transmission electron microscopy. The five layers depicted are: 1, RPE basement 
membrane; 2, the inner collagenous layer; 3, the middle elastic layer; 4, the outer 
collagenous layer; and 5, the basement membrane of the choriocapillaris (CC). 
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2.2 Age-Related Macular Degeneration 
2.2.1 Disease Prevalence & Risk Factors 
AMD is the leading cause of blindness in people over the age of 50 in the 
developed world [1 ,2]. Already affecting 1.75 million people in the United States, 
prevalence of the disease is expected to increase to 2.95 million by 2020 due to a rapidly 
aging population [36]. AMD is a multi-factorial disease that causes progressive central 
vision loss as photoreceptors in the macula degenerate. The most important risk factor for 
AMD is age (Figure 2.5); however, smoking [37], race [38], obesity [39], and genetic 
polymorphisms [ 40] have also been implicated as factors. AMD is divided into two 
distinct types, dry (geographic atrophy) and wet (choroidal neovascularization) which 
have the same end result, progressive central vision loss. Though less prevalent overall, 
wet AMD accounts for approximately 67% of the most severe "late" disease cases and is 
responsible for 80% of all AMD-associated blindness [41]. Fortunately, there are several 
pharmacological treatments for the wet form which are effective at slowing the disease. 
Alternately, there are no therapies currently available for the dry form [3]. 
~ c 
-
AMD Prevalence (Framingham Study) 
52-64 65-74 
Age (years) 
75-85 
Figure 2.5 Increasing prevalence of AMD with age based on data from [243]. 
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2.2.2 Disease Progression 
Dry AMD is the more prevalent, but slowly-progressing form of the disease 
characterized by RPE apoptosis and subsequent photoreceptor degeneration. The earliest 
clinically-observable hallmark of dry AMD is drusen formation which can be viewed 
using fundoscopy or optical coherence tomography (OCT) [ 42]. Drusen are extracellular 
accumulations of lipids, proteins, and carbohydrates that form in or on BrM (Figure 2.6). 
While drusen composition can be quite heterogeneous, major components typically 
include esterified cholesterol, apolipoprotein E, complement system proteins, vitronectin, 
and tissue inhibitor ofmetalloproteinase 3 [43,44] . Over time, RPE cells on top of drusen 
die and no longer perform the numerous metabolic functions required to maintain healthy 
photoreceptors and vasculature causing subsequent retinal degeneration and vision loss 
[ 45]. At the same time as RPE are becoming dysfunctional and apoptotic, BrM also 
undergoes structural alterations including thickening and cross-linking of ECM 
components which likely contribute to disease escalation [9,46]. A depiction of AMD-
associated outer retinal changes can be seen in Figure 2. 7. 
Although the underlying cause and cellular origins of drusen (RPE, blood, etc.) 
remain unclear, one current theory is that cumulative oxidative stress contributes to 
decreased RPE function and downstream drusen deposition. In this theory, a lifetime of 
oxidative stress in a high oxygen, light-rich environment has reduced the ability of RPE 
to fully process photoreceptor outer segments [ 4 7]. As a result, RPE cells excrete 
incompletely degraded byproducts that are unable to pass through BrM [8,48] and be 
cleared by the vasculature [ 49]. Instead these deposits grow and coalesce to further 
16 
exacerbate RPE and photoreceptor function. 
Wet AMD begins when blood vessels from the choriocapillaris breach BrM and 
grow into the outer retina. This process preferentially occurs in the macula where BrM 
has evolved to be thinner and more porous in order to minimize transport barriers [ 17]. 
These immature vessels leak fluid and evoke an inflammatory response that causes retinal 
scarring and degeneration. This process may proceed quickly, and in some cases, 
substantial vision loss can occur within weeks. Fortunately, several FDA approved anti-
VEGF agents are effective in treating wet AMD including ranibizumab (Lucentis by 
Genentech), bevacizumab (Avastin by Genentech), and aflibercept (Eylea by Regeneron). 
These treatments, which require periodic injection into the eye, inhibit blood vessel 
ingrowth to stop leakage and prolong vision [50]. 
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Figure 2.6 Drusen accumulation and Bruch's membrane cross-linking in AMD. 
Reproduced with permission from Johnson LV, Anderson DH. Age-related macular 
degeneration and the extracellular matrix. New England Journal of Medicine 
2004;351:320-2, Copyright Massachusetts Medical Society. 
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\ b Cro~-~ection of human eye 
d e Neova~cular AMD 
Figure 2. 7 Diagram of (A) normal retina architecture and (B) macular location within the 
eye. (C) Depiction of drusen and inflammation in early dry AMD potentially leading to 
(D) geographic atrophy (late dry AMD), in which RPE have been lost, or (E) choroidal 
neovascularization, (wet AMD) in which blood vessels invade the neural retina. 
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Immunology 
13:438-51 , Copyright 2013. 
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2.2.3 AREDS Classifications 
Dry AMD diagnosis and treatment is complicated by the fact that not all drusen 
are associated with pathological vision loss. Small drusen ( <63 !liD) are observed in most 
people at advanced age and are considered a normal part of aging [51]. However, larger 
and more numerous drusen have been correlated with a higher likelihood of progression 
to late AMD. The Age-Related Eye Disease Study (AREDS), a multi-center research 
effort, has put forth an initial classification scheme that aims to standardize dry AMD 
diagnosis. This grading system is: category 1 (no AMD), none or a few small drusen; 
category 2 (early AMD), fewer than 20 medium drusen 63-125!1-m in diameter when 
viewed via fundoscopy; category 3 (intermediate AMD), more than 20 medium drusen, at 
least one large (>125!1-m) druse, or geographic atrophy outside the fovea; and category 4 
(advanced) AMD, foveal geographic atrophy [1]. 
Higher AREDS categories correspond to increased risk of progression to the 
harmful late stage, but fall short of being predictive. Only 3% of patients classified as 
AREDS category 1 progress to late AMD within 5 years while 43% of those in category 
4 advance to late AMD within 5 years. Though this system has been marginally improved 
since it was introduced (0.3-53.2% 5-year progression in categories 1-4), it still leaves 
much to be desired [13]. Some patients progress quickly to severe vision loss while 
others never progress suggesting that drusen diameter alone is insufficient to accurately 
predict patient outcomes. Overall progression is low as just 4% of AMD patients progress 
to late AMD each year, so many patients may receive a seemingly worrisome diagnosis 
of early AMD while never experiencing appreciable vision loss [ 4]. In summary, while 
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helpful for standardizing diagnosis, the AREDS classification system has little, if any, 
power as a prognostic tool. 
2.2.5 Fundoscopy & Optical Coherence Tomography 
Fundoscopy and OCT are the two most common imaging modalities used to 
clinically assess AMD. Taken with light passed through a dilated pupil, fundus 
photographs provide an en face view of the retina including a clear "top-down" view of 
the macula, retinal vessels, and the optic nerve. This technique is the standard approach 
for AMD diagnosis and observation because it is non-invasive and inexpensive. Images 
collected using this method can be used to quantify the number and size of yellow 
regions that indicate hypopigmentation of RPE above drusen [52]. Fundus images of eyes 
with no pathology, early AMD, geographic atrophy, and choroidal neovascularization can 
be seen in Figure 2.8. 
Spectral-domain OCT is a more recently developed technique that has quickly 
gained widespread use for its ability to non-invasively image into the depth of a patient's 
retina (Figure 2.9) [53]. This imaging modality produces high resolution cross-sectional 
images through the entire retina down to the choroid, termed B-scans. These scans are 
collected in a spatially-sequential manner spanning the area of the macula and can be 
used to measure drusen height, sub-retinal fluid, and retinal thinning (i.e. degeneration) 
[54]. While OCT image analysis is typically used to qualitatively evaluate retinal 
morphology in AMD, there are numerous efforts currently underway to quantify and 
automate OCT analysis to improve diagnosis [55-57]. 
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Figure 2.8 Fundus images of (A) a normal eye, (B) an eye with early dry AMD, (C) an 
eye with late dry AMD, and (D) an eye with wet AMD. Arrows in B indicate 
hypopigmentation of RPE signifying drusen locations. The black asterisk in C indicates a 
large area of geographic atrophy (RPE death). The white asterisks in D denote blood that 
has leaked into the retina due to choroidal neovascularization. Images provided by Dr. 
Rizwan Haq, Massachusetts General Hospital, Boston, MA. 
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Figure 2.9 Labeled OCT B-scan into the depth of the retina in a (A) healthy eye and (B) 
eye with large drusen. 
2. 2. 6 AA!D Treatment Strategies 
While anti-VEGF therapies are effective at treating many patients with wet AMD, 
there is currently no treatment available for the dry form [3]. Because dry AMD is likely 
a group of diseases that lead to the same eventual pathology, identification and 
exploitation of druggable pathways will likely help only a subset of patients. However, 
cell-based therapies may offer hope for patients with all subcategories of dry AMD by 
introducing healthy engineered tissue to restore function. Since AMD is the result of 
accumulating age-related damage, these new "young" cells that have not sustained a 
lifetime of stressors will likely remain functional for the patient's remaining years. 
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Photoreceptor replacement, though attractive for its potential to reverse vision 
loss rather than stop disease progression, is unlikely to be successful in treating AMD as 
photoreceptor death is secondary to the loss of RPE [58]. Further, photoreceptor 
replacement is unlikely to be realized in the near future because of researchers' inability 
to maintain these cells in vitro [59] and poor understanding of neural integration [60]. 
Instead, RPE replacement is thought to be a more appropriate strategy for the treatment 
of dry AMD [5]. Fortunately, because AMD is frequently detected years before 
substantial vision is lost, there is a large time window for intervention. As both RPE and 
photoreceptors are quiescent in the adult, an external cell source will be required [ 61]. 
Adult cadaveric RPE [62], fetal RPE [63] , induced pluripotent stem cell (iPSC)-derived 
RPE [64], human embryonic stem cell-derived RPE [65], and retinal progenitor cells [66] 
have all been proposed as potential sources. While the healthy retina is considered 
immune privileged, AMD-related damage to BrM and the RPE likely compromise the 
immunological barrier. Therefore, autologous iPSC-derived RPE may be the most 
attractive ofthese options. 
One of the earliest studies aimed at cell-based therapy for AMD used a sub-retinal 
injection of RPE in suspension. This approach failed as cells exhibited poor survival, 
little engraftment, and no discemable function [ 5]. Further, this strategy also fails to 
address pathological changes to the host microenvironment including BrM thickening, 
cross-linking, and drusen accumulation [6]. Even in vitro, healthy RPE seeded onto aged 
or diseased BrM demonstrate a dramatic decline in cell behavior, gene expression, and 
function [67-69]. As a result, recent studies have focused on the use of scaffolds to 
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deliver a confluent monolayer of mature RPE and thereby enhance transplantation 
outcomes [70]. A variety of supports for delivering RPE have been proposed including 
re-surfaced BrM [46], amniotic membrane [71], and synthetic scaffolds [72,73]. 
Unfortunately, these approaches have yielded limited success due to some combination of 
poor cell adhesion, insufficient mechanical properties, and poor sub-retinal 
biocompatibility. 
2.2. 7 RPE Transplantation Design Criteria 
Although previous studies have clearly demonstrated the benefit of scaffolds for 
RPE delivery compared to scaffold-free approaches, existing scaffold design is far from 
optimal. However, these studies have helped to define the scaffold characteristics that are 
necessary for effective RPE transplantation. These scaffolds must ( 1) support RPE 
function, (2) exhibit sub-retinal biocompatibility, (3) allow for trans-scaffold diffusion, 
( 4) minimally displace adjacent tissues, (5) contain minimal surface topography, and (6) 
possess sufficient bulk properties for surgical handling. In order to be beneficial as an 
RPE scaffold the substrate must first promote cell adhesion and function. Ideally, RPE 
cultured on the candidate scaffold would closely match the size, morphology, gene 
expression profile, and numerous functions of native cells. 
Identifying biodegradable synthetic materials with appropriate sub-retinal 
biocompatibility has been surprisingly difficult due to the retina's sensitivity to 
degradation products. Poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) 
were two of the first materials proposed for supporting RPE delivery [72,74]. However, 
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despite their classification as generally biocompatible [75] both materials elicit 
widespread retinal degeneration when implanted in the sub-retinal space [10,11). This 
lack of tissue-specific biocompatibility is likely due to rapid degradation of these 
polymers (typically 1-18 months [76]) which leads to a buildup of acidic degradation 
products in the small sub-retinal space [77]. These products lower the local pH leading to 
inflammation and retinal cell death. As a result, recent sub-retinal implant studies have 
focused on non-degradable or slowly degrading polymers including poly(methyl 
methacrylate) [10,78), parylene-C, poly(ethylene glycol) [79], poly(£-caprolactone) 
(PCL) [80,81] and poly(glycerol sebacate) [82). In particular, PCL has demonstrated 
good sub-retinal biocompatibility in mice and pigs [11,80). Although PCL, like PLA and 
PLGA, degrades via hydrolytic cleavage of ester bonds [83), this occurs more slowly 
(typically over greater than 3 years [84,85]) and produces degradation products that are 
comparatively less acidic [76]. These differences help to minimize local alterations in pH 
and any associated inflammatory response [75]. 
After RPE support and biocompatibility, additional scaffold design criteria are 
intended to enhance the engineered tissue by mimicking native BrM properties. Scaffold 
permeability is required to maintain metabolite and waste exchange between the 
choriocapillaris and outer retina [86]. A minimal scaffold footprint near the thickness of 
BrM (1-4)lm) [31] will also be beneficial to minimize the barrier to transport [87]. In 
addition, a thin scaffold will also reduce adjacent tissue displacement thus preventing 
deformation of the soft neural retina which could cause visual abnormalities. Minimal 
(sub-micron) topography will also likely be beneficial as larger features have been shown 
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to induce irregular focal adhesion formation and may cause drusen-like RPE deformation 
[ 14,88]. Lastly, sufficient handling properties are necessary as a practical requirement 
since surgeons must be able to deliver the cell-seeded scaffold into the sub-retinal space 
without compromising construct integrity. This requirement, in concert with minimal 
scaffold thickness, limits the potential of soft hydrogels since these thin, weak materials 
would not maintain integrity during the process of implantation. 
2.3 Transport in the Retina 
2.3.1 Diffusion through Bruch's Membrane 
Insufficient metabolite delivery was first suggested as a possible mechanism of 
action in AMD during the very first description of drusen in AMD [89]. Metabolites and 
waste readily diffuse through BrM in their path between the choriocapillaris and the outer 
retina. While serum proteins up to 500 kDa are able to diffuse through BrM from young 
patients, BrM isolated from older patients show a lower molecular weight cut-off around 
200 kDa [ 48]. Further, overall permeability of BrM decreases drastically from about 
280J.lg/mm2 per day at age 10 to 50J.lg/mm2 per day at age 80-a nearly 6-fold reduction 
[ 48]. Another study observed a similar reduction in transport with age by tracking the 
diffusion of 21.2 kDa fluorescein isothiocyanate (FITC)-labeled dextran through BrM 
[90]. This study observed a 93.5% decrease in flux through sub-macular BrM between 
the first and ninth decades of life. Aging has an even more severe effect on fluid transport 
through BrM as hydraulic conductivity exponentially decays after the age of 19 resulting 
in just 2.2% of original conductivity at age 90 [90]. While drusen may contribute to 
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decreased permeability, reduction in protein and fluid flux was observed even in young 
and middle-aged samples free of drusen suggesting that BrM cross-linking and 
thickening also play major roles in reducing transport. 
2.3.2 Oxygen Diffusion 
The outer retina is one of the most metabolically active tissues in the body [20] 
and oxygen is well known to be its limiting metabolite [ 19]. In fact, the retina has the 
greatest oxygen demand per gram of any tissue in the body, including the brain [91]. The 
majority of this oxygen is consumed within the photoreceptor outer segment where 
densely packed mitochondria produce ATP via aerobic respiration [92-94]. Because a 
majority of the photoreceptor's energy is spent on maintaining the dark current, the 
amount of oxygen consumed in the outer retina may increase as much as 2.8-fold in the 
dark [95]. In the dark-adapted retina a majority (90%) of oxygen is supplied by the 
choriocapillaris while the remaining oxygen is supplied by the deep retinal vasculature 
[96,97]. To combat the retina's high rate of oxygen consumption, the choroid has evolved 
methods to maximize transport. For example, choroidal blood flow is not auto-regulated 
in response to hypoxia, but rather maintains a consistently high flow rate to minimize the 
drop in oxygen concentration along the vascular plexus. The result is a minute 1% drop in 
oxygen content between arteriole and venule [98,99]. Consequently, the barrier to oxygen 
delivery in AMD and other retinal diseases is not poor blood perfusion, but rather by 
oxygen solubility [12]. 
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2.3.3 Hypoxia in Retinal Disease 
The photoreceptor inner segment layer, where most oxygen in the outer is 
consumed, is distant from its main oxygen supply, the choriocapillaris. Further, because 
hemoglobin is confined to red blood cells within blood vessels, only dissolved oxygen 
travels to the inner segment despite the highly oxygen-buffered blood. This step severely 
limits the amount of oxygen that can be delivered as only about 2% of the total oxygen 
content of blood is in the form of soluble oxygen while the remaining 98% is bound to 
hemoglobin [100]. Dissolved oxygen is highest at the chorioretinal interface where it is 
solubility-limited as a function of the partial pressure of oxygen. Oxygen at this location 
then travels down a concentration gradient through the RPE and photoreceptor outer 
segments (which in comparison have very low metabolic requirements) before it reaches 
the photoreceptor inner segment and is consumed. Although only 50-60Jlm from the 
choriocapillaris [33] and therefore well within the 200Jlm from a blood vessel that is 
typically considered the upper limit for nourishment, the high metabolic requirements of 
photoreceptors results in near depletion of oxygen at steady state [101] . Animal studies 
using rats [102], cats [103], and non-human primates [104] have shown that the partial 
pressure of oxygen drops substantially between the choroid and photoreceptor inner 
segment even under healthy conditions. Two studies quantified this drop and estimated 
that the partial pressure of oxygen dropped from 80 mmHg at the chorioretinal interface 
to 2 mmHg in the photoreceptor inner segments layer [105,106]. While minimal excess 
oxygen may be evolutionarily beneficial to reduce oxidative stress, this tight regulation 
may lead to problems with advancing age [33]. 
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Numerous studies have shown that the regulation of oxygen concentration 1s 
critical for maintaining retinal cell homeostasis [87,107] and several groups have 
proposed oxygen deficiency as a key player in several degenerative retinal diseases 
including AMD [33,108-110], macular edema [111,112], and retinal detachment [113-
115]. The theory of hypoxia-induced retinal degeneration underlying vision loss is 
supported by a growing amount of in vitro, in vivo, ex vivo, and clinical evidence. 
Because oxygen concentration at the inner segment is so tightly-regulated, it is not 
unreasonable to hypothesize that disease-related morphological changes in retinal 
structure can disrupt this balance of supply and consumption. Drusen, for example, 
frequently double or triple the distance that oxygen must diffuse between the choroid and 
photoreceptor inner segment. Similarly, central serous retinopathy, macular edema, and 
retinal detachment can also produce increases in diffusion distance due to blood or fluid 
leakage beneath the retina [86, 111, 116]. 
The retinal hypoxia hypothesis also helps to explain why AMD occurs 
preferentially in the macula. First, there is no retinal vasculature in the macula, so all 
oxygen is supplied by the choriocapillaris [33]. Second, the volume of photoreceptor 
inner segments is larger in the macula due to dense packing of large color-sensitive cone 
photoreceptors [33, 177]. Finally, the color-sensitive cone photoreceptors that are found 
almost exclusively in the macula have higher metabolic needs due to their higher light 
activation threshold (i.e. the more costly dark current is "on" more often) [33,118]. An 
interesting, if not unfortunate, caveat is that BrM is thinner and more porous in the 
macula which minimizes diffusion barriers, but may ultimately contribute to this area's 
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susceptibility to wet AMD [33,93,119] . 
Wet AMD is likely the body's natural angiogenic response to hypoxia. Though 
helpful in a majority of the body, this response is deleterious when targeted to neuronal 
tissue [120,121]. When challenged with insufficient oxygen, cells of the retina attempt to 
increase vascular density and perfusion through a hypoxia-inducible factor 1 and VEGF-
dependent pathway [122]. In wet AMD, this pathway achieves its purpose of 
vascularizing hypoxic tissue, but to disastrous ends as vessel growth from the choroid 
leads to leakage, edema, and rapid vision loss. 
While the cascade of harmful events in wet AMD is rapid and immediate, the 
effects of dry AMD are more gradual and less severe. In dry AMD it appears that 
hypoxia induces photoreceptors to first enter a temporary state of reduced metabolism 
and function before chronic hypoxia leads to apoptosis. This two-stage process may also 
occur in other retinal pathologies. In central serous retinopathy, vision is lost while sub-
retinal fluid is present, but is fully recovered if the condition is resolved within four 
months. Alternately, if the condition persists longer and is resolved after more than four 
months there is some permanent vision loss [123]. The same delay in unrecoverable 
vision loss is seen in cases of macular edema that last for longer than 6-9 months [124] . 
Therefore, retinal hypoxia may not lead to photoreceptor apoptosis in days or weeks, but 
rather in months or years with the speed of progression corresponding to the degree of 
hypoxia-a hypothesis that is congruent with clinical observations. 
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2.3.4 Therapeutic Oxygen Supplementation 
Multiple studies have shown the benefits of oxygen supplementation in retinal 
disease. The goal of oxygen supplementation is to achieve normal oxygen delivery 
despite a pathological barrier. When the retina is separated from the choriocapillaris due 
to disease, oxygen must travel farther before being consumed. This increase in distance 
causes a decrease in delivery as the gradient is elongated according to Fick's laws of 
diffusion. Even though no oxygen is being consumed by the druse or sub-retinal fluid, 
less oxygen is being delivered because the same concentration difference is being spread 
out over a longer distance [87]. Oxygen supplementation uses an increase in the partial 
pressure of inhaled oxygen to raise the solubility of oxygen in body fluid. This change 
increases the amount of oxygen that can exit the choriocapillaris to counteract the effect 
of increased diffusion distance and achieve oxygen delivery despite the pathological 
barrier (Figure 2.1 0) [87] . 
This approach has been well-studied in animal models of disease and even in 
small clinical trials. In one study, 14 patients with advanced AMD demonstrated a 
significant improvement in visual acuity and/or visual field when treated with hyperbaric 
oxygen [ 116]. A similar study of patients with diabetic macular edema showed reduced 
retinal thinning when treated with oxygen supplementation [111]. Still another study 
demonstrated improved visual acuity in patients with cystoid macular edema when 
treated with periodic hyperbaric oxygen [112]. Oxygen supplementation also exhibited 
the same beneficial effect on visual function in animal models of retinal detachment 
[113-115] . 
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Figure 2.10 False color OCT image of a detached retina oriented with the right side 
facing the vitreous. Overlaid red graphs represent the drop in oxygen between the choroid 
and inner segments at their respective locations. Note that the bottom graph represents the 
normal location while the top depicts a retinal detachment that decreases oxygen delivery 
even though there is no consumption in this area. The white line depicts the goal of 
oxygen supplement which aims to increase the partial pressure of oxygen (and thus 
dissolved oxygen content) to achieve sufficient oxygen delivery to the inner segment. 
Reprinted from Progress in Retinal and Eye Research, 30, Stef{msson E, Geirsd6ttir, 
Sigurdsson H, Metabolic physiology in age related macular degeneration, 72-80, 
Copyright 2011 , with permission from Elsevier. 
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3.1 Pore-Cast Scaffold Fabrication 
3.1.1 Summary 
3.METHODS 
Pore casting IS a novel technique developed by our group [ 125] that uses 
photolithography, deep reactive 10n etching (DRIE), and spin-assisted templating to 
create thin porous scaffolds for tissue engmeenng. This approach has sub-micron 
resolution, is compatible with a variety of commonly used biomaterials, and allows for 
user-defined pore shape, size, and location. A computer-aided design program was used 
to design a photomask pattern of two-dimensional (2D) features that was then transferred 
into photoresist on a silicon wafer. The wafer was then etched vertically causing the 
pattern to extend into the depth of the silicon. After reaching the appropriate etch depth, a 
PCL solution was deposited onto the silicon wafer and spun at high speed to produce a 
solid polymer film of uniform thickness . The film was then submerged in water and 
slowly peeled using forceps. Because the film was thinner than the height of the features 
on the mold, the mold's features imprinted full-penetrating pores where polymer was 
displaced by silicon. A summary of the pore casting process is depicted in Figure 3 .1. 
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Figure 3.1 Pore casting scaffold fabrication process. The surface of a surface-oxidized 
silicon wafer was (A) coated with photoresist and (B) exposed to deep ultraviolet light 
through a photomask for pattern transfer. (C) Unexposed photoresist was developed away 
yielding bare silicon that was subsequently (D) removed using RIE. (E) Remaining 
protective photoresist was then removed to produce a silicon master mold with 
cylindrical features. (F) A PCL solution was deposited onto the mold and spun at high 
speed to create a thin solid polymeric film. (G) After solvent evaporation the film was 
peeled from the mold to yield a porous polymeric scaffold. Reprinted from Springer and 
the Journal of Materials Science: Materials in Medicine, 24, 2013, 1659-70, A novel 
porous scaffold fabrication technique for epithelial and endothelial tissue engineering, 
McHugh KJ, Tao SL, Saint-Geniez M, Figure 1, Copyright 2013 with kind permission 
from Springer Science and Business Media. 
3.1.2 Photolithography 
Photomask patterns were produced using L-Edit (Tanner EDA Software Tools, 
Monrovia, CA). In total, three patterns were produced: (1) a square array of circles lJ.!m 
in diameter with 5J.!m center-to-center spacing, (2) a square array of circles 2J.!m in 
diameter with 5J.!m center-to-center spacing, and (3) a staggered array of rectangles 
l.4J.!m x 10.4J.!m with 8.6J.lm horizontal spacing, 9.6J.lm vertical spacing, and 0.4J.!m 
35 
overlap at each end. These patterns can be seen in Figure 3.2. Once completed, the design 
files were sent to Toppan Photomasks (Santa Clara, CA) where they were printed as a 
quartz photomask with transparent circles on an opaque chrome background. 
• • • • • • • • • • • 
• • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • 
• • • 
. . . . . . [ 
• • • • • • 
• • • 
• • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
·s· • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
• • • • • • • • • • • • • 
c 
I I I I I I I I I I I I I 
I I I I I I 
..... 
~m 
Figure 3.2 Photomask patterns with (A) circles 1 ~-tm in diameter and 5 ~-tm spacing in a 
square array, (B) circles 2~-tm in diameter with 5~-tm spacing in a square array, and (C) 
rectangles 1.4~-tm x 10.4~-tm in a staggered array. 
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Photolithography was used to transfer the array of features from the photomask to 
a photoresist-covered silicon wafer suitable for DRIB in a clean room at Draper 
Laboratory or Boston University. The following procedure was used when processing 
wafers at Draper Laboratory. Boron-doped silicon wafers with 5000A of thermally-
grown silicon dioxide on their surface were purchased from University Wafer (South 
Boston, MA). Once cleaned and inspected, the wafers were coated with a thin layer of 
hexamethyldisilazane using an EVG 101 Advanced Resist Processing System (EV Group, 
Albany, NY) to serve as an adhesion promoter. They were then baked at 90°C on a hot 
plate for 1 minute, and subsequently coated with approximately 3000A of ma-N 2403 
(Micro Resist Technology GmbH, Berlin, Germany), a negative photoresist. Wafers were 
then soft baked at 1 00°C on a hot plate for 1 minute to remove excess solvent. After 
cooling, wafers were loaded one at a time beneath the patterned photomask under 
vacuum contact and exposed to deep ultraviolet light (220nm) for a total dose of 260 
mJ/cm2. Photoresist exposed to light through transparent areas in the photomask was 
cross-linked, while areas of photoresist beneath opaque chrome remained uncross-linked. 
Uncross-linked photoresist was then removed by developing in a solution of 5:1 
Microposit MF-319 (Shipley Company, Marlborough, MA) to water for 60 seconds and 
hard baked in an oven at 1 00°C for 30 minutes. A similar photolithography process was 
performed in the Boston University Photonics clean room using slightly different 
methods as detailed in Table 3 .1. 
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Table 3.1 Photolithography parameters at Draper Laboratory and Boston University 
Draper Boston University 
HMDS Yes Yes 
Ramp (RPM/s) 1000 1000 
Ramp Time (s) 4 3 
Speed (RPM) 4000 3000 
Time (s) 10 30 
Photoresist ma-N 2403 ma-N 1405 
Ramp (RPM/s) 1000 1000 
Ramp Time (s) 3 3 
Speed (RPM) 3000 3000 
Time (s) 20 30 
Soft Bake Apparatus Hot Plate Hot Plate 
Soft Bake Temperature (°C) 100 100 
Soft Bake Time (s) 60 60 
Peak Exposure Wavelength (nm) 220 365 
2 Exposure Dose (mJ/cm ) 260 200 
Developer 5:1 MF-319:H20 AZ300 MIF 
Development Time ( s) 60 120 
Hard Bake Apparatus Oven Oven 
Hard Bake Temperature (°C) 100 100 
Hard Bake Time (min) 30 30 
3.1.3 Wet Etching 
Silicon dioxide was etched in one of two ways depending on the clean room 
facility used. In the Draper Laboratory Clean Room, a 4 minutes and 15 seconds RIE 
processes was run using a platen power of 130W under a flow of 20 ml/min CHF 3 and 30 
ml/min CF4 at a pressure of 200 mTorr to etch through 5000A of silicon oxide in regions 
not protected by overlying photoresist. In the Boston University Photonics clean room, 
this process was replaced by a 4 minute and 30 second wet etch in 6:1 Buffered Oxide 
Etch (JT Baker, Center Valley, PA) at room temperature to remove JOOOA of unprotected 
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silicon dioxide. The latter approach was found to be highly variable with temperature and 
caused significant undercutting due to the angle of etching which substantially decreased 
feature size. 
3.1. 4 Deep Reactive Ion Etching 
DRIE was performed using an STS ASE HRM (Surface Technology Systems, 
Newport, United Kingdom) for 74 cycles of alternating etch and passivation steps with 
each cycle etching further into the unprotected surface of the wafer. The etch step recipe 
used 17W platen power, 600W electron cyclotron resonance (ECR) power, and a flow of 
130 ml/min SF6 with 13 mVmin Oz for 8 seconds at 20 mTorr. The passivation step used 
OW platen power, 600W ECR power, and a flow of 90 mVmin C4Fs for 5 seconds at 20 
mTorr. Again, different etch parameters were used in the Boston University Photonics 
clean room as described in Table 3.2. After a sufficient etch depth had been achieved, the 
wafer was treated with oxygen plasma in a March Asher PX-250 (Nordson, Westlake, 
OH) for 10 minutes at 200W and 150 mTorr to remove any remaining photoresist. The 
wafer was then placed in a buffered oxide etch (7: 1 v/v of 40% NH4F in water to 49% HF 
in water) for 8 minutes to strip the silicon oxide layer. Finally, wafers were cleaned in 
piranha solution (3: 1 v/v of HzS04 to 30% HzOz) for 20 minutes prior to polymer 
spmmng. 
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Table 3.2 Etching parameters at Draper Laboratory and Boston University 
Draper Boston University 
Silicon Dioxide Etch 
Etch Type RIE (Dry) 6:1 Buffered Oxide (Wet) 
Platen Power (W) 0 
Coil Power (W) 130 
Pressure (mTorr) 200 
Gas 1 CHF3 
Gas 1 Flow Rate (seem) 20 
Gas2 CF4 
Gas 2 Flow Rate (seem) 30 
Time (s) 255 270 
Silicon Etch 
Etch Type DRIE DRIE 
Cycles 74 89 
Etch Phase 
Platen Power (W) 17 20 
Coil Power (W) 600 600 
Pressure (mTorr) 20 8 
SF6 Flow Rate (seem) 130 132 
0 2 Flow Rate (seem) 13 13 
Time (s) 8.0 8.5 
Passivation Phase 
Platen Power (W) 0 0 
Coil Power (W) 600 600 
Pressure (mTorr) 20 12 
C4F8 Flow Rate (seem) 80 40 
Time (s) 5.0 3.0 
3.1.5 Spin-Assisted Polymer Templating 
A polymer solution of 2:15 w/v PCL in dichloromethane was stirred vigorously 
for 3 hours. Prior to polymer application, the wafer was treated with oxygen plasma in a 
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March Asher for 20 minutes at 150W to create a thin oxide layer and thereby increase 
surface hydrophilicity. The silicon mold was then coated with 10ml of the PCL solution 
and immediately spun on a CElOO Spinner (Brewer Science, Rolla, MO) at a ramp of 500 
RPM/second and a top speed of 1500 RPM for 30 seconds causing the polymer solution 
to thin and solidify on the mold as the remaining solvent evaporated. Next, the mold and 
adherent film were place into an oven at 67°C for 15 minutes tore-flow the polymer and 
allow for any local areas of heterogeneous thickness to resolve. After the wafer and 
adherent film passively cooled to room temperature (27°C), they were placed in a March 
Asher and treated with oxygen plasma for 20 minutes at 200W and 150 mTorr to remove 
polymer aggregation on the tips of features. Finally, the film was removed from the wafer 
by slow and careful peeling from the wafer edge using tweezers to grip the unpattemed 
regions of film. In some cases the films could be peeled without the final oxygen plasma 
treatment. A subset of films had their thickness measured prior to their removal from the 
wafer using an Alpha Step 500 Profiler (KLA-Tencor, Milpitas, CA). 
3.2 Electrospun PCL 
PCL was electrospun onto a slowly-rotating mandrel to increase mesh uniformity 
without inducing fiber alignment. Fiber diameter was tuned by altering the weight-by-
volume (w/v) percent of polymer in solvent, solvent composition, gauge of the dispensing 
needle, solution flow rate (ml/hour), applied voltage differential, and distance between 
the needle tip and collection surface. Different electrospinning parameters and the 
resulting fiber dimensions are listed in Table 3.3. In the formulation used for cell culture, 
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PCL (Mn 70,000-90,000) was dissolved in a 5: 1 chloroform-to-methanol ratio to form a 
solution that was 12% w/v. This solution was then dispensed at 10 ml/hour onto the 
collection mandrel at a working distance of 12cm using an applied voltage of 15 kV. 
Table 3.3 Electrospinning parameters 
Fiber Diameter %PCL Voltage Distance Flow Rate Solvent Comments 
(f.lm) (w/v) (kV) (em) (mllhr) 
3.68 ± 0.57 12 15 12 10 5:1 CHCI3:MeOH No beads 
1.09 ± 0.57 12 11 12 3 5:1 CHCI,:MeOH Little beading, some very large fibers 
1.37 ± 1.25 11 7.5 11 I 5:1 CHCI3:MeOH Tube-like beading 
1.79 ± 1.34 11 7.5 11 2 5:1 CHCI,:MeOH Subslantial beading 
1.46 ± 0.90 II 7.5 II 3 5:1 CHCI,:MeOH lbickened fibers 
1.66± 0.62 13 8 12 5:1 CHCI,:MeOH Thick, but boroogenous fibers 
2.18±0.51 13 7.5 12 2 5: 1 CHC I3:MeOH lbick, but hormgenous fibers 
1.52 ± 0.45 13 11 12 3 5:1 CHCI,:MeOH lbick, but homogenous fibers 
0.57 ± 0.37 10 12 16.5 7: 1 CHCI,:MeOH Many beads 
0.95 ± 0.73 10 20 24 7:1 CHCI, :MeOH Many circular beads 
1.77 ± 1.46 12 22 24 7:1 CHC I3:MeOH Some beading 
1.41 ± 0.87 14 22 24 7:1 CHCI:J :MeOH Two populations of fiber thickness 
1.87 ± 1.70 II 12 16.5 7:1 CHC!3:MeOH Minor beading, large fibers 
0.81 ± 0.47 11 20 24 7:1 CHCI:J:MeOH Large beads, very srrall fibers 
0.45 ± 0.18 9 20 24 8 7:1 CHC I3:MeOH Large beads, very srra ll fibers 
0.59 ± 0.30 10 20 24 8 7:1 CHCI,:MeOH Large beads, very srrall fibers 
0.74 ± 0.29 5 10 10 7 HFIP Mostly small fibers, but some thicker fibers 
1.22± 0.54 7 10 10 7 HFIP No beading, fibers a little too large 
1.2 ± 0.58 5 8 10 3 HFIP No beading, fibers a little too large 
0.87 ± 0.3 5 10.5 15 3 HFIP Somo beading, mil< ofnano- and micro-fibers 
1.13 ± 0.72 5 10 10 5 HFIP Beading 
0.94 ± 0.73 5 12 15 5 HFIP Beading, mil< of nano- and micro-fibers 
0.94 ± 0.61 13.5 15 7 HFIP Beading, many nanofibers, but somo large fibers 
1.80 ± 0.29 7 9 10 HFIP No beading, fibers too large 
1.12 ± 0.68 12 15 HFIP No beading, fibers a little too large 
1.77 ± 0.25 10 10 5 HFIP No beading, fibers too large 
1.31 ± 0.68 7 13 15 5 HFIP No beading, fibers a little too large 
1.66 ± 1.08 7 13.5 15 7 HFIP No beading, fibers too large 
0.355 ± 0.13 4 I HFIP Beading, very small fibers 
0.52 ± 0 .23 4 6.5 6 3 HFIP Beading, small fibers 
0.53 ± 0.31 4 8 8 3 HFIP Beading, srrall fibers 
0.65 ± 0.31 4 8 10 3 HFIP Beading, srrall fibers 
1.09 ± 0.52 5 5.5 5 HF1P Fibers fusing together, mediwn size 
1.16 ± 0.67 9 6 7 HFIP Blotchy fibers, fusing 
1.45 ± 1.51 11 8 7 HFIP Minor beading, mediwn fibers 
0 .75 ± 0.59 5 8 8 7 HFIP A little fusing at fiber intersections, smalllmed fibers 
1.03 ± 0.53 8 7 HFIP A little fusing at fiber intersections, rrediwn fibers 
0.34 ± 0.1 5 15 10 6 3 1:1 DCM:DMF Very blotclty with fused fibers, small fibers 
0.57 ± 0.43 15 12.5 10 1:1 DCM:DMF Very blotchy with fused fibers, small fibers 
0.42 ± 0.45 15 15 16 3 1:1 DCM:DMF BlotchY with fused fibers, small fibers 
1.53 ± 0.71 25 13.5 16 3 1:1 DCM:DMF No beading, medium-thick fibers 
1.12±0.73 25 16.5 19 3 1:1 DCM:DMF No beading, micro- and nano-populations 
Abbreviations- ChlorofOrm (CHCI,), Methanol (MeOH), Hexafluoro-2-propano1 (HFIP), Dichloromethane (DCM), Dirnethylfi:>rmamide (DMF) 
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3.3 Scaffold Characterization 
3.3.1 Scanning Electron Microscopy 
Silicon molds were imaged directly using a Hitachi S-3500N Scanning Electron 
Microscope (SEM) (Gaithersburg, MD) with an accelerating voltage of 5 kV. Scaffolds 
were imaged by mounting samples on aluminum stubs using double-sided copper tape 
and sputtered with approximately 1 Onm of gold-palladium alloy using a Cressington 
108auto Sputter Coater (Watford, United Kingdom) for 25 seconds at 20 rnA with a 
distance of 3cm to prevent surface charging. 
Electrospun scaffold morphology was assessed using ImageJ (National Institutes 
of Health, Bethesda, MD) and Photoshop (Adobe Systems Incorporated, San Jose, CA) 
analysis of SEM images. Briefly, surface pore size was estimated in the XY plane using 
images collected at 250x magnification with 2 kV accelerating voltage. This combination 
of parameters was found to focus on approximately the top three fiber layers which 
correspond to approximately one cell diameter in depth. The threshold function in hnageJ 
was then employed to create a binary discrepancy between fibers and pores for increased 
clarity. The modified image was used to quantify pore size in square microns using a 
known scale. Finally, pore size was represented as the diameter of a circle with 
equivalent area for ease of comparison to pore-cast scaffolds. A total of 100 pores were 
counted across multiple areas to determine pore size distribution. The "Oval Profile" 
plug-in with radial sums for directionality was used to assess potential electrospun fiber 
alignment as described elsewhere [126] . 
For biological imaging, cells were first fixed m a solution of O.IM sodium 
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cacodylate, O.lM sucrose, and 3% glutaraldehyde at room temperature. After 48 hours 
the primary fixative was removed and samples were rinsed twice with a mixture of O.lM 
sodium cacodylate and O.lM sucrose and then stored at 4°C until further use. The 
samples were then dehydrated by sequential treatment with 35%, 50%, 70%, 95%, 100% 
and 100% (again) of ethanol-in-water treatments for 10 minutes each. Dehydration was 
completed by covering samples with hexamethyldisilazane which was allowed to 
evaporate in a chemical fume hood at room temperature. After evaporation was complete, 
samples were attached to stubs and sputter-coated prior to SEM imaging. 
3.3.2 Atomic Force Microscopy 
Atomic force microscopy (AFM) was performed to determine the top surface 
roughness of spin-cast PCL film. A silicon probe with a tip radius of 9 ± 2 nm and spring 
constant of 2 N/m was attached to an MFP 3D Atomic Force Microscope (Asylum 
Research, Goleta, CA). A 90!-lm x 90!-lm area of PCL spun onto a non-patterned silicon 
wafer was measured in contact mode and the root mean square roughness was calculated 
automatically by the Asylum software. 
3.3.3 Protein Diffusion 
Scaffold samples were cut into circles approximately 1 em in diameter and 
submerged in horse serum at 4°C for at least 12 hours prior to the experiment to allow for 
equilibration of non-specific protein adsorption. On the day of the experiment, a 1 0011M 
solution of FITC-dextran in phosphate buffered saline (PBS) was added to the bottom of 
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blind well chambers (Neuro Probe, Gaithersburg, MD). Scaffold samples were then 
retrieved from the serum, rinsed quickly in PBS, and placed atop the FITC-dextran 
solution. The tops of the blind well chambers were then screwed on and washed twice 
with PBS to remove any contamination from the bottom chamber. PBS was then added to 
the top chamber. Samples were subsequently covered with an adhesive tape to eliminate 
evaporation, protected from light, and incubated at 37°C with 5% COz. After one hour of 
incubation, a 1 OOJ..Ll sample was removed from the top of each blind well chamber, read in 
a 96-well plate using a spectrophotometer ( excitation=485/20, emission=528/20), and 
added back to the top blind well chamber. This was repeated every hour for up to 8 hours 
and absolute FITC-dextran concentration in the top chamber was determined using a 
standard curve. The diffusion coefficient of each scaffold was calculated using the 
equation for single membrane diffusion identified by Lee and colleagues [ 127]: 
(V1 +~)(Vz +~) 
T = AV 
Where C2 is the current concentration in the upper chamber, N is the total moles of FITC-
dextran in the system, V is the total volume of the system, Cf is the initial concentration 
in the upper chamber, t is the current time, t 0 is the initial time, D1 the diffusion 
coefficient of the scaffold, h1 is the thickness of the membrane, V1 is the volume of the 
lower chamber, V2 is the volume of the upper chamber, and A is the exposed surface area 
of the scaffold. These equations were rearranged and coded into MA TLAB (Math Works, 
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Natick, MA) to solve for the diffusion coefficients of track-etched polyester and pore-cast 
PCL (Appendix 9.1). 
3.4 Surface Treatment 
3.4.1 Covalent Surface Modification 
Many ECM proteins share short peptide sequences that serve as integrin binding 
domains and thus enable cell adhesion. The key benefits of using oligopeptides instead of 
full length proteins is that they are non-immunogenic, can be synthetically synthesized, 
and contain only the protein's intergrin binding domain. Arginine-Glycine-Aspartic Acid 
(RGD) and Tyrosine-Isoleucine-Glycine-Serine-Arginine (YIGSR) are two such domains 
that have been well-studied in the literature [128]. These oligopeptides were covalently 
attached to the surface of Costar polyester transwells with 400nm track-etched pores 
(Coming Life Sciences, Corning, NY) using an aminolysis method first described by Zhu 
[129] and later repeated by Causa [130]. A schematic of the conjugation process for an 
RGD-containing oligopeptide can be seen in Figure 3.3. The ester groups in polyester and 
PCL were lysed to create free amine groups at the substrate surface using a 10% (w/v) 
solution of 1,6-hexanediamine in isopropanol. After 30 minutes incubation at room 
temperature, samples were rinsed with generous amounts of 0.3% (v/v) Tween-20 (Bio-
Rad, Hercules, CA) in deionized (DI) water. Next, samples were incubated for 30 
minutes at room temperature in a 2% (v/v) glutaraldehyde solution in DI water to attach a 
bifunctional cross-linker and spacer to the polymer surface. Samples were again washed 
with DI water and incubated in a solution of 2mg H-Glycine-Arginine-Glycine-Aspartic 
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Acid-Serine-OR (GRGDS) (EMD Millipore, Billerica, MA) or YIGSR (Bachem 
Americas, Torrance, CA) in a 13mM cyanoborohydride solution buffered to a pH of 8.5 
with sodium carbonate and sodium bicarbonate to covalently bind the oligopeptides to the 
free end group of glutaraldehyde. Finally, unreacted glutaraldehyde end groups were 
terminated by incubation in 1.22% (v/v) ethanolamine in sodium carbonate-sodium 
bicarbonate buffer for 30 minutes at room temperature. 
10% DEA in IPA 
15", 30', 60", 90' .... 24h 
ii GRGDY, GYDGR 
5mM NaBH, CN. 
50 mM Na,co, (pH 8,5), 4hs 
Figure 3.3 Oligopeptide conjugation to PCL. (1) Aminolysis of ester bonds in the 
polymer chain, (2) primary amine exposed at the PCL surface, and (3) tethering of the 
oligopeptide to the polymer surface. Reprinted with permission from Causa F, Battista E, 
Della Morglie R, Guarnieri D, Iannone M, Netti PA. Surface investigation on biomimetic 
materials to control cell adhesion: the case for RGD conjugation on PCL. Langmuir 
2010;26:9875-84. Copyright 2010 American Chemical Society. 
3.4.2 Laminin Adsmption Quantification 
Adsorption of laminin onto the transwell surface is the standard method used to 
promote RPE adhesion. In accordance with this standard, all substrates were coated with 
3001J.l of 101J.g/ml laminin from Engelbreth-Holm-Swarm murine sarcoma basement 
membrane (Sigma-Aldrich, St. Louis, MO) in PBS for 2 hours prior to cell culture. An 
enzyme-linked immunosorbent assay (ELISA) for laminin was developed to ensure 
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equivalent adsorption on different substrates and eliminate the possibility that unequal 
laminin coating was responsible for changes in cell behavior. This ELISA began by 
adsorbing laminin on polyester transwells, non-porous PCL, and pore-cast PCL for 2 
hours. Samples were then blocked for 1 hour at room temperature in a solution of 2.5% 
(w/v) bovine serum albumin (BSA), 50mM Tris-HCL, and 0.5% (v/v) Tween-20 in DI 
water at a pH of 6.8. Samples were then treated with rabbit anti-laminin primary antibody 
at 1:10,000. After 1 hour of incubation at room temperature, samples washed repeatedly 
with PBS, treated with donkey anti-rabbit horseradish peroxidase (HRP) at 1:15,000 (GE 
Healthcare, Buckinghamshire, UK) in blocking buffer for 1 hour at room temperature and 
again washed repeatedly with PBS. A 3,3',5,5'-Tetramethylbenzidine (TMB) Microwell 
Peroxidase Substrate System (KPL, Gaithersburg, MD) was then used to evaluate laminin 
adsorption to each material. The peroxidase substrate reacted with the HRP enzyme to 
create a blue colored compound that changed to yellow when the reaction was stopped 
with 1M phosphoric acid after 1 minute per the manufacturer's protocol. Absorbance was 
measured at 450nm using a Synergy 2 microplate reader (BioTek Instruments, Winooski, 
VT) and compared to a standard curve of covalently-bound laminin prepared in parallel 
for quantification. 
3.5 Cell Culture 
3. 5.1 Human Retinal Pigment Epithelium 
Primary fetal human RPE cells (fhRPE) isolated at 20 weeks gestation (Lot# 
0000181239) were purchased from Lonza Biologics (Allendale, NJ) at passage 2 and 
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expanded 1:3 in RtEBM media (Lonza Biologics) supplemented with 5% fetal bovine 
serum (FBS) (Atlanta Biologicals, Flowery Branch, GA), 5ng/ml basic fibroblast growth 
factor, 1% (v/v) GlutaMAX (Life Technologies, Carlsbad, CA) and 1% (v/v) penicillin-
streptomycin (Lonza) on tissue culture plastic at 37°C and 5% C02. At passage 5, fhRPE 
were plated at high density (300,000 cells/cm2) on porous PCL, non-porous PCL, and 
polyester transwells suspended in 12-well plates (Figure 3.4). Non-porous PCL and 
polyester transwells were used as controls for material and porosity respectively. PCL 
samples were mounted on transwell supports devoid of their original membrane. All 
substrates were coated with 300!J.l of 10!J.g/ml laminin in PBS for 2 hours as described 
above. 24 hours after seeding, media was changed to serum-free, growth factor-free 
RtEBM media supplemented with 1% (v/v) GlutaMAX and 1% (v/v) penicillin-
streptomycin. Cells were maintained at 3 7°C and 5% C02 with media changed twice per 
week for up to 8 weeks. 
Transwell 
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Figure 3.4 Cell culture set-up in transwells. Cells are cultured on a porous scaffold 
attached at the bottom of a hard plastic transwell insert. This insert divides the well into 
an apical (top) and basal (bottom) chamber which contain 0.5ml and 1.5ml of cell culture 
media respectively. 
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3.5.2 Canine Kidney Epithelium 
Madin-Darby Canine Kidney (MDCK), an immortalized kidney epithelial cell 
line, was purchased from A TCC (Manassas, VA). Pore-cast and electrospun scaffolds 
were attached to transwell inserts and laminin-coated as described above. Cells were 
seeded at 100,000 cells/cm2 and maintained in alpha-modified minimum essential media 
with 10% FBS, 1% GlutaMAX, and 1% penicillin-streptomycin for three days at 3 7°C 
and 5% C02. Cells were used within 5 passages of purchase. 
3.5.3 Human Colorectal Epithelium 
A human colon adenocarcinoma cell line (Caco-2) was purchased from ATCC. 
Cells were seeded at 40,000 cells/cm2 in alpha-modified minimum essential media with 
20% FBS, 1% GlutaMAX, and 1% penicillin-streptomycin. After 24 hours the media was 
replaced with serum-free media of the otherwise same formulation. Thereafter cells were 
re-fed every 2-3 days with the serum-free media and incubated at 37°C and 5% C02 until 
culture was terminated after 7 days. Again, cells were used within 5 passages of 
purchase. 
3.5.4 Human Umbilical Vein Endothelium 
Primary human umbilical vein endothelial cells (HUVECs) were generously 
provided by Dr. Michael A. Gimbrone's laboratory (Brigham and Women's Hospital, 
Boston, MA). HUVECs were seeded at 50,000 cells/cm2 and maintained in EBM-2 with 
20% FBS, Lonza EGM-2 SingleQuot, 1% GlutaMAX, and 1% penicillin-streptomycin at 
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37°C and 5% C02. Media was replaced 24 hours after seeding and every 2-3 days 
thereafter until the culture was ended at day 14. Cells used to collect data were at or 
below passage 5. 
3.6 Cell Adhesion 
Cell plating efficiency was assessed by counting the number of non-adherent cells 
at 24 hours. Media samples were collected from the bottom and top chambers of 
transwe11s taking care not to disturb adherent cells. Samples were then diluted and passed 
through a Coulter Counter (Beckman Coulter, Danvers, MA) to determine the number of 
non-adherent cells. This count was then compared to the number of cells initially seeded 
to determine a plating efficiency on each scaffold. 
3.7 Immunofluorescence 
All antibodies used for immunofluorescence were purchased from Life 
technologies unless otherwise noted. Likewise, all reagents used in this study were 
purchased from Sigma-Aldrich. Cells were fixed for 10 min in 4% paraformaldehyde and 
permeabilized with 0.1% Triton X-100 in PBS for 5 minutes. After washing, samples 
were incubated for 2 hours in a blocking buffer containing of 3% (v/v) goat serum and 
2.5% (w/v) BSA in PBS. Samples were incubated overnight at 4°C in blocking buffer 
containing 2.5J.!g/ml rabbit-raised antibody for zona occludin 1 (Z0-1), a tight junction-
associated protein. The following day samples were treated with 6.7J.!g/ml AlexaFluor 
488 goat anti-rabbit and 1 OJ.!Vrnl DAPI in blocking buffer for 1 hour. Some samples were 
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also co-stained for filamentous actin (f-actin) using a subsequent 20-minute incubation 
with AlexaFluor 594 phalloidin diluted 1:100 in blocking buffer. Finally, substrates were 
cut from their rigid transwell support, mounted onto glass cover slips, and imaged using 
an Axioskop MOT 2 (Carl Zeiss Meditec, Dublin, CA). fhRPE cell size was evaluated by 
manually tracing the cell borders defined by Z0-1 staining in Adobe Photoshop. 
3.8 Transepithelial Resistance 
Transepithelial resistance (TER) is a well-established measure of tight junction 
formation in epithelium [ 131]. Prior to cell seeding, a two-electrode TER instrument 
(World Precision Instruments, Sarasota, FL) was used to measure the basal electrical 
resistance of each scaffold. Additional measurements were made throughout the culture 
period to determine the increase in electrical resistance of the cell-scaffold construct over 
time. The "scaffold-only" TER value was subtracted from subsequent measurements to 
determine the cellular contribution to resistance. 
3.9 Gene Expression 
3.9.1 RNA Isolation 
Messenger RNA (mRNA) from fhRPE was extracted and isolated after 1 or 4 
weeks in culture. Cells were removed from the incubator, washed with PBS, and lysed 
withlml RNA-bee solution (AMS Biotechnology, Lake Forest, CA). Samples were then 
treated with 200f.ll of chloroform, vortexed briefly, and centrifuged at 4°C for 20 minutes 
at 17,200 G to purify the mRNA. The top aqueous layer was then transferred to a clean 
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tube. Next, 5Jll of linear acrylamide (Life Technologies, Carlsbad, CA) and 500Jll of 
isopropanol were mixed with the mRNA sample and stored on ice for 30 minutes. Tubes 
were then centrifuged at 4°C for 45 minutes at 17,200 G to pull down a pellet of mRNA 
and linear acrylamide. The isopropanol supernatant was removed from the tube without 
disturbing the pellet. 500Jll of 70% RNA-safe ethanol in water was added to wash the 
pellet. Samples were then centrifuged at 4 oc for 5 minutes at 17,200 G. Upon 
completion, the ethanol was removed and the pellet was allowed to air dry until it became 
transparent. Once dry, samples were resuspended in 15Jll of Ambion tris 
ethylenediaminetetraacetic acid (TE) buffer (Life Technologies) and stored at -80°C. 
3.9.2 Reverse Transcription 
A 1Jll aliquot of mRNA m TE buffer was loaded into a NanoDrop 2000 
microvolume spectrophotometer (Thermo Scientific, Wilmington, DE) to determine 
mRNA quantity. Relative sample purity was also obtained by determining the ratio 
between absorbance at 260nm and 280nm. Reverse transcription from mRNA to 
complementary DNA (eDNA) was performed using the iScript eDNA synthesis kit (Bio-
Rad). Briefly, nuclease-free water was added to 1Jlg of mRNA in TE buffer to create a 
15 Jll solution. 5 Jll iScript master mix was then added to the solution to achieve a final 
volume of 20Jll. Samples were then mixed and placed in a Techne T -512 thermal cycler 
(Bibby Scientific, Burlington, NJ) using a reaction protocol of 5 minutes at 25°C, 30 
minutes at 42°C, and 5 minutes at 85°C per the manufacturer' s protocol. After the 
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reaction was completed, eDNA samples were diluted in 180J.!l of nuclease-free water and 
stored at -20°C until further use. 
3. 9. 3 Quantitative PCR 
Primers were purchased from Qiagen (Valencia, CA) or ordered from Eurofins 
MWG Operon (Huntsville, AL) using sequences previously reported in existing literature 
and tested in silico against the human genome using the UCSC In-Silico PCR tool 
(http://genome.csdb.cn/cgi-bin/hgPcr) for specificity. Whenever possible, primer 
sequences were designed to produce amplicons that spanned an intron in order to 
minimize the amplification of genomic DNA. The primer sequences used to assess 
fhRPE gene expression are listed in Table 3.4. Quantitative polymerase chain reaction 
( qPCR) was performed using FastS tart SYBR Green Master mix and a LightCycler 480 
Real-Time PCR System (Roche Applied Science, Indianapolis, IN). 5.5J.!l master mix, 
2.5J.!l of nuclease-free water, and 2J.!l of eDNA, 0.5J.!l of 20J.!M forward primer, and 0.5J.!l 
of 20J.!M reverse primer were mixed and added to each well of a white 384-well PCR 
plate. Samples were prepared in technical duplicate, covered with LightCycler 480 
Sealing Foil and centrifuged at low speed to bring solution volume to the bottom of the 
plate. Samples were then loaded into the PCR machine and submitted to 35 cycles of 
60°C for 1 minute and 95°C for 15 seconds to amplify the eDNA. Melting curve data was 
also collected using a 0.11 °C/second ramp from 60°C to 97°C to ensure that only a single 
population of amplicons had been produced. Relative gene expression was determined 
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using the delta-delta Ct method after normalizing sample loading with the housekeeping 
genes GAPDH and HPRTl. 
Table 3.4 Quantitative PCR primer sequences for human genes 
Gene Name Forwanl Sequence Reve~e Sequence 
HPRTI CCTGGCGTCGTGATTAGTGAT AGACGTTCAGTCCTGTCCATAA 
RLBPl (CRALBP) CCAGGACAGTTGAGGAGAGG CACGCTGCCCAAGTATGATG 
MITF AGCCATGCAGTCCGAAT ACTGCTGCTCTTCAGCG 
VEGFA GGGCAGAATCATCACGAAGTG ATTGGATGGCAGTAGCTGCG 
SERPINFI (PEDF) TATCACCTTAACCAGCCTTTCATC GGGTCCAGAATCTTGCAATG 
SOD2 CGTTCAGGTTGTTCACGTAGG CCTCACATCAACGCGCAGAT 
OCLN CCCTTTTAGGAGGTAGTGTAGGC CCGTAGCCATAGCCATAACCA 
ATP1A2 ACAGCCTTCTTCGTCAGTATCGT CGAATTCCTCCTGGTCTTACAGA 
OTX2 TAAGCAACCGCCTTACG GCACTTAGCTCTTCGATT 
EZR GTTTTCCCCAGTTGTAATAGTGCC TCCGTAATTCAATCAGTCCTGC 
BEST! GAATTTGCAGGTGTCCCTGT ATCCTCCTCGTCCTCCTGAT 
TFEB CGCATCAAGGAGTTGGGAAT CTCCAGGCGGCGAGAGT 
TJPI (Z0-1) CAACATACAGTGACGCTTCACA GACGTTTCCCCACTCTGAAAA 
FGF2 ATCAAAGGAGTGTGTGCTAACC ACTGCCCAGTTCGTTTCAGTG 
MY07A CATGACGGGGAGTCCACAG TCTCTTGCTAGGTTGACAGAGG 
NOTCH2 CCAGAATGGAGGTTCCTGTA GTACCCAGGCCATCAACACA 
MMP2 CTTCCAAGTCTGGAGCGATGT TACCGTCAAAGGGGTATCCAT 
COIAA4 AGAGATTGCTCTGTTTGCCAC CGGTCCCCTCTCATTCCTT 
Note: Prime~ forGAPDH, RP£65, LOX, NGFB, THBSl , MMP7, COLI AI , COL18Al , ELN, FNJ , LAMB2, and DCN were 
purchased from Qiagen 
Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, 
Saint-Geniez M. Porous poly(£-caprolactone) scaffolds for retinal pigment epithelium 
transplantation 2014;55:1754-62. Copyright 2014 with permission from the Association 
for Research in Vision and Ophthalmology. 
3.10 Growth Factor & Cytokine Secretion 
3.10.1 VEGF &PEDF ELISA 
fhRPE culture media was replaced 3 days prior to time points at 1 and 4 weeks. 
After 72 hours of conditioning, this media was collected and stored at -80°C until relevant 
ELISAs were performed. Human ELISA kits for VEGF and PEDF were used to 
determine the concentration of these proteins in fhRPE-conditioned media. For VEGF 
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detection, a VEGF Sandwich ELISA (R&D Systems, Minneapolis, MN) was used. A 
1!-lg/ml solution of capture antibody in PBS was incubated in a 96-well polystyrene plate 
(Corning Life Sciences) overnight at room temperature. The following day, the plate was 
washed with 0.05% Tween-20 in DI water, dried, and blocked with 1% BSA in PBS at 
room temperature for 1 hour. After washing, conditioned media was added to each well 
and incubated for 2 hours. A standard curve of known VEGF concentration was prepared 
in parallel for absolute quantification. Wells were then treated with detection antibody 
diluted 1:180 (v/v) in blocking buffer for 2 hours at room temperature. Streptavidin-HRP 
was added to each well and incubated for 20 minutes at room temperature. Each well was 
then filled with substrate solution and incubated to induce a colorimetric reaction. After 
20 minutes, the reaction was ended using stop solution and read at 450nm absorbance 
with a 540nm wavelength correction using the Synergy 2 microplate spectrophotometer. 
Between each antibody incubation, wells were washed repeatedly with 1% BSA in PBS 
and briefly air dried. 
The PEDF ELISA (BioProducts MD, Middletown, MD) used a similar protocol 
except that plates were pre-coated with capture antibody. Briefly, conditioned media or 
PEDF standard dilutions were loaded into each well and incubated for 1 hour at 37°C. 
Next, samples were washed, incubated with PEDF detection antibody for 1 hour at 37°C, 
washed again, and incubated with streptavidin peroxidase working solution for 30 
minutes at 3 7°C. Wells were washed again and incubated with TMB substrate for 20 
minutes before stop solution was added to end the reaction. Absorbance was read at 
450nm using the BioTek Synergy 2. 
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3.10.2 Multiplex ELISAfor Inflammatory Cytokines 
Aliquots from the same conditioned media used for individual growth factor 
ELISAs were analyzed with a custom 19-analyte Milliplex Map multiplex ELISA (EMD 
Millipore) for human cytokines and chemokines. This kit was used to measure thRPE 
secretion of soluble epidermal growth factor (EGF), eotaxin, fibroblast growth factor 
(FGF)-2, CX3CL1 (fractalkine), granulocyte colony-stimulating factor (G-CSF), 
granulocyte-macrophage colony-stimulating factor (GM-CSF), CXCLl (GRO), 
interleukin (IL)-la, IL-l~, IL-lRA, IL-6, IL-8, IL-15, interferon y-induced protein 10 
(IP-10), platelet-derived growth factor (PDGF)-AA, PDGF-AB/BB, CCL5 (RANTES), 
transforming growth factor (TGF)-a, and tumor necrosis factor (TNF)-a. All conditioned 
media samples were run in technical duplicate. 
Lyophilized human cytokines of known concentration were resuspended and 
diluted in assay buffer to create a standard curve. Assay buffer was then added to each 
well of the Milliplex filter plate to block non-specific binding. After 10 minutes of 
incubation at room temperature, buffer was removed by applying vacuum to the filtered 
bottom of the plate. Next, standard dilutions, conditioned media samples, and quality 
controls were added to each well where they were subsequently mixed with antibody-
bead solution. The plate was then protected from light and incubated for 1 hour at room 
temperature on an orbital shaker. Solutions were removed via vacuum and rinsed twice 
with wash buffer. Detection antibodies were added and samples were incubated for 30 
minutes. Streptavidin-phycoerythrin was added to all wells (without washing) and 
incubated again for 30 minutes. Wells were washed two more times and then filled with 
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Bio-Plex Sheath Fluid (Bio-Rad). The Bio-Plex System was then calibrated and used for 
sample analysis. Standard curves were checked against quality controls to ensure 
accuracy prior to calculating cytokine concentration in conditioned media. 
3.11 Photoreceptor Outer Segment Phagocytosis 
Bovine eyes were obtained from Research 87 (Boylston, MA) within 6 hours of 
enucleation. Photoreceptor outer segments were then isolated based on a method 
previously reported [ 132]. 100 photoreceptor outer segment discs (POS) were loaded into 
the apical media of cells cultured for 4 weeks. After 16 hours of co-incubation, samples 
were washed extensively with PBS to remove unbound POS. Cells were then fixed with 
4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and immunostained with 
2f.lg/ml mouse anti-rhodopsin primary antibody (EMD Millipore) in blocking buffer 
overnight at 4°C. The next day cells were incubated with 1 Of.!llml DAPI and 2f.!g/ml 
AlexaFluor 594 rabbit anti-goat secondary antibody in blocking buffer for one hour, 
washed, mounted onto glass slides, and imaged using an Axioskop MOT 2. The relative 
number of bound or internalized POS per cell was quantified by dividing the number of 
red fluorescent pixels above a threshold by the number of DAPI-stained nuclei in that 
area. The size of bound and phagocytosed POS in these images was also assessed using 
the "threshold" and "analyze particle" functions in ImageJ. 
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3.12 Computational Modeling of Retinal Oxygen 
3.12.1 Data Acquisition and Anonymization 
The use and anonyrnization of clinical OCT images were performed in 
accordance with IRB 13-009H approved by the Massachusetts Eye and Ear Infirmary 
(MEEI) Human Studies Committee. Dr. Leo J(jm (MEEI!Schepens Eye Research 
Institute, Boston, MA) identified patients in the existing MEEI database that met the 
inclusion criteria of dry AMD at AREDS stage 2-3 with OCT images collected at 
multiple time points. Identifying information was removed from files and replaced with a 
code in the form of "MSG _XXX" where "XXX" was the sample number. Samples were 
then exported as JPEG or E2E files for further analysis. All potentially-relevant 
information (gender, age, date of visit, etc.) corresponding to each naming code was 
stored in a password-protected file. 
3.12. 2 Optical Coherence Tomography Image Segmentation 
The dimensions of outer retinal layers were initially determined by hand tracing 
the boundaries between outer retinal layers on OCT images in Adobe Photoshop. The 
BrM, RPE, IS-OS junction, ONL, and OPL were each traced with a unique color and 
then analyzed using a custom MATLAB script (Appendix B) which raster scanned each 
pixel column from top to bottom until it found the color corresponding to each layer. 
Pixel number was then translated to distance using a scale bar on the image. A 3D map 
could then be created using XZ coordinates from multiple spatially-sequential OCT B-
scans. 
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However, while manual OCT segmentation was useful for small subsets of 
images, it was far from ideal for large data sets due to slow segmentation speed and tracer 
bias. Therefore, we developed a collaboration with Dr. Sina Farsiu at Duke University, to 
perform semi-automated OCT image segmentation as previously described [133] which 
yielded 3D spatial coordinates. The segmentation tool was unable to automatically trace 
the external limiting membrane, so this boundary was hand traced. A three-dimensional 
(3D) map was then created by combining the segmented B-scans containing x-z position 
with the corresponding fundus containing x-y information using MATLAB. Coordinates 
for each boundary were then exported as a tab-delimited text file using custom MA TLAB 
code (Appendix C). Text files with x, y, and z spatial coordinates were loaded into Global 
Mapper 14 (Blue Marble Geographies, Hallowell, ME) as an elevation grid from 3D 
point data and exported in digital elevation model (DEM) format which could be 
imported into finite element analysis software. 
3.12.3 Finite Element Modeling 
COMSOL Multiphysics (Burlington, MA), a finite element analysis toolbox, was 
used to analyze steady state oxygen concentration based on 3D representations of outer 
retinal morphology. This approach employed the "transport of diluted species" physics 
engine to study both generic and patient-specific models. The preliminary generic studies 
used layer dimensions previously reported in the literature while patient-specific retinal 
studies used custom geometries obtained from OCT segmentation. Generic models were 
built using the block, sphere, and Boolean tools in which retinal layers were treated as 
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rectangular slabs. In a scenario meant to replicate drusen in dry AMD, a hemispherical 
"druse" was introduced to provide an additional barrier to oxygen diffusion and 
proportionally deform vertically adjacent retinal layers. 
For patient-specific retinae, topographical maps corresponding to the boundaries 
between outer retinal layers were imported into COMSOL as parametric surfaces and 
formed into a solid continuous structure with multiple domains. The five domains of 
interest were: (1) BrM, (2) RPE and photoreceptor outer segments, (3) photoreceptor 
inner segments, (4) ONL, and (5) OPL. A fixed oxygen concentration was applied at both 
the basal side of the BrM domain and apical surface of the OPL to represent the 
choriocapillaris and deep retinal vasculature respectively. Oxygen consumption was set 
to occur only within the inner segment layer where the vast majority of retinal oxygen is 
used by photoreceptor mitochondria for aerobic respiration [33,87]. After these 
parameters were applied, finite element analysis was run to determine the steady state 
oxygen concentration across the retina. Qualitative results were exported as maps of 
oxygen concentration and quantitative data was exported to Microsoft Excel (Redmond, 
WA) in a 150x150x20 sampled grid. 
3.12. 4 Spatial Correlation 
Oxygen concentration maps were overlaid onto heat maps of combined ONL & 
OPL thickness to qualitatively observe the co-localization of hypoxia and retinal 
thinning. Data exported into Excel was analyzed as scatter plots of oxygen concentration 
versus retinal thinning the change in thickness between OCT collections) and thickness 
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during the second OCT collection. In order to automate this process for potential 
widespread use, no manual selection of a data corresponding to drusen locations was 
used. Instead, the lowest oxygen concentration through the thickness of the in silico 
retina organized in a 150x150 grid was plotted against the thickness of the immediately 
overlying thickness of ONL and OPL. 
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4. CHARACTERIZATION OF PORE-CAST SCAFFOLDS 
4.1 Introduction 
Tissue engineering has the potential to revolutionize medicine by creating 
replacement tissues and organs that restore physiological function lost due to damage or 
disease. However, cells alone are generally incapable of spontaneously forming a well-
organized, functional tissue. To overcome this challenge, tissue engineers have employed 
natural or synthetic biomaterial scaffolds to promote cell adhesion, proliferation, and 
organization [134]. Due to recent studies that systemically assess cell-biomaterial 
interactions, it has become increasingly clear that the mechanical and physical properties 
of these scaffolds play key roles in regulating cell behavior [135-137] . As a result, the 
current aim of scaffold design is to mimic the properties of a cell type's native 
microenvironment including geometry, mechanical properties, and molecular transport. 
Though the desired physical and mechanical properties can vary greatly between cell 
types [138] , all tissues universally require transport to maintain the exchange of oxygen, 
nutrients, and waste. 
Porous scaffolds have gained popularity as a tool to produce 3D tissues and/or 
minimize transport barriers, especially for tissues whose growth would otherwise be 
limited by oxygen diffusion [139-141]. The key parameters that characterize scaffold 
porosity include pore size, total porosity, surface area-to-volume ratio, interconnectivity, 
and tortuosity [142]. Of these features, pore size is arguably the most critical for inducing 
the desired tissue morphology. For example, 3D tissue engineering frequently employs 
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scaffolds with large pores to allow for cell penetration and proliferation to fill the void 
volume [143]. Alternately, largely 2D tissues such as epithelium and endothelium require 
pores small enough to prevent cell penetration, but sufficient for transport. Native 
epithelium forms a monolayer or stratified multilayer on ECM to function as a physical 
barrier and regulator of molecular transport between tissue compartments [ 144]. 
However, if 2D tissues are supported by scaffolds with large pores, they will deform into 
these pores and assume irregular 3D organization that may compromise their role as a 
selective barrier [137]. Therefore, the ideal epithelial scaffold morphology would be thin 
with tightly controlled pore dimensions and minimal cell-scale topography. This scaffold 
would have a minimal spatial footprint and permit transport while promoting confluent 
cell coverage in 2D. 
Electrospinning has become the most common method used to fabricate porous 
scaffolds due to its modest cost and range of achievable pore sizes. This technique is 
popular for creating both 2D and 3D tissue engineering scaffolds [137,145-147] with 
applications ranging from neural [146,148] and cardiovascular [149] to bone [147], 
connective tissue [150], and skin [151]. Electrospinning produces topographically-intense 
meshes of overlaid fibers with a high surface-area-to-volume ratio and interconnected 
tortuous pores. To induce appropriate tissue architecture, electrospun scaffolds for 20 
tissues should have smaller pore size to prevent cell infiltration while 3D tissue scaffolds 
should promote infiltration and proliferation with large pores to form a bulk tissue [139-
141]. Unfortunately, electrospinning is an inherently stochastic process that produces a 
wide distribution of pore sizes which make them non-ideal for 2D tissues in which proper 
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organization is critical for function [ 152,153]. 
Though proponents of electrospinning tout the morphological similarity to native 
ECM, discerning the net effect of this feature remains complicated by confounding 
variables in scaffold properties and the numerous cell types of interest [152]. In fact, 
many cells may not benefit from electrospun fiber topography [14,134] and may impede 
proper epithelial function rather than enhance it [152,153]. In addition, achieving a 
particular average pore size represents a major practical challenge that involves a 
refinement process to find the correct combination of six or more parameters which may 
be unique to a particular polymer and lab set-up. However, even after the appropriate 
average pore size has been achieved, the scaffold will still be at risk for cell invasion. 
Due to the heterogeneity of pore size and shape, a small proportion of large pores will 
persist due to a wide size distribution despite a small average pore size. For example, one 
study found that electrospun meshes with 300nm fibers contained an average pore 
diameter of 5!-!m, yet the maximum diameter was 30!-!m, much larger than the size of 
most human cells [ 154]. 
Unfortunately, other scaffold fabrication methods may also be inappropriate for 
many 2D applications because of their own set of inherent limitations that result in 
insufficient resolution and control over pore size. Hydrogels can allow for greater 
molecular flux than to solid polymers due to their high porosity, but at the cost of 
mechanical properties and potentially undesirable topography [155]. Track etched films, 
while capable of creating exceptionally small pores down to 1 Onm in a flat surface, 
possess an array of fundamental and practical limitations including random pore 
65 
distribution, fused pores with double (or more) the intended pore diameter, the need for 
rare fabrication equipment, and developmental challenge when used applied to a new 
material [156]. As a result, fabrication techniques are typically chosen based on their 
ability to produce a scaffold that meets one or more of the most important design criteria 
for a particular application [ 157 -160]. 
The need for additional scaffold fabrication techniques has long been recognized 
[160]. The ideal porous scaffold fabrication technique would be a robust, low-cost 
process with a high degree of control over pore size, shape, location, tortuosity, 
interconnectivity, and topography that is also compatible with a wide variety of natural 
and synthetic materials [157,158,161 ,162]. While no current method achieves even 
several of these criteria, tissue engineers may be able to leverage existing technology 
from other fields to develop new techniques that avoid some of the shortcomings of 
existing methods. 
Microfabrication IS one such technology with the potential to revolutionize 
scaffold fabrication due to its fine control over micro- and nano-architecture 
[ 146, 148, 149, 160]. Desai saw the potential for micro fabrication over a decade ago and 
commented that tissue engineering could greatly benefit from these methods that allow 
fine control over scaffold architecture [157]--a sentiment echoed more recently by other 
researchers [139,163,164]. To date there are many reports using microfabrication tools to 
topographically pattern surfaces [165-167], but limited literature on creating full-
thickness pores in scaffolds [135,164,168-170], and at the time of publication, only our 
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group's paper describing the pore casting process has been able to produce a pore size 
relevant for 2D tissues [125]. 
The most similar predecessor to pore casting was reported by Jackman and 
colleagues using soft lithography patterned directly off of photoresist rather than etched 
silicon. This technique, though capable of effectively producing large and shallow pores, 
was insufficient for molding small and/or high aspect ratio pores due to 
polydimethylsiloxane (PDMS) deformability, poor mechanical stability, and swelling 
[169]. These same issues were also noted by other groups who have utilized a similar 
process to create wells and lOOf.lm full-thickness pores [170-172]. In addition, Vozzi and 
colleagues also noted non-uniform scaffold thickness around pores which they attributed 
to the hydrophobicity of PDMS [170]. Our approach may overcome the problems and 
limitations encountered when molding porous scaffolds using soft lithography by using 
non-deformable silicon instead ofPDMS. 
This chapter describes the process of pore casting, a novel fabrication technique 
capable of creating thin film scaffolds with well-defined, reproducible pores at sub-
micron resolution. Pore casting begins with the creation of a silicon master mold using 
microfabrication tools. This mold is then used as a substrate for spin assisted templating 
which results in a polymeric scaffold with sub-micron pores. High aspect ratio features 
on the mold protrude through the surface of the solidifying polymer during casting to 
induce fully-penetrating, non-tortuous pores in the thin film scaffold. The properties of 
these pores including size, shape, and spacing are completely determined by the user 
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based on computer-aided design. The pattern used in these studies was chosen to fall 
within the size requirements of a scaffold for RPE transplantation (Table 4.1 ). 
Table 4.1 RPE scaffold design criteria 
Design Criteria Relevant Size Motivation Source 
Photolithography exposure wavelength 
Pore Size 0.4-3. 0 )llll and pore casting film removal imposed a [244,245] 
mininnnn pore size while endothelial cells 
can migrate through pores larger than 3 Jllll 
Mold features spaced closer than 2f..llll 
substantially affected sidewall angle and 
did not allow for uniform pore cross 
Pore Spacing 2.0-10.5 )llll section while pores spaced more than [178] 
1 0. 5 Jllll apart would not guarantee each 
cell redundant pore access based on ideal 
RPE size and shape 
Films less than 5J..tm were extremely 
Scaffold Thickness 5-90)llll difficult to handle while modeling of films [70] 
thicker than 90)llll would likely impact sub-
retinal architecture 
RPE behavior on microfubricated posts 
Scaffold Topography < 5)llll 5 ) .. nn in diameter display irregular [88] 
morphology, growth, and focal adhesions 
4.2 Process Development 
Many of the steps required to create the molds for pore casting are standard in the 
field of microfabrication including photolithography, wet etching, and dry etching. The 
most critical of these steps for pore casting is DRIE due to its substantial effect on final 
feature shape. Controlling the sidewall angle of the silicon features was absolutely 
68 
essential in producing a film that could be released without mold fracture or scaffold 
tearing. Cylindrical features with 90° sidewall angles are optimal for creating pores with 
uniform cross-sectional area. Features with larger tips than bases were fractured during 
scaffold delamination as the slightly smaller cross-section pore produced by the narrower 
feature base were unable to deform around the wider mold tips. Much greater than 90° 
features, though easily removed, produce conical pores that limit pore aspect ratio and 
spacing. Examples of negatively angled features (larger tip than base), positively angled 
features (larger base than tip), and approximately 90° features are displayed in Figure 4.1. 
Due to the brittle nature of silicon, mold fracture during scaffold delamination 
was perhaps the greatest practical challenge in pore casting. As anticipated, high aspect 
ratio features were more prone to breaking than shorter or wider features. A scaffold with 
700nm pores served as an extreme stress test to demonstrate the capabilities of pore 
casting for creating pores well below the size required to prevent epithelial cell 
transmigration. Scaffolds with circular pores 1.51J.m in diameter and rectangles 1.51J.m x 
1 0~-tm were also fabricated. These larger features were easier to fabricate and still likely 
sufficient to prevent epithelial cell transmigration. For some applications, it may be 
preferable to use a silicon-selective wet etchant such as potassium hydroxide to dissolve 
the features and thus release the scaffold without damage. Although this process would 
require a new mold for every scaffold, it could be necessary when using an especially 
weak material or small/densely packed pores. 
69 
Figure 4.1 Scanning electron microscopy images of silicon molds with (A) negatively 
angled features, (B) positively angled features, and (C) approximately 90° features. 
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4.3 Scaffold Morphology 
After extensively tuning etch processing parameters, molds with high aspect ratio 
cylinders with sub-micron diameter and near-perpendicular sidewalls were produced. 
After 74 cycles (approximately 16 minutes process time) a feature height of 16.2 ± 0.2jlm 
was achieved. The diameter of the cylindrical features at the base and tip were 790 ± 
50nm and 680 ± 20nm respectively (Figure 4.2A) corresponding to a sidewall angle of 
90.2°. This angle provided a compromise that produced a scaffold nearly-cylindrical 
pores that could also be removed from the mold. The details of the fmal etch recipes are 
listed in Table 3.2. 
Films produced by spinning PCL onto the silicon mold were 9.9 ± 0.3jlm thick 
which was less than the 16.2~.tm feature height indicating that pores fully traversed the 
thickness of the scaffold. This observation was confirmed by SEM which showed 
cylinders protruding beyond the PCL surface during molding (Figure 4.2B) and openings 
on both sides of the scaffold after delamination which were 790 ± 50nm and 680 ± 20nm 
in diameter at the base and tip respectively (Figure 4.2C-D). There was no significant 
difference between silicon feature diameter and pore size for the top (p=0.40) or bottom 
(p=0.32) of the scaffold. The total porosity of the scaffold was 0.90 ± 0.05%. For the sake 
of comparison, polyester transwells were found to have an average pore diameter of 449 
± 8nm and total porosity of0.64 ± 0.06%, both of which were significantly different from 
porous PCL (p<0.05). We also demonstrated the ability to form anisotropic shapes 
including rectangular pores (Figure 4.3) which could serve a dual purpose as pore and 
topographical feature to guide cell alignment. In addition, because epithelium generally 
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respond to nano- rather than micro-scale topography, we assessed the surface of spin-cast 
scaffolds using AFM. The top film surface had a root mean square roughness of llnm 
indicating that the top of the film was very smooth (Figure 4.4). Due to the practical 
issues of measuring a thin PCL film via AFM after peeling, the bottom roughness was not 
measured; however, this surface is cast onto the molecularly smooth silicon wafer, and 
should likewise be similarly smooth. 
Figure 4.2 Scanning electron microscopy images of a silicon mold and PCL scaffold 
during the pore casting process. (A) Silicon mold, (B) PCL spun onto the mold, and the 
(C) top and (D) bottom of the porous PCL mold after being removed from the wafer. 
Reprinted from Springer and the Journal of Materials Science: Materials in Medicine, 
24, 2013, 1659-70, A novel porous scaffold fabrication technique for epithelial and 
endothelial tissue engineering, McHugh KJ, Tao SL, Saint-Geniez M, Figure 2, 
Copyright 2013 with kind permission from Springer Science and Business Media. 
72 
Figure 4.3 Scanning electron microscopy images of (A) a rectangular mold and (B) the 
porous PCL scaffold produced using this mold. 
B 
0.0 
Figure 4.4 Nanoscale topography of spin-cast PCL determined by atomic force 
microscopy displayed in (A) two dimensions and (B) three dimensions. 
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Figure 4.5 Scanning electron microscopy image of (A) track-etched polyester transwells 
and (B) pore-cast PCL. White arrowheads indicate locations where tracks have merged to 
produce larger pores. Reprinted from Investigative Ophthalmology & Visual Science, 
McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(E-caprolactone) scaffolds for retinal 
pigment epithelium transplantation 20 14;55: 1754-62. Copyright 2014 with permission 
from the Association for Research in Vision and Ophthalmology. 
4.4 Protein Transport 
In order for pore-cast scaffolds to fill a niche for epithelial tissue engineering they 
must support transport through the scaffold. To characterize the transport properties of 
pore-cast scaffolds, FITC-dextran was used as a model protein to track diffusion in a cell-
free environment. The lower chamber of blind wells were filled with FITC-dextran in 
PBS that was separated from PBS in the upper chamber by either pore-cast PCL or a 
polyester transwell membrane (Figure 4.5). The concentration of FITC-dextran in the top 
chamber was then measured over time using fluorescence and used to calculate the 
diffusion coefficient through each scaffold using the equation for single-membrane 
diffusion presented by Lee and colleagues [127] . 
As expected, smaller 20 kDa FITC-dextran traveled through both membranes 
more quickly than the larger 70 kDa FITC-dextran. After 8 hours, approximately twice as 
much 70 kDa FITC-dextran had crossed the pore-cast PCL scaffolds compared to the 
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polyester transwells. However, the difference in the speed of diffusion between scaffolds 
was not as large for the 20 kDa FITC-dextran (Figure 4.6). The difference in FITC-
dextran concentration in the top chamber was statistically different (p<O.O 1) between 
scaffolds for all time points and molecular weight molecules except for 20 kDa at 8 
hours. In all cases, the top chamber concentration did not reach equilibrium (S011M) 
within 8 hours, but the trend appeared to show an asymptotic approach to this 
concentration as would be expected. Longer experiments were attempted, but issues of 
fluorescence loss in PBS over long times and evaporation at high temperature 
complicated these trials. 
The blind well data was then used to calculate diffusion coefficient and flux. The 
diffusion coefficients for each scaffold were statistically similar for 20 kDa FITC-
dextran, but pore-cast PCL displayed a significantly higher (p<O.Ol) diffusion coefficient 
than polyester transwells for the larger 70 kDa molecule. These values were compared to 
previously published values for BrM [173], parylene-C [73], and human lens capsule 
[127] which have also been proposed as RPE scaffolds. The diffusion coefficient for both 
polyester transwells and porous PCL were higher than BrM (p<O.OOl) and parylene-C, 
but lower than human lens capsule (Figure 4.7). Unfortunately, statistical comparisons to 
parylene-C and lens capsule were not possible as the raw data and number of replicates 
tested were not reported. Because the polyester and PCL scaffolds are essentially the 
same thickness (about l011m), the difference in diffusion coefficient was preserved at the 
level of protein flux (Figure 4.8). Flux through BrM and parylene-C was closer to that 
observed through polyester transwells and pore-cast PCL because the former scaffolds 
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were comparatively thinner (3~-tm and 300nm respectively). This change illustrates that 
flux can be increased by changing the total porosity or by making the scaffold thinner and 
thus sho~ening the length of the bottleneck in the gradient between opposite 
compartments. Despite being 10% the thickness of native BrM, the parylene-C scaffold 
replacement still fails to achieve the level of protein flux through native membrane. 
Alternately, transwells and pore-cast PCL supported greater protein diffusion then BrM, 
perhaps as a result of being uncharged which may otherwise slow diffusion. Although the 
effect of excess transport capacity on tissue function is not entirely clear, there is some 
reason to think that it would be innocuous as a key role of epithelium is selective 
transport between body compartments. Also, while FITC-dextran does not mimic the 
properties of all proteins, it has been widely used in the past as a model protein [73,127] 
and provides a cursory indication of how other proteins will pass through the scaffolds. 
Finally, because the pores in both membranes are on the order of hundreds of nrn (500-
700nrn) and therefore much larger than the 1 0-25nrn globular protein diameter associated 
with a vast majority of proteins [73], the scaffold itself is not expected to serve as a filter 
for large proteins. 
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## ## ### ### ### ### ### ### 
Time (hours) 
........ Transwell, 20kD FITC-Dextran 
- Porous PCL, 20kD FITC-Dextran 
-.-· Transwell, ?OkD FITC-Dextran 
-T-· Porous PCL, ?OkD FITC-Dextran 
Figure 4.6 Concentration of FITC-dextran in the top chamber of blind well chambers 
over 8 hours. Values reported as the mean± standard error of the mean. ## p<O.Ol and 
### p<O.OOl for 70kD FITD-dextran. ** p<O.Ol and *** p<O.OOl for 20kD FITD-
dextran. 
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Figure 4. 7 Graph comparing the diffusion coefficients of native BrM, parylene-C, 
polyester transwells, pore-cast PCL and human lens capsule. Data reported as mean ± 
standard error of the mean. *** p<O.OOl. Data for BrM, parylene-C and lens capsule 
taken from [173,73,127]. 
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Figure 4.8 FITC-dextran flux through BrM, parylene-C, polyester transwells, and porous 
PCL. Data for transwells and porous PCL reported as mean ± standard error of the mean. 
*** p<0.001. Data for BrM, parylene-C and lens capsule taken from [173, 73]. 
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4.5 Summary 
Pore casting is capable of producing scaffolds with a high degree of control over 
pore s1ze, shape, and location with sub-micron resolution. Although this technique 
reqmres a more substantial initial effort to develop than the PDMS-based molding 
methods described by Jackman [169] and Vozzi [170], the 10- to 100-fold gam m 
minimum feature size is paramount in creating porous scaffolds appropriate for 2D tissue 
engineering. Uniform, reproducible pores substantially reduce the variability between 
scaffolds and eliminate the possibility of larger pores that would be at risk for cell 
invasion. Further, control over pore shape could be co-opted to provide topographical 
cues to induce cell alignment via contact guidance in order to further improve cell 
organization. 
Unlike many other fabrication processes, pore casting allows the user to easily 
alter scaffold morphology without re-developing processing parameters. This is a major 
practical advantage compared to techniques such as electrospinning and track etching 
which require substantial process refinement when altering pore architecture and/or 
material. Instead of redeveloping the fabrication process, which can be time-consuming 
and expensive, pore casting be easily customized for a specific tissue application. The 
same silicon mold can be used for casting pores in multiple materials which would allow 
researchers to isolate the effects of a particular material irrespective of pore size and 
distribution. Similarly, a different photomask pattern can be used with the same etching 
recipe to alter pore size, shape, and distribution. As a result, pore casting is uniquely 
positioned as an accessible and robust technique for the production of porous scaffolds 
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customized for 2D tissues. This degree of control will be most important in applications 
where topography and pore characteristics are critical to the success of the engineered 
tissue. 
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5. RETINAL PIGMENT EPITHELIUM ON PORE-CAST SCAFFOLDS 
5.1 Introduction 
Dry AMD is a slowly progressing disease that eventually results in central vision 
loss. Although a non-invasive pharmacological treatment would be ideal, the mechanisms 
underlying AMD progression are largely unknown. In addition, AMD may actually be a 
group of diseases with the same eventual pathology, RPE dysfunction leading to 
subsequent photoreceptor degeneration, and therefore not unanimously respond to one 
druggable biochemical pathways. As a result, cell-based approaches have been proposed 
as a promising strategy for the treatment of AMD with a particular focus on RPE 
transplantation into the sub-retinal space. In this strategy, healthy RPE would be 
implanted beneath a patient's retina prior to photoreceptor atrophy. The transplanted cells 
would then perform the homeostatic functions of healthy native RPE to maintain a 
microenvironment that promotes the survival of nearby photoreceptors and the 
choriocapillaris. Because adult RPE are quiescent (non-dividing or very slowly dividing), 
alternative cell sources such as fetal human RPE (fhRPE) [63], embryonic stem cell-
derived RPE [65] , and induced pluripotent stem cell (iPSC)-derived RPE [64] have been 
proposed. Fortunately, AMD is typically diagnosed years before substantial vision loss 
has occurred which presents a large time window for preventative treatment. This is 
especially exciting because it provides the time needed to collect and transform 
fibroblasts into patient-matched iPSC-derived RPE that will not be rejected or require 
immune suppression [174]. In addition to finding an adequate cell source, this therapy is 
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also likely to require a tissue engineering scaffold to support the formation of a confluent 
and mature RPE monolayer [70]. 
RPE implantation without scaffolds (e.g. bolus injections of single-cell 
suspensions) have failed because cells did not adhere and self-organize in the sub-retinal 
milieu [5]. Efforts to repopulate native BrM have achieved similarly poor results due to 
age- and disease-related changes to local ECM [ 6-9]. Therefore, it has become 
increasingly clear that RPE and BrM from a diseased eye must be removed and replaced 
with healthy analogs to restore appropriate long-term function. As mentioned in Chapter 
2, many materials have been implanted in the sub-retinal space with varying degrees of 
biocompatibility. This study aims to characterize the in vitro behavior of RPE on a thin, 
pore-cast PCL film as a potential scaffold for therapeutic RPE delivery in AMD. 
PCL was selected for its proven biocompatibility with the sub-retinal space of 
m1ce and pigs [11,80] and ability to degrade in vivo. Unfortunately, solid PCL is 
impermeable to metabolites and therefore will not support the transport between the 
choroid and photoreceptors as a continuous sheet. Therefore, PCL scaffolds with 
micropattemed pores were fabricated to ensure that cells had uniform and redundant 
access to pores in order to permit sufficient metabolite exchange. This chapter assesses 
the behavior of thRPE cells on pore-cast scaffolds compared to non-porous PCL and 
Costar polyester transwells with 400nm track-etched pores, the standard in vitro culture 
and maturation substrate in the RPE field. fhRPE were used due to their availability and 
capacity for in vitro expansion. Cells were observed after 1, 4, and 8 weeks of culture to 
track the maturation process. The metrics used to assess cell this progression included 
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assays for morphology, gene expressiOn, and key RPE functions (protection against 
oxidative damage, epithelial barrier formation, growth factor secretion, and outer 
segment phagocytosis). 
5.2 Pigmentation & Morphology 
Bright field microscopy revealed little-to-no fhRPE pigmentation after 1 and 4 
weeks of culture. However, after 8 weeks, fhRPE displayed varying degrees of 
pigmentation depending on their culture substrate (Figure 5.1 ). Cells on porous polyester 
transwells displayed the least amount of pigmentation with few dark cells. A slightly 
higher proportion of fhRPE on non-porous PCL appeared pigmented while the most 
pigmentation was observed on porous PCL. On all scaffolds, pigmented fhRPE appeared 
to be localized in foci interspersed amongst non-pigmented cells. Pigmentation has been 
widely used as an overt marker of RPE maturity [175], but also serves a functional role 
by absorbing light to minimize scatter for improved vision [176]. Therefore, increased 
pigmentation on porous PCL serves as an indication that these fhRPE are more mature 
and functional, at least in terms of light absorption. 
fhRPE shape and size were determined using immunofluorescence. Z0-1 and 
DAPI staining indicated that cells on all substrates generally assumed hexagonal 
morphology with nuclei located towards their lateral edge that is characteristic of RPE 
(Figure 5.2). Cell density was similar on polyester transwells and non-porous PCL, but 
significantly higher (p<0.001) on porous PCL at 8 weeks as illustrated in Figure 5.3. 
fhRPE on porous PCL achieved an average cell density of 3317 ± 171 cells/mm2 which 
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was between the average cell densities previously reported for the mid-periphery (3002 ± 
460 cells/mm2) and fovea (4220-4980 cells/mm2) [177,178]. Comparatively, fhRPE on 
porous polyester transwells and non-porous PCL were less densely packed and similar to 
the cell density found at the periphery (1600 ± 411 cells/mm2) [ 1 77] . As a result, RPE 
cultured on porous PCL are likely more suitable for sub-macular RPE replacement 
therapies that require densely packed, high-functioning cells similar to native central 
RPE. 
fhRPE cultured for 8 weeks were also imaged usmg SEM. These images 
qualitatively revealed an increase in apical microvilli on porous PCL compared to 
polyester transwells (Figure 5.4). In addition, these microvilli appeared to be more evenly 
distributed across the surface of the cell instead of localized at the cell border. In vivo, 
microvilli are present across the apical surface of the cell and in direct contact with 
photoreceptor outer segments. These microvilli play a key role mediating a number of 
RPE functions including phagocytosis of outer segment discs, nutrient/waste transport, 
and visual pigment recycling [179,180]. In addition, age and disease have been shown to 
disrupt microvilli, causing them to disorganize or atrophy [181]. Apical microvilli have 
also served to indicate that RPE are polarized and mature [182]. Therefore, increased 
RPE microvilli on porous PCL serve as another indication that this scaffold is better 
suited for retinal tissue engineering in AMD. 
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Polyester Transwell Non-Porous PCL Porous PCL 
Figure 5.1 fhRPE pigmentation on (A&D) polyester transwells, (B&E) non-porous PCL, 
and (C&F) porous PCL after 8 weeks of culture. Reprinted from Investigative 
Ophthalmology & Visual Science, McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(c:-
caprolactone) scaffolds for retinal pigment epithelium transplantation 2014;55: 1754-62. 
Copyright 2014 with permission from the Association for Research in Vision and 
Ophthalmology. 
Figure 5.2 Immunofluorescent staining of fhRPE cultured 8 weeks on (A) polyester 
transwells, (B) non-porous PCL, and (C) porous PCL. Tight junction associated protein-1 
(Z0-1) staining in green and DAPI (nuclei) staining in blue. Reprinted from Investigative 
Ophthalmology & Visual Science, McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(c:-
caprolactone) scaffolds for retinal pigment epithelium transplantation 2014;55:1754-62. 
Copyright 2014 with permission from the Association for Research in Vision and 
Ophthalmology. 
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Polyester Non-Porous Porous 
Transwell PCL PCL 
Figure 5.3 fhRPE density ( cells/mm2) after 8 weeks of culture on polyester transwells, 
non-porous PCL, and porous PCL. Data reported as mean ± standard error of the mean. 
*** p<O.OOl. Reprinted from Investigative Ophthalmology & Visual Science, McHugh 
KJ, Tao SL, Saint-Geniez M. Porous poly(£-caprolactone) scaffolds for retinal pigment 
epithelium transplantation 2014;55:1754-62. Copyright 2014 with permission from the 
Association for Research in Vision and Ophthalmology. 
Polyester Transwell Porous PCL 
Figure 5.4 Scanning electron microscopy images showing microvilli density and 
distribution on the apical surface of fhRPE cultured on (A&C) polyester transwells and 
(B&D) porous PCL for 8 weeks. 
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5.3 Barrier Function 
Epithelial barrier formation was assessed using tight junction staining (Figure 5 .2) 
and TER (Figure 5.5). Z0-1 staining of fhRPE cultured for 8 weeks on polyester 
transwells was generally diffuse, though faint localization was observed at cell borders. 
Cells on non-porous PCL displayed moderate Z0-1 localization at cell-cell borders, but 
again showed a considerable amount of diffuse intracellular staining. In comparison, Z0-
1 staining of fhRPE on porous PCL was more intense and continuous at the cell-cell 
interface indicating the formation of mature tight junctions. Intense Z0-1 staining, like 
that seen on porous PCL, has been associated with the native macular RPE while low 
intensity staining, like that observed on porous polyester transwells, is characteristic of 
peripheral RPE [ 183]. Thus, porous PCL scaffolds again appear to be a superior option 
for cell-based AMD therapies as they elicit a macular fhRPE phenotype that may be 
indicative of enhanced function. 
The improvement in tight junction formation was quantitatively confirmed by 
measuring TER. Figure 5.5 illustrates the progression of cell-derived electrical resistance 
over the course of 8 weeks. At all time points other than day 0, fhRPE on porous PCL 
exhibited a significantly higher resistance than cells on polyester transwells (p<0.01); 
however, the statistics for time points greater than 28 days are not reported due to the 
limited number of biological duplicates used (n=2). While the resistance of fhRPE on 
transwells increased slowly and plateaued, the resistance of cells on porous PCL 
increased rapidly and continued to increase through 8 weeks of culture. By the end of the 
study, fhRPE on transwells and porous PCL achieved TER values of 31 ± 2 and 182 ± 4 
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Q*cm2 respectively. Although not the highest TER values reported for fhRPE in vitro, the 
difference between these values help to illustrate the importance of cell culture substrate. 
Similar TER of commercially-available RPE bad been previously reported by Geisen and 
colleagues [184] who observed a plateau at 25 Q*cm2 on polyester transwells--very 
similar to the maximum TER on transwells in our study. Suboptimal TER is likely a 
consequence of using commercially-available cells which are aggressively isolated, 
shipped frozen, and used at a higher passage than in-bouse isolated fhRPE [ 185-187]. 
While the protocols for isolating fhRPE have been published [63,188], limited tissue 
availability prohibited our group from using these cells. However, in spite of the poor 
quality of cells relative to in-house isolated fhRPE that had never been frozen, these cells 
were able to achieve 6-fold higher resistance on porous PCL than transwells in just 8 
weeks. Because barrier formation is required for many homeostatic functions including 
fluid transport, maintenance of the blood-retinal barrier, and polarized growth factor 
secretion [176], the substantial increase in resistance by cells on porous PCL may be 
especially critical for success in RPE transplantation therapies. 
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Figure 5.5 Transepithelial resistance (Q*cm2) of fetal human RPE on polyester transwells 
and porous PCL over time. Data reported as mean ± standard error of the mean. ** 
p<O.Ol, *** p<O.OOl. Note that data from greater than 28 days was not subject to 
statistical measures because only two biological replicates were used. Reprinted from 
Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, Saint-Geniez M. 
Porous poly(£-caprolactone) scaffolds for retinal pigment epithelium transplantation 
2014;55:1754-62. Copyright 2014 with permission from the Association for Research in 
Vision and Ophthalmology. 
5.4 Gene Expression 
Gene expression analysis of fhRPE cultured for 1 and 4 weeks on each substrate 
revealed several differentially-expressed genes associated with RPE differentiation, 
homeostasis, and function (Tables 5.1 & 5.2). While a majority of the genes tested did 
not display major differences between culture substrates, many genes critically involved 
in visual or neurotrophic functions such as RPE65, RLBPl, BESTl, and SERPINFl 
(PEDF) were strongly upregulated in RPE cultured on porous PCL compared to polyester 
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transwells (Figure 5.6). Interestingly, the enzyme SOD2, which acts as an antioxidant in 
RPE [189], was downregulated on porous PCL suggesting that these cells may be under 
less oxidative stress than cells on either control material. In addition, there were also a 
number of ECM-associated genes that were differentially expressed by fhRPE on porous 
PCL and polyester transwells (Figure 5.7). Collagen I, MMP2, and MMP7 were all 
significantly downregulated on porous PCL while collagen IV, laminin, fibronectin, and 
decorin trended down, though not significantly. This universal downward trend in the 
expression of genes associated with ECM and ECM-modifying proteins suggests that 
RPE are not remodeling their physical microenvironment on porous PCL as actively as 
they are on polyester transwells. This may indicate a preference for the mechanical 
properties of PCL compared to polyester which are substantially lower. 
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Table 5.1 Relative gene expression by fhRPE after 1 week of culture 
Trans well Non-porous PCL Porous PCL 
OCLN 1.00 ± 0.02 0.97 ± 0.03 0.93 ± 0.04 
ATP1A2 1.00 ± 0.02 1.04 ± 0.04 1.08 ± 0.05 
RPE65 1.03 ± 0.18 0.86 ± 0.14 3.90 ± 0.62* 
MITF 1.01 ± 0.08 0.95 ± 0.02 0.87 ± 0.10 
RLBP1 (CRALBP) 1.00 ± 0.03 0.79 ± 0.08 1.50 ±0.27 
OTX2 1.01 ± 0.13 0.94 ± 0.02 0.99 ± 0.09 
VEGFA 1.00 ± 0.04 1.06 ± 0.05 0.96 ± 0.15 
PEDF 1.01 ± 0.11 1.38 ± 0.13 2.03 ± 0.75 
EZR 1.01 ± 0.11 0.89 ± 0.09 1.01 ± 0.15 
THBS1 1.05 ± 0.20 0.60 ± 0.04 0.44 ± 0.07* 
BEST1 1.00 ± 0.06 0.65 ± 0.02** 3.39 ± 0.97 
COL1A1 1.05 ± 0.07 0.95 ± 0.07 0.58 ± 0.10* 
COL18A1 1.00 ± 0.06 1.14 ± 0.17 1.08 ± 0.14 
COL4A4 1.00 ± 0.01 0.83 ± 0.09 0.94 ± 0.15 
LAMB2 1.00 ± 0.04 0.67 ± 0.06** 0.97 ± 0.12 
FN1 1.01 ± 0.12 0.97 ± 0.23 0.68 ± 0.16 
DCN 1.00 ± 0.07 1.54 ± 0.30 0.84 ± 0.30 
ELN 1.01 ± 0.10 0.83 ± 0.15 0.98 ± 0.23 
LOX 1.01 ± 0.08 0.77 ± 0.17 0.51 ± 0.25 
FGF2 1.02 ± 0.15 0.86 ± 0.19 0.83 ± 0.11 
NGFB 1.00 ± 0.05 0.90 ± 0.16 1.62 ± 0.91 
TFEB 1.00 ± 0.05 1.00 ± 0.12 1.30 ± 0.17 
TJP1 (Z0-1) 1.00 ± 0.07 0.86 ± 0.11 1.11±0.13 
MY07A 1.00 ± 0.07 2.28 ± 0.24** 2.78 ± 0.49* 
MMP2 1.00 ± 0.04 1.25 ± 0.04* 1.46 ± 0.26 
MMP7 1.00 ± 0.05 0.98 ± 0.02 0.97 ± 0.14 
SOD2 1.00 ± 0.03 1.44 ± 0.11 * 1.47 ± 0.22 
NOTCH2 1.01 ± 0.08 1.60 ± 0.17* 1.84 ± 0.19* 
Note: values represent mean± standard error of the mean. * p<0.05, ** p<0.01 
compared to fhRPE on transwells. 
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Table 5.2 Relative gene expression by fhRPE after 4 weeks of culture 
Trans well Non-porous PCL Porous PCL 
OCLN 1.00 ± 0.03 1.19 ± 0.02* 1.09 ± 0.01 
ATP1A2 1.00 ± 0.03 0.84 ± 0.01 * 0.91 ± 0.01 
RPE65 1.00 ± 0.07 0.43 ± 0.06** 6.45 ± 0.46*** 
MITF 1.00 ± 0.07 0.94 ± 0.07 0.85 ± 0.05 
RLBP1 (CRALBP) 1.01 ± 0.09 1.19±0.18 2.19 ± 0.34* 
OTX2 1.00 ± 0.07 1.08 ± 0.14 0.93 ± 0.06 
VEGF 1.00 ± 0.07 0.88 ± 0.05 1.16±0.05 
PEDF 1.00 ± 0.06 1.84 ± 0.65 2.43 ± 0.13*** 
EZR 1.00 ± 0.01 1.07 ± 0.12 1.22 ± 0.03 * 
THBS1 1.02 ± 0.14 1.55 ± 0.51 1.25 ± 0.18 
BEST1 1.01 ± 0.10 0.67 ± 0.12* 1.74 ± 0.12* 
COL1A1 1.02±0.14 1.13 ± 0.33 0.35 ± 0.01 ** 
COL18A1 1.01 ± 0.10 2.01 ± 0.61 0.75 ± 0.08 
COL4A4 1.03 ± 0.17 1.79 ± 0.58 0.64± 0.04 
LAMB2 1.02±0.14 1.61 ± 0.42 0.52 ± 0.09 
FN1 1.02±0.14 1.28 ± 0.52 0.54 ± 0.03 
DCN 1.01 ± 0.09 1.57 ± 0.6 0.43 ± 0.05* 
ELN 1.01 ± 0.12 1.89 ± 0.85* 0.83 ± 0.04 
LOX 1.02±0.14 1.45 ± 0.36 0.80 ± 0.10 
FGF2 1.00 ± 0.06 1.01 ± 0.01 1.03 ± 0.03 
NGFB 1.02±0.14 0.81 ± 0.15 0.70 ± 0.08 
TFEB 1.02 ± 0.13 0.66 ± 0.09 0.75 ± 0.43 
TJP1 (Z0-1) 1.00 ± 0.00 0.99 ± 0.09 0.94 ± 0.79 
MY07A 1.02 ± 0.15 1.14±0.14 1.14 ± 0.23 
MMP2 1.00 ± 0.05 0.74 ± 0.10 0.46 ± 0.06** 
MMP7 1.01 ± 0.09 0.65 ± 0.07* 0.41 ± 0.13* 
SOD2 1.00 ± 0.02 0.88 ± 0.07 0.53 ± 0.08* * 
NOTCH2 1.01 ± 0.07 1.06 ± 0.06 0.62 ± 0.11 * 
Note: values represent mean± standard error ofthe mean.* p<0.05, ** p<0.01, *** 
p<0.001 compared to fuRPE on transwells. 
Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, 
Saint-Geniez M. Porous poly(E-caprolactone) scaffolds for retinal pigment epithelium 
transplantation 2014;55: 1754-62. Copyright 2014 with permission from the Association 
for Research in Vision and Ophthalmology. 
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Figure 5.6 Relative expression of RPE-associated genes on polyester transwells, non-
porous PCL, and porous PCL including (A) function and (B) secreted growth factors. 
Data reported as mean ± standard error of the mean. * p<0.05, ** p<O.Ol, and *** 
p<O.OOl. Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, 
Tao SL, Saint-Geniez M. Porous poly(£-caprolactone) scaffolds for retinal pigment 
epithelium transplantation 2014;55 : 1754-62. Copyright 2014 with permission from the 
Association for Research in Vision and Ophthalmology. 
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Figure 5.7 Relative expression of extracellular matrix-associated genes by fhRPE 
cultured for 4 weeks. Data reported as mean± standard error of the mean. * p<0.05 , ** 
p<O.Ol. 
5.5 Growth Factor Secretion 
Secretion of the major RPE-produced growth factors , VEGF-A (subsequently 
referred to as VEGF) and PEDF, was characterized over time by ELISA. As expected, a 
significant increase in the secretion of both cytokines was observed during fhRPE 
maturation on all substrates (Figure 5.8). However, VEGF and PEDF secretion were 
highest on porous PCL mimicking the results obtained at the mRNA level (Figure 5.6) 
and suggesting that the production of these growth factors are largely controlled at the 
transcriptional level. These production and secretion rates are also similar to what has 
been previously reported for fhRPE [ 190]. While changes in VEGF expressiOn were 
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rather minor and unlikely to result in major physiological differences, PEDF expression 
was highly upregulated on porous PCL compared to polyester transwells. Because PEDF 
serves as both a neurotrophic and anti-angiogenic factor [12,191 ], upregulation on porous 
PCL may indicate a superior ability to both support photoreceptors and maintain 
neuroretinal avascularity (i.e prevent progression to wet AMD) if implementl:fd as a 
therapy. The cell culture substrate used also affected the polarization of growth factor 
secretion. fhRPE cultured on polyester transwells obtained higher apical media 
concentrations of VEGF and higher basal media concentrations of PEDF relative to the 
adjacent chamber which is the reverse of what is expected in vivo (Table 5.3). 
Alternately, cells on porous PCL assumed a secretion profile more characteristic of native 
RPE with higher levels of VEGF in the basal media and higher levels of PEDF in the 
apical media [30, 188]. 
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Figure 5.8 (A) VEGF and (B) PEDF secretion by fhRPE cultured for 4 weeks. Data 
reported as mean ± standard error of the mean. * p<0.05, ** p<0.01, *** p<O.OOl. 
Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, 
Saint-Geniez M. Porous poly(E-caprolactone) scaffolds for retinal pigment epithelium 
transplantation 2014;55: 1754-62. Copyright 2014 with permission from the Association 
for Research in Vision and Ophthalmology. 
95 
Table 5.3 VEGF and PEDF concentrations (ng/ml) in fhRPE-conditioned media 
Scaffold Apical VEGF Basal VEGF ApicalPEDF BasalPEDF 
Porous Polyester 2.14±0.14 1.73 ± 0.14 122 ± 66 183 ± 87 
Non-Porous PCL 4.40 ± 0.24*** ot 1010 ± 192 ot 
Porous PCL 2.34± 0.32 2.54 ± 0.34*** 996±317*** 918 ± 322*** 
Note: values indicate mean± standard error ofthe mean * p<0.001 compared to porous polyester. t Zero 
value due non-porous substrate. 
Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, 
Saint-Geniez M. Porous poly(c-caprolactone) scaffolds for retinal pigment epithelium 
transplantation 2014;55: 1754-62. Copyright 2014 with permission from the Association 
for Research in Vision and Ophthalmology. 
A multiplex ELISA was used to determine the production of inflammatory 
cytokines by fhRPE on each substrate in order to better evaluate the clinical potential of 
porous PCL scaffolds for RPE transplantation. The production of inflammatory cytokines 
by fhRPE on all substrates was very low compared to VEGF and PEDF and a majority of 
cytokines analyzed were not detected (<2.2pg/day) in conditioned media (Table 5.4). The 
analytes that were present above the minimum threshold for detection were EGF, 
CX3CL1, CXCL1, IL-6, and PDGF-AA, all of which were produced in similar amounts 
by fhRPE on polyester transwells and porous PCL. Of these, CX3CL1, CXCL1, and IL-6 
were all produced in such minimal amounts relative to serum levels to be negligible in 
vivo [192-194]. fhRPE on all three substrates secreted PDGF-AA at a similar rate which 
was about 5-fold higher than what has been reported for quiescent fhRPE, but much 
lower than the level produced by fhRPE after TGF-~ stimulation [195]. Overall, this 
analysis suggests that RPE on any of these three scaffolds are unlikely to significantly 
affect intrinsic inflammatory cytokine secretion by RPE. 
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Table 5.4lnflammatory cytokine production (pg/day) by fhRPE at 4 weeks 
Porous Transwell Non-Porous PCL Porous PCL 
EGF 2.07 ± 0.29 0.77 ± 0.29*** 2.08 ± 0.55 
Eotaxin ND ND ND 
FGF-2 ND ND ND 
CX3CL1 (fractalkine) 29.19 ± 4.77 20.92 ± 2.40 34.36 ± 2.89 
G-CSF ND ND ND 
GM-CSF ND ND ND 
CXCLl (GRO) 31.26 ± 2.63 28.88 ±1.42 26.93 ± 3.46 
IL-l a ND ND ND 
IL-l~ ND ND ND 
IL-lRA ND ND ND 
IL-6 15.21 ± 1.78 13.38 ± 0.74 12.08 ± 0.97 
IL-8 ND ND ND 
IL-15 ND ND ND 
IP-10 ND ND ND 
PDGF-AA 262.30 ± 9.92 245.50 ± 7.93 243.30 ± 13.47 
PDGF-AB/BB ND ND ND 
CCL5 (RANTES) ND ND ND 
TGF-a ND ND ND 
1NF-a ND ND ND 
Note: values represent mean± standard error oftbe mean. *** p<O.OOl compared to 
polyester transwells. ND =not detected (<2.2pglday). 
Reprinted from Investigative Ophthalmology & Visual Science, McHugh KJ, Tao SL, 
Saint-Geniez M. Porous poly(s-caprolactone) scaffolds for retinal pigment epithelium 
transplantation. In press doi: 10.1167/iovs.13-12833. Copyright 2014 with permission 
from the Association for Research in Vision and Ophthalmology. 
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5.6 Phagocytosis 
The phagocytic function of fhRPE on each scaffold was compared by quantifying 
the number and size of bovine photoreceptor outer segment discs (POS) bound or 
internalized after 16 hours of co-incubation. Phagocytosis was expressed as rhodopsin-
labeled fluorescence per cell (analogous to POS bound/internalized per cell) revealed no 
statistically significant difference between fhRPE cultured for 4 weeks on any of the 
substrates (Figure 5.9D). However, POS fragments were significantly smaller and more 
numerous on porous PCL compared to polyester transwells (p<O.Ol) as seen in Figure 
5.9E. After POS are shed by photoreceptors and internalized by RPE they enter 
phagolysosomes where they are degraded into their component proteins, peptides, and 
lipids. Therefore the presence of smaller, more numerous fluorescent fragments in fhRPE 
suggests that RPE on porous PCL are further along in the process of degrading POS due 
to more rapid processing. This improvement in POS degradation on porous PCL would 
be especially beneficial from a translational perspective as inadequate processing has 
been identified as a possible cause of drusen accumulation in BrM [ 69]. 
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Figure 5.9 Phagocytosis of bovine outer segments by fhRPE cultured for 4 weeks on (A) 
polyester transwells, (B) non-porous PCL, and (C) porous PCL. (D) Quantification of 
total outer segment uptake and (E) fragment size. Data reported as mean ± standard error 
of the mean. ** p<O.Ol. Reprinted from Investigative Ophthalmology & Visual Science, 
McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(E-caprolactone) scaffolds for retinal 
pigment epithelium transplantation 2014;55: 1754-62. Copyright 2014 with permission 
from the Association for Research in Vision and Ophthalmology. 
5.7 Summary 
Overall, the results of this study indicate that porous PCL enhances RPE 
morphology, packing density, barrier formation, gene expression, and protein secretion 
compared to cells on porous polyester, the current standard for in vitro RPE culture. 
Interestingly, it appears that both substrate composition and porosity have an effect on 
fhRPE behavior. However, because both polyester and PCL are synthetic and therefore 
biologically inert, the effect of substrate composition is likely due to the material 
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properties. One likely property that may cause this difference is Young's (elastic) 
modulus. The elastic modulus of spin-cast PCL (258 MPa [164]) is lower than polyester 
transwells (440 MPa, manufacturer's data) and closer to the modulus of healthy human 
BrM ( 4-19 MPa [ 196, 197]). Therefore, RPE may prefer the properties more similar to 
their native environment and demonstrate improved function. However, RPE on non-
porous PCL did not experience the same degree of improvement as cells on porous PCL 
suggesting that substrate porosity also has a beneficial effect on behavior. 
While pores may cause a minor decrease in apparent stiffness, it 1s likely that 
permeability itself is responsible for a majority of the improvement in RPE behavior. 
BrM porosity and permeability decrease with both age and disease suggesting that 
impaired basal RPE flux may contribute RPE dysfunction [48,198]. Although reduced 
flux in vivo is likely due to BrM thickening, cross-linking, or high lipid content, non-
porous artificial RPE substrates are likely to have the same effect in vitro leading to 
reduced cell function. Again, substrates that more closely approximate the properties of 
healthy native BrM are likely to achieve the best RPE behavior. In this study, the most 
porous scaffold, pore-cast PCL, demonstrated the best cell function because it was the 
most permeable. In addition to its sub-retinal biocompatibility and sufficient mechanical 
properties for surgical handling, we now demonstrate that porous PCL also improves 
RPE maturation. As a result, porous PCL, which benefits from both material properties 
and porosity, appears to be a promising scaffold for RPE maturation and delivery in cell-
based therapies for AMD. 
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6. MDCK, CAC0-2, & HUVECS ON PORE-CAST SCAFFOLDS 
6.1 Introduction 
Although pore casting was originally developed to create well-defined scaffolds 
for RPE transplantation, it may also be useful for other largely 2D tissues such as 
epithelium and endothelium. Native epithelium forms a largely 2D monolayer or 
stratified multilayer which acts as a physical barrier and regulator of transport between 
adjacent body compartments [144]. While the field of tissue engineering has overlooked 
2D tissues in recent years in favor of studying cell behavior in 3D environments 
[134,139,199-203], these tissues are likely to have the most immediate impact as 
commercialized cell-based therapies in the clinic [203-205]. The limited number of cell 
types required (as few as one), limited architectural guidance, and well-established 
history of culturing planar cells in vitro will all serve to accelerate the development of 2D 
tissue engineering. However, forming epithelial or endothelial tissues de novo is likely to 
require a scaffold that supports both appropriate tissue morphology and epithelial 
transport [137,143]. Pores in solid materials, such as those formed by pore casting, are 
capable of providing this type of selective barrier, but only if they are sufficiently small 
to prevent cell invasion. 
Epithelia are responsible for forming the interface as well as a physical, chemical, 
and sometimes immune boundary between adjacent body compartments. As a result, 
these tissues are uniquely suited to come in contact with vastly different 
microenvironments on their apical and basal sides. Membrane-bound surface proteins, 
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especially receptors and ion channels, can be preferentially located on one side or the 
other giving the cell polarized morphology and function. As with RPE, some cells require 
polarization to secrete growth factors in the appropriate direction to support adjacent 
tissues that may have very different requirements. 
Epithelial cell damage or dysfunction has been implicated in many diseases of the 
lung [206], kidney [207], and gastrointestinal track [208]. Tissue engineering is one 
approach to replace damaged or diseased tissue with healthy cells. As discussed in 
Chapter 4, promoting native epithelial organization is critical for proper tissue function 
and will require a scaffold support at some point during the cell growth and maturation 
process. However, in addition to assuming the proper morphology, many of these cells 
will also require a scaffold that supports transport through the tissue. For example, the 
key role of lung, colon, and kidney epithelia are gas (C02/0 2) exchange, nutrient 
transport, and filtration respectively, all of which require exchange between opposite 
sides of the epithelium. Therefore, pore-cast scaffolds, which support 2D cell 
organization as well as transepithelial transport, could be useful for these applications. 
Pore-cast scaffolds may also be attractive as endothelial cell scaffolds for small-
diameter vascular tissue engineering. Current research efforts to produce substitutes for 
small-diameter (<6mm) vessels has been stymied by thrombogenicity, patency, and 
bursting [209-216]. However, there is a great clinical need for these small vessels for 
vascular disease. Additionally, finding an appropriate strategy for creating these vessels 
may also help with the development of pre-vascularized engineered tissues and the study 
of angiogenesis in cancer. Several recent attempts at forming functional small-diameter 
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blood vessels have focused on rolling cell sheets with or without an underlying scaffold 
to recapitulate native architecture [212-215]. Scaffold-free approaches may encounter 
difficulties retaining their integrity when experiencing in vivo shear forces, while 
approaches using electrospun scaffolds are prone to thrombogenesis because of direct 
blood-biomaterial contact [21 0,216]. A porous yet flat scaffold may be able to overcome 
these challenges by providing mechanical support while promoting complete surface 
coverage to prevent thrombogenesis. In this chapter, we evaluate the behavior of canine 
kidney epithelial (Madin-Darby canine kidney, MDCK) cells, human colorectal epithelial 
cells (Caco-2), and primary human umbilical vein endothelial cells (HUVECs) on pore-
cast PCL and electrospun PCL. The MDCK and Caco-2 cell lines have been used 
extensively as model in vitro systems for kidney and intestine research respectively and a 
drug screening study has shown that these cells grow well on permeable supports like 
those tested in this study [217]. Likewise, HUVECs are the most commonly reported cell 
type in the vasculature due to their availability [218]. 
6.2 Electrospun Scaffold Comparison 
Electrospun scaffold properties were chosen based on handling (a practical 
requirement for surgical manipulation), inherent electrical resistance, and precedence in 
the literature [213, 219-223]. Unfortunately, obtaining these properties resulted in 
obvious differences between pore-cast and electrospun scaffolds. Electrospun scaffolds 
appeared to have a generally rough surface topography and possessed pores that were 
both larger and more variable in size. However, electrospun fiber diameter was similar to 
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several previous studies that used these meshes for tissue engineering of small diameter 
vessels [219-221], though other reports used smaller fibers with an average diameter of 
500-1000nm [213,222,223]. In any case, average fiber diameter alone is not fully 
representative of scaffold morphology as it fails to describe the range of fiber sizes and 
pore size distribution (which can be very broad) [213 ,224,225]. 
Electrospun scaffolds had baseline resistances of 5.2 ± 0.3 fhcm2 which was 
close to the 6. 7 ± 0.5 Q*cm2 of pore-cast scaffolds, although not quite statistically similar 
(p=0.06). Alternately, electrospun scaffold morphology qualitatively appeared very 
different than pore-cast PCL (Figure 6.1). Electrospun fibers were 3.68 ± 0.57!J.m in 
diameter and resulted in surface-level pores 8.85 ± 4.40!J.m across and significantly larger 
than cast pores at 0.68 ± 0.02!J.m (p<0.001). The scaffolds were also much thicker at 246 
± 23!J.m compared to 10 ± O!J.m (p<0.001). Fast Fourier transform analysis revealed that 
the scaffold did not display a preferred fiber orientation (p=0.84). 
Figure 6.1 Scanning electron microscopy image of (A) electrospun and (B) pore-cast 
PCL scaffolds with very different morphology and pore size. Reprinted from Springer 
and the Journal of Materials Science: Materials in Medicine, 24, 2013 , 1659-70, A novel 
porous scaffold fabrication technique for epithelial and endothelial tissue engineering, 
McHugh KJ, Tao SL, Saint-Geniez M, Figure 3, Copyright 2013 with kind permission 
from Springer Science and Business Media. 
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6.3 Cell Adhesion 
Twenty-four hours after seeding, 92.5 ± 2.5% of MDCK cells were adherent to 
the electrospun scaffold compared to 97.1 ± 1.5% on pore-cast scaffolds (p<O.OO 1 ). 
Caco-2 cells showed similar plating efficiencies on each material with 89.8 ± 1.5% 
adherence on electrospun PCL compared to 89.8 ± 2.0% on pore-cast scaffolds (p=0.96). 
HUVECs also displayed statistically similar levels of adherence on each scaffolds with 
97.1 ± 0.3% and 97.2 ± 0.6% adhesion on electrospun and pore-cast PCL respectively 
(p=0.85). These results are summarized in Figure 6.2. 
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Figure 6.2 Percentage of adherent cells on electrospun and pore-cast PCL 24 hours after 
seeding. Data reported as mean± standard error of the mean. ** p<O.Ol. Reprinted from 
Springer and the Journal of Materials Science: Materials in Medicine, 24, 2013 , 1659-70, 
A novel porous scaffold fabrication technique for epithelial and endothelial tissue 
engineering, McHugh KJ, Tao SL, Saint-Geniez M, Figure 4, Copyright 2013 with kind 
permission from Springer Science and Business Media. 
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6.4 Cell Morphology 
MDCK cells on electrospun scaffolds closely followed the shape of the 
underlying fibers and as a result, displayed non-epithelial, 3D tissue architecture (Figure 
6.3). Scaffold coverage appeared to be incomplete with poor coverage between widely-
spread fibers. In addition, many cells with rounded morphology were present, particularly 
those just below the surface layer of fibers. Alternately, MDCK cells on pore-cast PCL 
completely covered the scaffold surface as a confluent monolayer with individual cells 
assuming well-spread, polygonal morphology (Figure 6.3, column 1). Caco-2 cells on 
electrospun PCL formed small islands separated by large areas of exposed scaffold. Cell 
coverage was poor even in the most densely populated regions (Figure 6.3, column 2). 
Compared to MDCK, Caco-2 cells appeared more capable of spanning large pores. As a 
result, scaffold invasion was reduced, though still present in some areas. In contrast, 
Caco-2 cells on pore-cast scaffolds were well-spread, flat, and completely covered the 
surface as a confluent monolayer. HUVECs on electrospun PCL exhibited poor surface 
coverage and appeared suspended between fibers at the surface and several layers below 
(Figure 6.3 , column 3). Cells also displayed numerous cell processes that extended to 
adjacent fibers and nearby cells. HUVECs on pore-cast scaffolds were confluent and 
well-spread with processes extended radially to adjacent cells. 
Taken together, these results suggest that the minimum pore size conducive to 
infiltration varies by cell type, an observation that has been previously reported by other 
groups [226,227]. The sub-micron pores in pore-cast scaffolds were sufficiently small to 
prevent endothelial cell invasion and promote the formation of a cell monolayer while the 
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large pores in electrospun scaffolds could not. Caco2 cells displayed some ability to span 
the large pores in the electrospun meshes, but MDCK and HUVECs migrated freely into 
the scaffold creating a multi-layered tissue not characteristic of normal kidney epithelium 
or endothelium. HUVEC invasion of electrospun scaffolds was especially surprising 
because a previous study had found that these cells attached and spread on 6J.Lm 
electrospun fibers at similar levels as on flat tissue culture polystyrene [219]. Thus, the 
smaller (3.67J.Lm) fibers used in this study were expected to induce a similar, if not better, 
morphological outcome, but instead caused cells to stretch between fibers at and below 
the surface. 
Figure 6.3 Scanning electron microscopy images of MDCK, Caco-2, and HUVECs 
cultured for 3, 7, and 14 days respectively on electrospun and pore-cast PCL scaffolds. 
The white arrowheads indicate cracking which is an artifact of dehydration/fixation and 
not representative of true cell morphology. Reprinted from Springer and the Journal of 
Materials Science: Materials in Medicine, 24, 2013, 1659-70, A novel porous scaffold 
fabrication technique for epithelial and endothelial tissue engineering, McHugh KJ, Tao 
SL, Saint-Geniez M, Figure 5, Copyright 2013 with kind permission from Springer 
Science and Business Media. 
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6.5 Cell Organization & Tight Junction Formation 
MDCK cells on electrospun scaffolds displayed virtually no Z0-1 localization at 
cell-cell borders, but stained intensely for f-actin in stress fibers centralized within dense 
cell clusters (Figure 6.4, row 1, asterisks). Cell nuclei appeared to deform around 
electrospun fibers and were visible in multiple focal planes indicating scaffold 
penetration. Alternately, MDCK on the pore-cast scaffolds appeared to form a monolayer 
of polygonal, flat, and well-distributed cells with centralized nuclei. Z0-1 staining 
revealed intense localization at cell-cell borders indicating the proper tight junction 
formation (Figure 6.4, row 2, arrowheads). All cell types including MDCK exhibited 
minimal f-actin staining on pore-cast scaffolds, so fluorescent intensity was increased 
using image processing techniques until staining became visually apparent. After image 
enhancement, f-actin was found preferentially at the cell border indicating cortical 
localization of micro filaments that is characteristic of mature epithelium. 
Caco-2 cells on electrospun scaffolds showed generally poor epithelial 
morphology (Figure 6.4, row 3). Z0-1 was localized at some cell-cell junctions, but 
lacking in many others. Cortical f-actin was also only observed in a small subset of cells. 
Like MDCK, Caco-2 cell nuclei were observed in multiple focal planes suggesting 
scaffold penetration and 3D tissue formation. Caco-2 cells on the pore-cast scaffold, 
however, formed a well-organized epithelium which displayed good Z0-1 localization 
and cortical f-actin staining (Figure 6.4, row 4). Cells were evenly spread across the 
surface of the scaffold and did not appear to overlap or deform due to scaffold 
architecture. 
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Figure 6.4 Immunofluorescent staining of cells for Z0-1 (green, column 1 ), f-actin (red, 
column 2), DAPI (blue, column 3), and the merged imaged (column 4). MDCK, Caco-2, 
and HUVEC cultured for 3, 7, and 14 days respectively. Areas of cell enriched in stress 
fibers are indicated by an asterisk. Arrowheads indicate membranous Z0-1 localization. 
Asterisks indicate intense f-actin staining. In the images above, the gain and collection 
time for f-actin on pore-cast samples was drastically increased relative to electrospun 
samples to view organization. Reprinted from Springer and the Journal of Materials 
Science: Materials in Medicine , 24, 2013, 1659-70, A novel porous scaffold fabrication 
technique for epithelial and endothelial tissue engineering, McHugh KJ, Tao SL, Saint-
Geniez M, Figure 6, Copyright 2013 with kind permission from Springer Science and 
Business Media. 
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HUVECs were highly heterogeneous on electrospun PCL and displayed 
fibroblastic morphology (Figure 6.4, row 5). Z0-1 staining of HUVECs was generally 
diffuse and poorly enriched at cell borders. Numerous [-actin-positive stress fibers were 
also observed. Cells appeared to overlap in most locations, though sparse areas of 
monolayer were present. HUVECS on pore-cast PCL displayed normal epithelial 
morphology, with uniform cell shape and prominent membranous localization of both f-
actin and Z0-1 (Figure 6.4, row 6). 
Overall, cells on electrospun scaffolds displayed heterogeneous and incomplete 
Z0-1 localization at cell-cell borders indicating that scaffold topography disrupted tight 
junction formation. However, cells on pore-cast scaffolds exhibited well-localized, 
continuous Z0-1 staining suggesting the formation of a substantial barrier. This 
observation was quantitatively confirmed by TER which was significantly higher for all 
cell types on pore-cast PCL (Table 6.1 ). Both MDCK and Caco-2 cells on pore-cast 
scaffolds quickly attained very high TER values indicating proficient epithelial barrier 
function. Although HUVECs on both scaffolds displayed a low resistance compared to 
the other cell types, this is expected for some types of endothelial cells [228]. Cells on 
pore-cast scaffolds also displayed cortical f-actin localization which is characteristic of 
mature, well-formed epithelium [229]. Alternately, cells on electrospun PCL contained 
densely-packed stress fibers that are indicative of a challenged state. 
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Table 6.1 Transepithelial resistance on pore-cast and electrospun PCL scaffolds 
Electrospm 
Pore-Cast 
Scaffold Only 
5±0 
7±1 
MDCK 
15 ± 7 
381 ± 84* 
Caco-2 
5±2 
1850 ± 240* 
HUVECs 
1 ± 1 
13 ± 2* 
Note: values expressed as mean± standard deviation.* p<0.05 compared to electrospun PCL. 
Reprinted from Springer and the Journal of Materials Science: Materials in Medicine , 
24, 2013 , 1659-70, A novel porous scaffold fabrication technique for epithelial and 
endothelial tissue engineering, McHugh KJ, Tao SL, Saint-Geniez M, Table 1, Copyright 
2013 with kind permission from Springer Science and Business Media. 
6.6 Summary 
Electrospun scaffolds inhibited the formation of a normal epithelial monolayer. 
While this poor response would likely have been mitigated somewhat by using thinner 
fibers , meshes with thin fibers were difficult to fabricate. Achieving sub-micron fibers 
with homogeneous diameter while avoiding "beading" requires a substantial development 
process [230]. Despite numerous attempts, we were unable to fabricate electrospun PCL 
fibers that met this set of criteria. However, even if thin fibers had been successfully 
fabricated, large pores with the potential for invasion would still persist due to a wide 
pore size distribution. Though decreasing fiber size decreases the spatial frequency of 
large pores, the randomness of electrospinning makes it statistically probable that large 
openings would exist somewhere in the scaffold as Kwon and colleagues [154] reported 
that 300nm fibers possessed pores 30).lm in diameter. This large maximum pore size is 
especially concerning because any cell invasion is inappropriate for 2D tissues. Kwon's 
group also found that maximum pore size increased dramatically with even slight 
increases in fiber diameter. Increasing the average fiber diameter from 300nm to 1.16).lm 
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resulted in a new maximum pore size of 400!-lm [154]. Consequently, there may be no 
ideal fiber size that achieves an appropriate balance of mechanical properties, sufficient 
porosity, and reliable prevention of cell invasion. 
Alternately, cells on pore-cast scaffolds displayed improved morphology, surface 
coverage, monolayer formation, and barrier function compared to cells on electrospun 
meshes. Cell adhesion was similar or superior on pore-cast scaffolds and generally high 
for all conditions with a minimum of 89.8% plating efficiency. As a result, it does not 
appear that adhesion should play a major role in scaffold selection. Instead, surface 
coverage and epithelial tissue architecture are more critical criteria for proper tissue 
function. While electrospun meshes performed poorly in these metrics, pore-cast 
scaffolds excelled as all three cell types appeared flat either confluent or approaching 
confluency on pore-cast scaffolds after only a brief time in culture. These properties 
would be especially valuable for engineered blood vessels in which platelet aggregation 
on exposed biomaterial surfaces results in thrombosis and loss of patency [209-211]. 
Therefore, pore-cast scaffolds show promise for 2D tissue engineering, especially for 
applications that require complete cell coverage, trans-scaffold transport, and mechanical 
properties. 
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7. COMPUTATIONAL MODELING OF OXYGEN IN THE OUTER RETINA 
7.1 Introduction 
The potential impact of drusen on metabolite delivery was first recognized during 
the original description of drusen in AMD [89], yet has been little-studied because 
ophthalmologists lack the appropriate tools. Oxygen is well known to be the limiting 
outer retinal metabolite used by photoreceptors [ 19,231 ], so hypoxia may be the 
mechanism underlying retinal degeneration in AMD. While drusen width is the standard 
method used to diagnose AMD, drusen height is actually more correlated with adjacent 
photoreceptor thinning as seen in Figure 7.1. In one study of large drusen, the 
relationship between drusen height and photoreceptor thinning was stronger than drusen 
width and thinning. Each micron of drusen height was associated with 0.32% thinning of 
photoreceptors (p<0.05) while each micron of drusen width was associated with just 
0.02% photoreceptor thinning and was not significant (p=0.42) [232]. Although 
surprising, this finding is congruent with the concept of hypoxia-induced photoreceptor 
degeneration. An increase in drusen height will at the very least increase the distance 
oxygen must diffuse from the choriocapillaris to photoreceptor inner segments and may 
further decrease delivery if the druse has a lower oxygen diffusion coefficient than the 
water-like retina [87] . Alternately, increased width will reduce oxygen transport in a less 
direct way by increasing the lateral distance excess oxygen must travel from laterally-
adjacent tissue that could otherwise ameliorate hypoxic photoreceptors over drusen. 
Other hallmarks of AMD such as thickening of BrM, decreased BrM hydrolytic 
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conductivity, and vascular dropout may interfere with oxygen delivery through similar 
mechanisms and contribute to AMD pathology [87,90,189,233]. In fact, wet AMD may 
be the body's natural vascularization response to tissue hypoxia [87]. 
This study aims to develop a patient-specific computational model to predict 
retinal degeneration in patients with AMD based on Fick's first law of diffusion: 
] = -D\l<p 
Where j is flux, D is the diffusion coefficient, 'il is the 3D spatial derivative and <p is the 
species under consideration, in this case oxygen. Unlike current methods that use drusen 
size to assess AMD severity, this approach attempts to formulate a prognosis based on 
the physiologically meaningful mechanism of hypoxia-induced photoreceptor 
degeneration. This approach is enabled by recent advances in OCT, which allows for 
non-invasive measurement of drusen size and photoreceptor thinning. [232]. Further, by 
using OCT data collected from the same patient at multiple time points, this model can be 
trained using real world outcomes and later be tested against an experimental data set 
with no knowledge of outcome to assess prognostic accuracy. 
The outer retina is ideal for modeling due to its laminar structure and well-defined 
regions of oxygen delivery and consumption. To establish the feasibility of modeling the 
outer retina, this study first used retinal parameters from literature. We then probed the 
model by introducing artificial drusen to observe the resulting effect on steady state 
oxygen concentration. From there, the project advanced to using real patient data to make 
predictions about retinal degeneration based on the results of steady state oxygen 
concentration in the retina. First, a series of OCT images was used to reconstruct a 
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patient's retinal topography in silica. Then, this geometry was imported into a finite 
element modeling program (COMSOL Multiphysics) and given parameters that had been 
empirically determined. The software then applied Fick's laws of diffusion to determine 
steady state oxygen concentration throughout the retina for the given geometry. These 
results were then compared to the change in retinal thickness at a later time point to 
observe spatial correlation between regions of predicted hypoxia and photoreceptor 
degeneration. 
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Figure 7.1 Scatter plots showing a good correlation between photoreceptor layer thinning 
and drusen (A) height or (B) width. Reprinted from Ophthalmology 2009, 116, Schuman 
SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA, Photoreceptor layer thinning 
over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-
domain optical coherence tomography, 488-96, Copyright 2009 with permission from the 
American Academy of Ophthalmology. 
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7.2 Assumptions 
All oxygen is consumed at the photoreceptor inner segment and is directly related 
to the volume occupied. In the outer retina, a vast majority of oxygen is consumed by 
photoreceptors while comparatively negligible amount is consumed by the RPE [234]. 
Ignoring the oxygen consumption from other layers has been suggested by other groups 
to create an accurate, yet simplistic model of the outer retina [ 108,231]. Photoreceptors 
constitute four layers of the outer retina (the outer segment, inner segment, ONL, and part 
of the OPL), but only the inner segments contain mitochondria that metabolize oxygen to 
generate ATP [33,87]. Therefore, only tissue within the outer segment layer consumed 
oxygen. This region was bounded by the inner segment-outer segment junction and the 
external limiting membrane at the bottom and top respectively. Also, because cellular 
oxygen consumption has been reported per tissue mass, the retinal tissue was assumed to 
be the density of water (lg/cm3). As a result, oxygen consumption in the inner segment 
layer was proportional to the volume of that layer. 
Oxygen transport is based on Fick's laws of diffusion. While the RPE pumps fluid 
from the retina into the sub-retinal space, this occurs on a drastically longer time scale 
than oxygen diffusion and can safely be ignored (Peclet number 5 x 10-5 to 5 x 10-3) 
[8,235]. The oxygen diffusion coefficient for all areas was set to be equal to those 
previously measured for retina and healthy Bruch's membrane and roughly equal to water 
[236,237]. Other groups have also used this approach to model oxygen transport in the 
retina [234]. 
The choriocapillaris was treated as a homogenous boundary with fixed oxygen 
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concentration. Like the retinal vasculature, the choriocapillaris is a vascular plexus. 
However, unlike the retinal vasculature, the choriocapillaris is unable to auto-regulate 
flow, instead relying on a consistently high flow to achieve a high oxygen concentration 
at the vessel-BrM interface and minimal drop (1 %) in concentration from arteriole to 
venule [98,99]. Because hemoglobin is only present within the vasculature, the maximum 
oxygen concentration at the vessel-BrM interface is limited by oxygen solubility in 
extracellular fluid (set equivalent to water at 37°C) according to Henry's law. As SD-
OCT and fundus are currently unable to distinguish vascular density beneath the retina 
this model did not include the potential effects of vascular dropout, although these 
changes could be incorporated as imaging improves. 
The deep retinal vasculature was treated as a homogenous layer with either 
constant oxygen flux or at a fixed oxygen concentration above the OPL. These vessels 
form a plexus with inter-capillary spacing that is fairly negligible compared to the 
distance from the photoreceptor inner segments. It is unclear if this boundary should 
behave as an oxygen source with constant flux or constant concentration. On one hand, 
the use of constant flux reflects the ability of the retinal vasculature to auto-regulate flow 
in order to achieve consistent metabolite delivery [231]; however, the true bottleneck of 
the system is dissolved oxygen which is concentration-limited suggesting that constant 
concentration may be more appropriate. These two methods were compared using patient 
data from the training set. Finally, while modeling this vasculature directly above the 
fovea may not accurately represent the true physiology, as no retinal vessels are present 
in this region, this was a compromise made to simplify the model and remove manual 
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bias in determining foveal location. 
The model is representative of the parameters used under dark adaptation - the 
retina's more metabolically active state. As aforementioned, the retina uses more oxygen 
when protected from light due to the substantial metabolic cost associated with 
maintenance of the dark current. Therefore, initial modeling parameters were assigned 
based on results from dark adaptation studies. 
Retinal curvature is negligible at the length scale of oxygen diffusion. OCT 
segmentation was translated into rectangular coordinates with the bottom of the BrM 
serving as the flat base. This slight decrease in curvature should not have any appreciable 
effect on oxygen transport as the change will be reflected in all retinal layers including 
those responsible for supplying and consuming oxygen. The use of slightly curved 
surfaces as flat has been reported for both OCT collection [238] and outer retinal 
modeling [108] without issue. 
7.3 Parameter Selection 
Due to the invasiveness of reliable oxygen measurement techniques in the human 
retina, a majority of the parameters used were derived from animal studies. For example, 
photoreceptor oxygen consumption was set to that obtained experimentally in cats 
[97,105]. However, human parameter values were used whenever they were available in 
the existing literature. Many studies have used histology and, more recently, OCT, to 
study average retinal geometry, so these retinal measurements were implemented for the 
generalized model of the outer retina [33,86,104,239]. 
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7.4 Generalized Model of Outer Retinal Oxygen 
Before attempting to model oxygen using real patient data, a generalized model of 
the healthy outer retina was first created. Based on the parameters in Table 7.1 and 
morphological parameters available in the existing literature, a slab model was 
constructed. This model contained BrM, metabolically-inert RPE and photoreceptor outer 
segments, metabolically-active photoreceptor inner segments, and an inert ONL. The 
bottom of the BrM layer was set to a constant oxygen concentration to mimic the choroid 
and the top of the ONL was set to constant oxygen flux to represent the deep retinal 
vasculature. Oxygen consumption only occurred at the photoreceptor inner segment layer 
and was uniform in the xy-plane. 
Finite element modeling of this healthy retinal geometry resulted in an oxygen 
profile that was similar to those see in experimental studies (Figure 7.2) [86]. Oxygen 
concentration was highest near the choroid, dropped to a minimum in the inner segment 
layer, and reached a local maximum at the retinal vasculature. These results encouraged 
further model analysis using simulated drusen. Although drusen come in various shapes 
and sizes depending on the type of druse, many hard drusen are hemispherical (Figure 
7.3) [240]. Further, 63f.lm is a critical size threshold used for dry AMD diagnosis. Drusen 
with a diameter less than 63 f!m are seen as non-pathogenic while larger drusen are 
considered a risk factor for disease progression. Therefore, a 63 f!m hemispherical drusen 
was inserted into the model to probe its effects on local oxygen concentration. Although 
not consuming oxygen, the drusen caused vertically adjacent retinal layers to move 
farther from the choriocapillaris (the main source of oxygen), resulting in decreased 
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delivery (Figure 7.4A). Remarkably, this druse caused the m1mmum oxygen 
concentration to drop from 5 mmHg to nearly 0 mmHg (Figure 7.4B) suggesting that 
631J.m is clinically useful for AMD diagnosis because it corresponds generally with 
anoxia. Subsequent trials with larger drusen yielded anoxic regions of increasing size. 
Table 7.1 Retinal oxygen modeling parameters from literature 
Variable Value Species Source 
Oxygen diffusivity in retina 1.97x10-5 cm2/sec Cat [236] 
Oxygen consmnption by inner segments 3.33 ~(g*sec) Cat [234] 
Percent oxygen supplied by choroid 85% I 89% (in dark/light) Monkey [86,104] 
Partial pressure of oxygen at choroid 48mmHg Monkey [104] 
Partial pressure of oxygen at inner segment 3.8 rmnHg Monkey [104] 
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Figure 7.2 Oxygen concentration through a generic slab model of the outer retina. (A) 
Oxygen concentration (mM) through the outer retina which approaches, but does not 
reach zero. (B) Oxygen profile through the depth of the in silico retina (blue) overlaid 
onto an experimentally-determined profile from cat. Part B adapted from Linsenmeier 
RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the 
normal and detached retina. Investigative Ophthalmology & Visual Science 
2000;41:3117-23. 
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Figure 7.3 (A-F) Hard drusen size and shape. Soft drusen are typically wider, but not as 
tall. Reprinted from Johnson PT, Lewis GP, Talaga KC, Brown MN, Kappel PJ, Fisher 
SK, Anderson DH, Johnson LV. Drusen-associated degeneration in the retina. 
Investigative Ophthalmology & Visual Science 2003 ;44:4481-8. 
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Figure 7.4 Introduction of a druse into the in silico outer retinal modeL (A) A 
hemispherical druse 63J..Lm in diameter in the retina and (B) resulting change in partial 
pressure of oxygen. The green line indicates normal oxygen profile through the thickness 
of the retina while the blue line shows the oxygen profile through the druse. Note that the 
minimum partial pressure of oxygen is lower and shifted to the right with a 63J..Lm druse 
because the photoreceptor inner segments are vertically displaced. 
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7.5 Patient-Specific Models of Outer Retinal Oxygen 
Although interesting in the general sense, the slab retinal model is not particularly 
useful for diagnosis, prognosis, or treatment of individual patients. As a result, this study 
aimed to model outer retinal oxygen using real patient data (Figure 7.5A). The first 
challenge of this approach was to accurately defme retinal topography. Initially, this 
process was performed by hand-tracing key retinal layers: BrM, RPE, photoreceptor 
inner segment-outer segment junction, external limiting membrane, and the top of the 
ONL. Though successful (Figure 7.5B), this approach was prone to tracer bias and very 
time intensive, limiting its value. As a result, automated retinal layer segmentation which 
also included tracing of additional retinal layers was used to map the retinal layer as 
previously described (Figure 7.5C) [133]. Measurements from individual OCT images 
were then combined to create 3D heat maps of retinal layer thickness. An example of 
numerous layers from one patient with early AMD can be seen in Figure 7.6. Heat map of 
drusen height and distribution may also be useful when overlaid onto fundus photography 
(Figure 7.7). 
Retinal geometry was then imported into COMSOL Multiphysics and analyzed 
using finite element modeling. After a cursory analysis, it was clear that external limiting 
membrane segmentation was unreliable, which is a common problem with this 
segmentation technique (Dr. Sina Farsiu, personal communications). As a result, other 
methods were used to determine the thickness of this layer. Multiple associations were 
attempted, but the best representation of this layer was as 40% the thickness of the 
photoreceptor outer segment layer located directly below that location. This results in a 
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thickness that is still physiologically meaningful function since outer segment and inner 
segment thickness should be related. Also, because visual artifacts are common between 
the ONL and OPL, the sum of these layers was used as the output for retinal 
degeneration. Even after these considerations, it was apparent that patient-derived 
topography was substantially different from the geometry of the generalized in silico 
retina. Therefore, oxygen parameters at the choriocapillaris and deep retinal vasculature 
interfaces were altered as needed to optimize predictive capability. A cohort of 5 patients 
with early to intermediate AMD (AREDS stage 2-3) were used to train the parameters of 
the model which are included in Table 7 .2. The time between OCT collections for 
patients 1, 2, 3, 4, and 5 were 2 years 9 months, 1 year 2 months, 11 months, 1 year 1 
month, and 1 year 8 months respectively. 
Table 7.2 Patient-specific modeling parameters 
Modeling Parameter 
Diffusion Coefficient of02 in the Retina 
Diffusion Coefficient of02 in Bruch's Membrane 
Photoreceptor Inner Segment 0 2 Consumption 
Chroidal 0 2 Supply 
Deep Retinal Vasculature 0 2 Supply 
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Value 
1.97x10-9 m2/s 
1.97x10-9 m2/s 
0.1488 moVm3*s 
137)-M (fixed concentration) 
32)-M (fixed concentration) 
Figure 7.5 OCT images as (A) raw data and after (B) manual or (C) automatic 
segmentation. From bottom to top these lines trace BrM (yellow), RPE (cyan), the 
photoreceptor inner segment-outer segment junction (magenta), the external limiting 
membrane (blue), ONL (green), OPL (yellow), inner nuclear layer (cyan), ganglion cell 
layer (magenta), and nerve fiber layer (blue). Note that the top four layers were not 
manually traced as they were not initially used for modeling. 
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Figure 7.6 Topographical maps of retinal layers from a patient with early dry AMD 
including the thickness of (A) drusen and RPE, (B) outer segments, (C) inner segments, 
(D) ONL and OPL, (E) the outer retina, and (F) the full retina. Color scale in )lm. 
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Figure 7.7 Drusen visualization via fundus and OCT segmentation. (A) Fundus image as 
typically seen by ophthalmologist and (B) drusen height segmented from OCT overlaid 
onto the same image. 
After parameter training, the model was run to predict locations of steady state 
hypoxia. These regions were then compared to areas where the photoreceptor layer had 
become thinner between first and second OCT image collection. For ease of analysis, 
each in silica retina was divided into a 150 x 150 x 20 (length x width x height) point 
grid. Custom MA TLAB code determined the minimum partial pressure of oxygen 
(analogous to oxygen concentration) at a particular point which universally occurred at 
the photoreceptor inner segment. These values were used for all subsequent analysis. 
First, heat maps of retinal hypoxia were qualitatively compared to the combined 
thickness of the ONL and OPL (Figure 7.8). These images demonstrated a strong and 
consistent relationship between drusen height hypoxia, and retinal degeneration. 
Although areas of tall drusen were frequently represented in the hypoxia maps, drusen 
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that were tall but narrow did not have as severe of an effect on oxygen concentration as 
would be expected due to isotropic diffusion. 
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Figure 7.8 Predicted hypoxia versus actual ONLIOPL thinning. Each column represents 
an individual patient. The first row depicts RPE height which is corollary for drusen 
height since RPE height variance is negligible. Row 2 depicts the regions predicted to be 
hypoxic based on computational modeling of retinal geometry collected at an early time 
point (Time 1). Row 3 and 4 are the thickness of the combined ONL/OPL at Time 1 and 
during a later collection date (Time 2) respectively. Rows 1, 3, and 4 color bars are 
thickness in 11m, row 2 is oxygen concentration in 11M. 
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Quantitative analysis of model-predicted hypoxia and retinal thinning was also 
performed to assess the function of the model. In order to make a model appropriate for 
widespread use, great care was taken to limit the need for expert analysis. As a result, 
rather than identifying specific areas above large drusen, unbiased analysis of all points 
along the grid was performed. The downside of this approach was that many areas of 
lesser interest, such as those peripheral to the macula, added noise to the system. For 
example, while attempting to determine the specificity and sensitivity of the model, it 
became clear that locations of OPL and ONL thinning along the grid that were not 
changing far outnumbered those that were changing. Therefore, instead of reporting 
specificity and sensitivity, we have chosen instead to report only accuracy (Table 7.3). 
For this analysis the combined thickness of the ONL and OPL was considered thinned at 
the time of the second OCT collection if it measured less than 90% of patient-matched 
average thickness. In addition, the partial pressure threshold for pathologic hypoxia was 
set at 6 mmHg. Overall accuracy was fairly high, but type 1 error (hypoxia detected, but 
little or no degeneration observed) was common for all patients except Patient 3. 
This study then investigated the relationship between low oxygen concentration 
and retinal thinning. Instead of looking at the thickness of the ONL and OPL at the time 
of second OCT collection (which does not factor in retinal thinning prior to the collection 
of the first OCT), this second arm of the study addressed the change in ONL and OPL 
thickness between OCT collections. This approach would be especially important for 
using the oxygen model as a tool for predicting AMD progression. If the hypothesis 
linking retinal degeneration to hypoxia is correct and the model parameters are 
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appropriately set, one would expect increased thinning with lower steady state oxygen. 
We see a significant relationship between these metrics in three out of five patients 
(p<O.Ol), and the same trend, albeit not significant in a fourth patient. Again, while 
unbiased analysis of retinal physiology adds noise to the system (Figure 7.9), the 
relationship still achieves statistical significance due to the large number of points 
analyzed with the divided grid. The most important information obtained from this 
scatterplot is the slope of the linear regression line which is negative signifying "more" 
retinal thinning (a positive value) with less oxygen in four out of five patients. The slopes 
of these lines and correlation coefficients are reported in Table 7.4. The expected 
association of predicted hypoxia with retinal degeneration was not significant in Patient 1 
(p=0.08) and the opposite trend was observed in Patient 4, though this was not significant 
(p=0.80). 
Table 7.3 Relationship between hypoxia prediction and later retinal thickness 
Accuracy 
Patient 1 92.5% 
Patient 2 62.0% 
Patient 3 81.4% 
Patient 4 68.3% 
Patient 5 77.1% 
Note: for this analysis, accuracy was the frequency with which hypoxic regions (<6 
mmHg) corresponded to substantial ONLIOPL thinning and normoxic regions 
corresponded to healthy ONLIOPL thickness. 
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Figure 7.9 Pixel-by-pixel plots of combined ONLIOPL thinning versus predicted 
minimum oxygen concentration showing varying levels of correlation. Note: positive 
"thinning" values represent a decrease in ONLIOPL thickness (i.e. degeneration) while 
negative values indicate areas that have thickened. Therefore, a best-fit line with negative 
slope indicates that higher oxygen concentrations are associated with reduced thinning. 
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Table 7.4 Correlation of predicted oxygen (<10 mmHg only) with retinal degeneration 
Slope of Thinning vs. 
R2 Value 
Correlation P Value Expected 
Oxlgen Coefficient 
n Summary 
Patient 1 -0.026 0.002 0.046 1500 0.08 Yes Not Significant 
Patient2 -1.133 0.161 0.401 8426 <0.0001 Yes Less Oxygen -+ More Thinning 
Patient 3 -0.431 0.024 0.154 422 <0.01 Yes Less Oxygen -+ More Thinning 
Patient4 0.036 0.000 0.007 1479 0.8 No Not Significant 
Patient 5 -0.2 14 0.004 0.063 9413 <0.0001 Yes Less Ox:rgen -+ More Thinnin11, 
Note that a negative slope of thinning versus oxygen indicates the expected association of 
hypoxia with retinal degeneration. 
7.6 Summary 
Computational modeling of oxygen concentration in the outer retina appears to be 
a promising strategy for improved AMD prognosis. Our longitudinal study represents the 
first step toward improved this goal by demonstrating a relationship between predicted 
hypoxia and future retinal degeneration. Qualitatively, retinal thinning appears to 
preferentially occur in locations that have been identified by the model as hypoxic. 
Quantitative spatial correlation between predicted hypoxia and retinal thinning was 
somewhat less encouraging as statistically significant correlation was observed in three 
out of five patients. This inaccuracy may be due to a number of factors including sub-
optimal parameter selection, data set size, OCT resolution, or due to the assumptions used 
to simplify this preliminary form of the model. A major emphasis of future work should 
be focused on systematic parameter adjustment using a larger data set to obtain more 
consistent results. Nevertheless, this work is important because it is the first attempt to 
evaluate oxygen concentration in the back of the eye using real data from human patients. 
In addition, it is the first study that aims to analyze sub-regions of the retina rather than 
treat the tissue as a whole which will likely be critical for the future of AMD diagnosis 
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and prognosis. 
The ultimate goal of this approach is to use data from OCT to assess a patient's 
risk for future retinal degeneration. This information could be critical for determining 
which patients will progress to a visually debilitating stage of AMD and therefore require 
close medical monitoring, treatment, or lifestyle changes. Unlike current assessment tools 
which aim only to assess the current stage of AMD using morphological markers, this 
approach uses physiologically relevant data to predict future outcomes. In addition, this 
method also suggests that drusen are not only a benchmark of AMD, but also a major 
contributor to retinal degeneration. As such, pharmacologically resorbing drusen may 
present an opportunity for AMD treatment. Drusen resorption has achieved some success 
in ameliorating other sub-retinal pathologies [241,242] and is currently being studied for 
AMD. 
This study demonstrates the feasibility of performing computational simulations 
on an in silico retina reconstructed from OCT and fundus images. However, a much 
larger number of patients are needed to further train the model. Then, additional patient 
data will be needed to test the model's ability to predict degeneration in patients that are 
not part of the initial training set. In particular, a large set of healthy control patients with 
OCT images collected at multiple time points (currently unavailable), would be critical to 
better understand non-pathological retinal morphology and establish a low false detection 
rate. Finally, increasing the complexity of the model to better mimic the in vivo state, 
such as altering the diffusion coefficient of drusen and eliminating retinal vasculature 
above the fovea, will likely help improve prognostic value. 
135 
8. CONCLUSIONS 
8.1 Synopsis 
Already prevalent among the elderly, AMD is becoming even more common due 
to an aging population. While there are no treatments currently available for dry AMD, 
early diagnosis and slow disease progression present opportunities for potential 
therapeutic intervention. Herein we present a tissue engineering strategy to restore 
healthy RPE function and prevent further vision loss. In this thesis, we have presented a 
new method to create polymer scaffolds well-suited for RPE delivery, assessed the ability 
of this scaffold to promote the function of RPE and other epithelial cell types, and 
developed a method for predicting patients most likely to progress to advanced AMD and 
therefore benefit from this RPE transplantation or other therapeutic intervention. 
8.2 Pore Casting 
Pore casting is a microfabrication-based technique with the ability to produce thin 
scaffolds with extensive control over pore size, shape, and location. This level of control 
at sub-micron resolution enables tissue engineers to create scaffolds that present 
homogeneous porosity and topography rather than relying on stochastic fabrication 
processes. For example, RPE require a permeable scaffold for metabolite transport, but 
are incompatible with large pores that prevent the formation of a confluent monolayer. As 
a result, pore casting, which can reproducibly fabricate scaffolds uniformly small pores, 
is more appropriate than electrospinning, which produces scaffolds with highly 
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heterogeneous pore size across a wide probability distribution. In addition, there are 
several other characteristics of pore casting which present unique opportunities for tissue 
engineering. Control over pore shape with sub-micron resolution allows for the 
combination of topography and porosity to improve cell behavior. The ease of changing 
pore characteristics and/or component material without full process redevelopment also 
enables the systematic study of pattern and polymeric libraries which is not possible 
using competing techniques such as electrospinning and track etching. Finally, as a 
practical benefit, the ability to quickly reuse patterned molds without destruction is 
conducive to scale up which may be more commercially viable than traditional 
microfabrication-based approaches. In summary, pore-cast films appear to be well-suited 
for 2D tissue engineering, especially in applications that require high degrees of 
organization such as epithelium and endothelium. 
8.3 Pore-Cast Scaffolds for Retinal Pigment Epithelium 
This study showed that fhRPE cultured on pore-cast PCL scaffolds in vitro exhibit 
superior behavior compared to cells on non-porous PCL or track-etched polyester 
transwells, the standard RPE culture substrate. Porous PCL induced a number of 
improvements in RPE function that will likely be critical for restoring healthy tissue 
function in patients with dry AMD including increased pigmentation (light adsorption), 
improved tight junction integrity and TER (barrier formation), and polarized PEDF and 
VEGF secretion (maintenance of the photoreceptor and choroidal microenvironments 
respectively) while eliciting little inflammatory cytokine release. In addition to functional 
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improvements, porous PCL also enhanced other markers of maturation such as cell size, 
microvilli distribution, and upregulation of RPE-specific genes. These changes are likely 
due to a combination of material properties and porosity as fhRPE on porous polyester 
and non-porous PCL failed to achieve similar results. Because both the commercially-
available polyester and PCL are synthetic polymers, the most likely cause for the 
difference in cell behavior is material elasticity. The elastic modulus of spin-cast PCL is 
about half that of transwells and closer to native healthy BrM. Increased porosity also 
contributes to improved fhRPE function by more closely mimicking the permeability of 
healthy BrM. 
8.4 Pore-Cast Scaffolds for Endothelium and Epithelium 
Like fhRPE, canine kidney epithelium, human colorectal epithelium, and human 
umbilical vein endothelium exhibited improved morphology on pore-cast PCL compared 
to large-bore electrospun PCL. The most drastic difference between each scaffold was 
cell shape and surface coverage. All three cell types assumed generally flat morphology 
and completely covered the surface of pore-cast scaffolds while cells on electrospun 
scaffolds appeared stretched between fibers and failed to cover the entire surface. The 
ability to span the gaps between electrospun fibers varied based on cell type. Cells on 
pore-cast PCL also demonstrated superior f-actin and tight junction localization 
compared to electrospun meshes. The latter improvement in barrier function was also 
observed quantitatively via TER. Overall, these results suggested that pore-cast scaffolds 
represent more appropriate substrates for epithelial and endothelial cell culture. 
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8.5 Outer Retinal Oxygen Modeling 
Initial development of a patient-specific computational model for predicting 
retinal degeneration in AMD was imperfect, but promising. With the exception of the 
external limiting membrane, automated segmentation of OCT images was reliable and 
useful for determining retinal geometry. Qualitative analysis demonstrated good spatial 
agreement of hypoxia and retinal thinning; however, only three out of five patients 
exhibited the expected and significant relationship between reduced steady state oxygen 
and increased retinal thinning using quantitative analysis. Still, this work is important for 
its novel application of oxygen concentration in AMD prognosis-a major change from 
the purely responsive observation-based diagnosis currently used. While this work is still 
in its seminal stages, additional development may advance this approach to the point at 
which it can be integrated into the best practices of care for dry AMD. 
8.6 Future Work 
The most important future study for the tissue engineering portion of this thesis 
will be the in vivo evaluation of transplanted RPE on pore-cast PCL. This study was 
initiated in mice, but was too surgically challenging due to the small size of the murine 
eye. As a result, the next step will be to attempt the procedure in a larger animal model 
such as the rabbit or pig. This step will be critical for evaluating the potential of tissue 
engineered RPE to integrate with native tissue and restore function. At the same time, in 
vitro studies will be performed to optimize the pore-cast scaffold for RPE function. In the 
present experiments, a lower elastic modulus and increased porosity were both associated 
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with enhanced RPE behavior, so altering these parameters further to approach native 
BrM properties could yield additional improvements. Additionally, iPSC-derived RPE 
that are currently being developed in our and others' labs hold the potential for an ideally-
compatible cell source. 
Predictive modeling of AMD possesses its own set of challenges that must be 
overcome before approaching clinical relevance. In our study we analyzed five patients 
with AMD, but many more must be used to train the model before it will be sufficiently 
robust for widespread use. This not only requires longitudinal follow-up of patients 
which, at present, is sparse, but also optimization of modeling parameters. For this, a 
prospective study (rather than the retrospective study used here) would be ideal to obtain 
well-controlled input data. In addition, although outer retinal thickness is widely thought 
to be related to visual acuity, the exact relationship has yet to be established. Therefore, 
the prospective study could also utilize microperimetry, a technique capable of measuring 
visual acuity in a small user-defined region of the retina, to track vision loss as a function 
of photoreceptor thinning. Further, the model could be substantially improved by 
increasing the complexity of the model and incorporating the avascular fovea, thinning of 
the choriocapillaris, altering the diffusion coefficient in drusen, and differential oxygen 
consumption by the cone-rich fovea. 
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9. APPENDICES 
9.1 Appendix A: MA TLAB Code for Diffusion Coefficient Calculation 
Diff_ Coeff_ Solver. m 
clear all; 
close all; 
%CHANGE C2 (bottom chamber concentration) & t as appropriate 
C2=4.195/1 000000000; %concentration in mol/ml 
N=0.00000002; %Total moles FITC-dextran (corresponds to 200ul of 100uM) 
h1=0.001 ; %membrane thickness (em)- 0.001=10um, 0.0005=5um 
t=8*60*60; %Enter time in seconds 
V1=0.21 ; %bottom chamber volume (cm3) 
V2=0.2; %top chamber volume (cm3) 
V=V1+V2; %total system volume (cm3) 
A=0.18; %area (cm2) 
%C2=(( concentration_ mg/1 OOO)/MW)N2; 
tau=((Vl +((A *h1)/2))*(V2+((A *h1)/2)))/(A *V); 
C20=0; %initial dextran concentration in top chamber (mol/ml) 
D=-log(1-((C2*V)/N))*((tau*h1 )It) 
%Check answer 
C2 _ calc=(NN)-(N/V -C20)*exp( -(t/tau)*(D/h 1 )); 
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9.2 Appendix B: MA TLAB Code for Manual OCT Segmentation 
9. 2.1 MSG _ 001 Jar_ heatmap _script. m 
% Master m-file called "OCT"to analyze a stack of OCT images 
clear all; 
close all; 
clc; 
global ONL_top IS_top OS_top RPE_bottom BRM_bottom slice_number 
ONL _top = zeros(l 024, 16); % create master xy vector with z-values filled in for the top 
of the outer nuclear layer 
IS_ top = zeros (I 024, 16); % create master xy vector with z-values filled in for the top of 
the inner segments 
OS_top = zeros(1024,16);% create master xy vector with z-values filled in for the top of 
the outer segments 
RPE_bottom = zeros(l024,16);% create master xy vector with z-values filled in for the 
bottom of RPE 
BRM_bottom = zeros(1024,16);% create master xy vector with z-values filled in for the 
bottom of Bruch's membrane 
slice_ number = 1 ; 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG m 
odeling_ 00 1_ image26 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 00 1 \MSG m 
odeling_ 00 1_ image2 7 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 l_image28 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
ode ling_ 00 1_ image29 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 00 1 \MSG m 
odeling_ 00 l_image30 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG m 
odeling_ 00 1_ image31_ traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_image32 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image3 3 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_001_image34_traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image3 5 _traced') 
MSG _ 00 1_ for _heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_001_image36_traced') 
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MSG_OOl_for_heatmap_colors('C:\modeling_data\Traced\MSG_modeling_OOl\MSG_m 
odeling_ 00 l_image3 7 _traced') 
MSG _ 00 l_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image38 _traced') 
MSG _ 00 l_ for_ heatmap _ colors('C:\modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image3 9 _traced') 
MSG _ 00 1_ for_ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image40 _traced') 
MSG _ 00 l_for _ heatmap _ colors('C: \modeling_ data\ Traced\MSG _modeling_ 001 \MSG _ m 
odeling_ 00 1_ image41_ traced') 
% and so on ... 
% fill in straight lines for any columns that were missed by tracer 
for counter I = 1:16 
for counter2 = 2:1024 % fill in blank values left to right 
if ONL _top( counter2,counter 1) == 0 
ONL _top( counter2,counter 1) = ONL _top( ( counter2-1 ),counted); 
end 
if IS top( counter2,counter 1) == 0 
IS _top( counter2,counted) = IS _top(( counter2-1 ),counted); 
end 
if OS_ top( counter2,counter 1) = 0 
OS_ top( counter2,counter 1) = OS_ top( ( counter2-1 ),counter 1 ); 
end 
if RPE _bottom( counter2,counter 1) == 0 
RPE _bottom( counter2,counter 1) = RPE _bottom( ( counter2-1 ),counter 1 ); 
end 
if BRM _bottom( counter2,counter 1) == 0 
BRM _bottom( counter2,counter 1) = BRM _bottom( ( counter2-1 ),counter 1 ); 
end 
end 
for counter2 = 1024:-1:1% fill in blank values right to left 
ifONL_top(counter2,counterl) = 0 
ONL _top( counter2,counter 1) = ONL _top( ( counter2+ 1 ),counter 1 ); 
end 
if IS_ top( counter2,counter 1) == 0 
IS_ top( counter2,counter 1) = IS_ top( ( counter2+ 1 ) ,counter 1 ); 
end 
ifOS_top(counter2,counterl) = 0 
OS_top(counter2,counter1) = OS_top((counter2+ 1),counterl) ; 
end 
ifRPE bottom(counter2,counter1) == 0 
RPE _bottom( counter2,counted) = RPE _bottom(( counter2+ 1 ),counter!) ; 
end 
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if BRM _bottom( counter2,counter 1) == 0 
BRM _bottom( counter2,counter 1) = BRM _bottom( ( counter2+ 1 ),counter 1 ); 
end 
end 
end 
% Compute the cross-distance of one layer (x coordinate) 
Xcoordinate = ones(1 024,1 ); 
for row2 = 1 : 1 024 
X coordinate( row2) = ( row2-1) * 6.25 ; 
end 
% Compute the space between each layer (y coordinate) 
Ycoordinate = ones(166,1); 
for row3 = 1:166 
Ycoordinate(row3) = (row3-1)*6; 
end 
scalingfactor = 3.92/4;% scaling factor in microns per pixel 
ONL _thick = (IS_ top - ONL _top) * scalingfactor; 
IS_thick = (OS_top- IS_top) * scalingfactor; 
OSRPE _thick = (RPE _bottom - OS_ top) * scalingfactor; 
BRM_thick = (BRM_bottom- RPE_bottom) * scalingfactor; 
TOT_ thick = (BRM _bottom - ONL _top) * scalingfactor; %NEW 1-31-13 
% Calculates overall z-dimensions relative to others 
zBRM_RPE = BRM_thick; 
zOS_IS = zBRM_RPE + OSRPE_thick; 
ziS _ ONL = zOS _IS + IS_ thick; 
zONL_top = ziS_ONL + ONL_thick; 
Creates .stl files to be imported to Paraview 
surf2stl('BrM _1 .stl',66, 1.47 ,zBRM _bottom); 
surf2stl('RPE _l.stl',66, 1.4 7 ,zBRM _ RPE); 
surf2stl('IS-OS _ 1.stl' ,66, 1.4 7 ,zOS _IS); 
surf2stl('IS-ONL _ l.stl',66,1.47,ziS _ ONL); 
surf2stl('ONL _l.stl',66, 1.4 7 ,zONL _top) ; 
hold on; 
plot(Xcoordinate,zBRM _bottom,' cyan'); 
plot(Xcoordinate,zBRM _RPE, 'magenta'); 
plot(Xcoordinate,zOS _ IS,'red'); 
plot(Xcoordinate,ziS _ ONL,'green'); 
plot(Xcoordinate,zONL _ top,'blue'); 
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Fills in coordinates ifupsampled y is desired for data export (to DEM) 
BRM_XYZ = zeros(4096*16,3); 
RPE XYZ = zeros(1024*166,3); 
ISOS XYZ = zeros(1024*166,3); 
ILM_XYZ = zeros(1024*166,3); 
ONL XYZ = zeros(1024*166,3); 
for stack num = 1:16 
for row num = 1:1024 
BRM _ XYZ(((stack _ num-1 )*4096)+row _ num, 1) = Xcoordinate(row _ num); 
BRM _ XYZ(((stack _ num-1 )*4096)+row _ num,2) = Y coordinate( stack_ num); 
BRM _ XYZ(((stack _ num-1 )*4096)+row _ num,3) = 
zBRM _bottom( row_ num,stack _ num); 
ISOS _XYZ(((stack _ num-1)* 1024)+row _num,1) = Xcoordinate(row _num); 
ISOS_ XYZ(((stack _ num-1)* 1024)+row _num,2) = Y coordinate( stack _num); 
ISOS_XYZ(((stack_num-1)*1024)+row_num,3) = zOS_IS(row_num,stack_num); 
ILM_XYZ(((stack_num-1)*1024)+row_num,1) = Xcoordinate(row_num); 
ILM _ XYZ(((stack _ num-1 )* 1 024)+row _num,2) = Y coordinate( stack_ num); 
ILM _ XYZ(((stack _ num-1 )* 1 024)+row _ num,3) = ziS _ ONL(row _ num,stack _ num); 
ONL_XYZ(((stack_num-1)*1024)+row_num,1) = Xcoordinate(row_num); 
ONL_XYZ(((stack_num-1)*1024)+row_num,2) = Ycoordinate(stack_num); 
ONL_XYZ(((stack_num-1)*1024)+row_num,3) = 
zONL _top( row_ num,stack _ num); 
if stack num == 16 
RPE _ XYZ( ( (stack_ num-1) * 1024 )+row_ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1) * 1 024 )+row_ num,2) = Y coordinate( (stack_ num * 11 )-
10); 
RPE_XYZ(((stack_num-1)*1024*11)+row_num,3) = 
zBRM _ RPE(row _ num,stack _ num); 
else 
%Set all X coordinates for RPE 
RPE_XYZ(((stack_num-1)*1024*11)+row_num,1) = Xcoordinate(row_num); 
RPE_XYZ(((stack_num-1)*1024*10)+row_num,1) = Xcoordinate(row_num); 
RPE _ XYZ( ((stack_ num-1 )* 1024 *9)+row _ num, 1) = Xcoordinate(row _ num); 
RPE_XYZ(((stack_num-1)*1024*8)+row_num,1) = Xcoordinate(row_num); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 *7)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 *6)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 * 5)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1 )* 1 024 *4)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ((stack_ num-1 )* 1024 *3)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1 )* 1 024 *2)+row _ num, 1) = Xcoordinate(row _ num); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 )+row_ num, 1) = Xcoordinate(row _ num); 
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%Set allY coordinates for RPE 
RPE XYZ(((stack num-1)*1024*11)+row num,2) = 
- - -
Y coordinate( stack_ num * 11 ); 
RPE_ XYZ(((stack_num-1)* 1024* 10)+row _num,2) = 
Y coordinate( (stack_ num * 11 )-1); 
RPE_XYZ(((stack_num-1)*1024*9)+row_num,2) = 
Y coordinate((stack _ num* 11)-2); 
RPE_XYZ(((stack_num-1)*1024*8)+row_num,2) = 
Y coordinate( (stack_ num * 11 )-3); 
RPE_XYZ(((stack_num-1)*1024*7)+row_num,2) = 
Ycoordinate((stack_num*11)-4); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 *6)+row _ num,2) = 
Y coordinate((stack _ num* 11 )-5); 
RPE_XYZ(((stack_num-1)*1024*5)+row_num,2) = 
Y coordinate( (stack_ num * 11 )-6); 
RPE _ XYZ(((stack _ num-1 )* 1 024*4)+row _ num,2) = 
Y coordinate( (stack_ num * 11 )-7); 
RPE XYZ(((stack num-1)*1024*3)+row num,2) = 
- - -
Y coordinate((stack _ num* 11 )-8); 
RPE_XYZ(((stack_num-1)*1024*2)+row_num,2) = 
Y coordinate((stack _ num* 11 )-9); 
10); 
RPE_XYZ(((stack_num-1)*1024)+row_num,2) = Ycoordinate((stack_num*ll)-
%Interpolate all Z coordinates for RPE 
RPE_XYZ(((stack_num-1)*1024*11)+row_num,3) = 
zBRM _ RPE(row _ num,stack _ num); 
RPE_XYZ(((stack_num-1)*1024*10)+row_num,3) = 
(10*(zBRM_RPE(row_num,stack_num) + zBRM_RPE(row_num,stack_num+1))111); 
RPE _ XYZ(((stack _num-1 )* 1 024*9)+row _ num,3) = 
(9*(zBRM_RPE(row_num,stack_num) + 2*zBRM_RPE(row_num,stack_num+ 1))/11); 
RPE_XYZ(((stack_num-1)*1024*8)+row_num,3) = 
(8*(zBRM _ RPE(row _ num,stack_ num) + 3 *zBRM _RPE(row _ num,stack _ num+ 1 ))/ 11 ); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 *7)+row _ num,3) = 
(7*(zBRM _ RPE(row _ num,stack _ num) + 4 *zBRM _ RPE(row _ num,stack _ num+ 1) )/ 11 ); 
RPE_XYZ(((stack_num-1)*1024*6)+row_num,3) = 
(6*(zBRM_RPE(row_num,stack_num) + S*zBRM_RPE(row_num,stack_num+ l))/11); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 * 5)+row _ num,3) = 
(5*(zBRM _ RPE(row _num,stack _ num) + 6*zBRM _ RPE(row _num,stack _ num+ 1 ))/ 11 ); 
RPE_XYZ(((stack_num-1)*1024*4)+row_num,3) = 
(4*(zBRM_RPE(row_num,stack_num) + 7*zBRM_RPE(row_num,stack_num+1))/ 11); 
RPE _ XYZ( ( (stack_ num-1 )* 1024 *3 )+row_ num,3) = 
(3*(zBRM_RPE(row_num,stack_num) + 8*zBRM_RPE(row_num,stack_num+1))/11); 
RPE_XYZ(((stack_num-1)*1024*2)+row_num,3) = 
(2*(zBRM_RPE(row_num,stack_num) + 9*zBRM_RPE(row_num,stack_num+1))111); 
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RPE _ XYZ(((stack _ num-1 )* 1 024)+row _ num,3) = 
( (zBRM _ RPE(row _ num,stack _ num) + 1 O*zBRM _ RPE(row _ num,stack _ num+ 1) )Ill); 
end 
end 
end 
Create comma separated variable files with xyz coordinates of each feature 
csvwrite('BRM _ XYZ.csv',BRM_ XYZ); 
csvwrite('RPE _ XYZ.csv',RPE _ XYZ); 
csvwrite('ISOS _ XYZ.csv',ISOS _ XYZ); 
csvwrite('ILM _ XYZ.csv',ILM _ XYZ); 
csvwrite('ONL _ XYZ.csv',ONL _ XYZ); 
% Create txt files with xyz coordinates for dem import 
fid=fopen('RPE4DEM.txt','w'); %NEW 1-31-13 
fprintf(fid,'%f%f%f\n',RPE_XYZ'); %NEW 1-31-13 
fclose(fid); %NEW 1-31-13 
fid=fopen('ISOS4DEM. txt','w'); %NEW 1-31-13 
fprintf(fid,'%f%f%f\n',ISOS_XYZ'); %NEW 1-31-13 
fclose(fid); %NEW 1-31-13 
fid=fopen('ELM4DEM.txt','w'); %NEW 1-31-13 
fprintf(fid,'%f%f%f\n',ILM_XYZ'); %NEW 1-31-13 
fclose(fid); %NEW 1-31-13 
fid=fopen('ONL4DEM.txt','w'); %NEW 1-31-13 
fprintf(fid,'%f%f%f\n',ONL_XYZ'); %NEW 1-31-13 
fclose( fid); %NEW 1-31-13 
% 
%Heat Maps 
% 
%Creates a mesh grid of xy coordinates based on pixel spacing for x and stack spacing 
for y 
[ x,y ]=meshgrid(0:5.88 :6015 .24,0:6:990); 
% Upsampling y values in order to create a heatmap with nearly square pixels 
new_RPE = zeros(1024,166); 
new ISOS = zeros(1024,166); 
new_ILM = zeros(1024,166); 
new ONLtop = zeros(1024,166); 
new_ONLthick = zeros(1024,166); 
new_ TOTthick = zeros( 1 024, 166); 
for stack num = 1:15 
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for row num = 1:1024 
new_RPE(row_num,(stack_num*11)-10) = zBRM_RPE(row_num,stack_num); 
new_RPE(row_num,(stack_num*11)-9) = 
(10*(zBRM_RPE(row_num,stack_num)) + zBRM_RPE(row_num,stack_num+ 1))111; 
new_RPE(row_num,(stack_num*11)-8) = 
(9*(zBRM _ RPE(row _ num,stack _ num)) + 2*zBRM _ RPE(row _ num,stack_ num+ 1 ))/11; 
new_ RPE(row _ num,(stack _ num* 11 )-7) = 
(8*(zBRM_RPE(row_num,stack_num)) + 3*zBRM_RPE(row_num,stack_num+ 1))/11; 
new_RPE(row_num,(stack_num*11)-6) = 
(7*(zBRM_RPE(row_num,stack_num)) + 4*zBRM_RPE(row_num,stack_num+ 1))/11; 
new_RPE(row_num,(stack_num*11)-5) = 
(6*(zBRM_RPE(row_num,stack_num)) + 5*zBRM_RPE(row_num,stack_num+1))111; 
new RPE(row num,(stack num*11)-4) = 
- - -
(5*(zBRM _ RPE(row _ num,stack _ num)) + 6*zBRM _RPE(row _ num,stack _ num+ 1 ))/11; 
new_RPE(row_num,(stack_num*ll)-3) = 
(4*(zBRM_RPE(row_num,stack_num)) + 7*zBRM_RPE(row_num,stack_num+1))111; 
new RPE(row num,(stack num*11)-2) = 
- - -
(3*(zBRM_RPE(row_num,stack_num)) + 8*zBRM_RPE(row_num,stack_num+1))/ 11; 
new_RPE(row_num,(stack_num*11)-1) = 
(2*(zBRM_RPE(row_num,stack_num)) + 9*zBRM_RPE(row_num,stack_num+ 1))/11; 
new _RPE(row _ num,stack _ num* 11) = ((zBRM _ RPE(row _ num,stack _ num)) + 
1 O*zBRM _ RPE(row _ num,stack _ num+ 1) )/ 11; 
new_ RPE(row _ num, 166)=zBRM _ RPE(row _ num, 16); 
new_ISOS(row_num,(stack_num*11)-10) = zOS_IS(row_num,stack_num); 
new_ ISOS(row _ num,(stack _ num* 11 )-9) = (1 O*(zOS _ IS(row _ num,stack_ num)) + 
zOS _ IS(row _ num,stack _ num+ 1 ))/11; 
new_ISOS(row_num,(stack_num*11)-8) = (9*(zOS_IS(row_num,stack_num)) + 
2*zOS_IS(row_num,stack_num+ 1))/11; 
new_ISOS(row_num,(stack_num*ll)-7) = (8*(zOS_IS(row_num,stack_num)) + 
3 *zOS _IS( row_ num,stack _ num+ 1) )/ 11 ; 
new_ISOS(row_num,(stack_num*11)-6) = (7*(zOS_IS(row_num,stack_num)) + 
4 * zOS IS( row num,stack num+ 1) )/ 11 ; 
- - -
new_ISOS(row_num,(stack_num*11)-5) = (6*(z0S_IS(row_num,stack_num)) + 
5*z0S_IS(row_num,stack_num+ 1))/11; 
new_ISOS(row_num,(stack_num*11)-4) = (5*(zOS_IS(row_num,stack_num)) + 
6*zOS_IS(row_num,stack_num+ 1))/11; 
new_ISOS(row_num,(stack_num*ll)-3) = (4*(zOS_IS(row_num,stack_num)) + 
7*zOS_IS(row_num,stack_num+ 1))/11; 
new_ISOS(row_num,(stack_num*11)-2) = (3*(zOS_IS(row_num,stack_num)) + 
8 * zOS _IS( row_ num,stack _ num+ 1) )/ 11 ; 
new_ IS OS( row_ num,( stack_ num * 11 )-1) = (2 *(zOS _ IS(row _ num,stack_ num)) + 
9*z0S IS(row num,stack num+ 1 ))/11; 
- - -
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new_ISOS(row_num,stack_num*ll) = ((zOS_IS(row_num,stack_num)) + 
10*z0S IS(row num,stack num+l))/11; 
- - -
new ISOS(row num, 166)=zOS IS(row num, 16); 
- - - -
new_ILM(row_num,(stack_num*11)-10) = ziS_ONL(row_num,stack_num); 
new_ILM(row_num,(stack_num*11)-9) = (10*(ziS_ONL(row_num,stack_num)) 
+ ziS _ ONL(row _ num,stack _ num+ 1 ))/11; 
new_ILM(row_num,(stack_num*11)-8) = (9*(ziS_ONL(row_num,stack_num)) + 
2*ziS_ ONL(row_num,stack_num+ 1))/11 ; 
new_ILM(row_num,(stack_num*11)-7) = (8*(ziS_ONL(row_num,stack_num)) + 
3*ziS ONL(row num,stack num+1))/11; 
- - -
new_ ILM(row _ num,(stack _ num* 11 )-6) = (7*(ziS _ ONL(row _ num,stack _ num)) + 
4*ziS ONL(row num,stack num+l))/11; 
- - -
new_ILM(row_num,(stack_num*11)-5) = (6*(ziS_ONL(row_num,stack_num)) + 
5*ziS ONL(row num,stack num+1))/11; 
- - -
new_ILM(row_num,(stack_num*11)-4) = (5*(ziS_ONL(row_num,stack_num)) + 
6*ziS ONL(row num,stack num+ 1))/ 11 ; 
- - -
new_ILM(row_num,(stack_num*11)-3) = (4*(ziS_ONL(row_num,stack_num)) + 
7*ziS _ ONL(row _ num,stack _ num+ 1) )/11 ; 
new_ILM(row_num,(stack_num*11)-2) = (3*(ziS_ONL(row_num,stack_num)) + 
8*ziS ONL(row num,stack num+1))/11 ; 
- - -
new_ ILM(row _ num,( stack_ num * 11 )-1) = (2 *(ziS _ ONL(row _ num,stack _ num)) + 
9*ziS ONL(row num,stack num+1))111; 
- - -
new_ILM(row_num,stack_num*11) = ((ziS_ONL(row_num,stack_num)) + 
1 O*ziS _ ONL(row _ num,stack _num+ 1 ))/11; 
new_ ILM(row _ num, 166)=ziS _ ONL(row _ num, 16); 
new_ONLtop(row_num,(stack_num*11)-10) = zONL_top(row_num,stack_num); 
new_ONLtop(row_num,(stack_num*11)-9) = 
(10*(zONL_top(row_num,stack_num)) + zONL_top(row_num,stack_num+ 1))/11 ; 
new_ ONLtop(row _ num,( stack_ num * 11 )-8) = 
(9*(zONL_top(row_num,stack_num)) + 2*z0NL_top(row_num,stack_num+1))111 ; 
new ONLtop(row num,(stack num*11)-7) = 
- - -
(8*(zONL_top(row_num,stack_num)) + 3*z0NL_top(row_num,stack_num+l))/11 ; 
new_ ONLtop(row _ num,( stack_ num * 11 )-6) = 
(7*(z0NL_top(row_num,stack_num)) + 4*zONL_top(row_num,stack_num+ 1))/11 ; 
new_ ONLtop(row _ num,(stack _num* 11 )-5) = 
(6*(zONL_top(row_num,stack_num)) + 5*zONL_top(row_num,stack_num+ 1))/11; 
new_ONLtop(row_num,(stack_num*11)-4) = 
(5*(zONL_top(row _num,stack_num)) + 6*z0NL_top(row _num,stack_num+ 1))/11; 
new_ ONLtop(row _ num,( stack_ num * 11 )-3) = 
( 4 *( zONL _ top(row _ num,stack _ num)) + 7*zONL _ top(row _ num,stack _ num+ 1) )/ 11 ; 
new_ONLtop(row_num,(stack_num*11)-2) = 
(3*(zONL_top(row_num,stack_num)) + 8*z0NL_top(row_num,stack_num+1))111 ; 
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new_ONLtop(row_num,(stack_num*ll)-1) = 
(2*(zONL_top(row_num,stack_num)) + 9*z0NL_top(row_num,stack_num+l))/ l l ; 
new_ ONLtop(row _ num,stack _ num* 11) = ((zONL _top( row_ num,stack _ num)) + 
1 O*zONL _top( row_ num,stack _ num+ 1 ))Ill; 
new_ ONLtop(row _ num, 166)=zONL _top( row_ num, 16); 
new_ ONLthick = new_ ONLtop - new_ ILM; 
new_ TOTthick = new_ ONLtop - new_ RPE; 
end 
end 
for c=l:l66 
for r=l : 1024 
new_ RPE( c,r)=zBRM _ RPE(r,c ); 
new _ISOS( c,r)=zOS _ IS(r,c ); 
new_ ILM( c,r)=ziS _ ONL(r,c ); 
new_ ONLtop( c,r)=zONL _ top(r,c ); 
new_ ONLthick( c,r)=ONL _ thick(r,c ); 
new_ TOTthick( c,r)=TOT _ thick(r,c ); 
end 
end 
close all 
%Plots surface maps of each layer 
figure 
surf(x,y,new _ RPE','EdgeColor','none'); % Figure 1 is RPE height 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Retinallayer height (microns)'); 
title('RPE Height','FontSize',20); 
caxis([O 1 20]); 
colorbar; 
xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print(' -dtiff', '-r600', 'MSG _modeling_ 00 1_ RPE _height'); 
figure 
surf(x,y,new _ ISOS','EdgeColor','none') ; % Figure 2 is ISOS height 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Retinalla yer height (microns)'); 
title('IS-OS Junction Height','FontSize',20); 
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caxis([O 150]); 
colorbar; 
xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print('-dtiff,'-r600','MSG _modeling_ OOl_IS-OS _height'); 
figure 
surf(x,y,new_ILM','EdgeColor','none');% Figure 3 is ELM height 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Retinallayer height (microns)'); 
title('ELM Height','FontSize',20); 
caxis([O 175]); 
colorbar; 
xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print(' -dti ff, '-r600', 'MSG _modeling_ 00 1_ ELM_ height'); 
figure 
surf(x,y,new _ ONLtop','EdgeColor','none') %Figure 4 is the top of the ONL 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Retinallayer height (microns)'); 
title('ONL Height (Top)','FontSize',20); 
caxis([O 275]); 
colorbar; 
xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print('-dtiff,'-r600','MSG _modeling_ 00 1_ ONL _height'); 
figure 
surf(x,y,new _ ONLthick','EdgeColor','none') %Figure 5 is the ONL thickness 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thickness (microns)'); 
title('ONL Thickness','FontSize',20); 
caxis([O 150]); 
colorbar; 
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xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print(' -dtiff, '-r600', 'MSG _modeling_ 00 1_ ONL _thickness'); 
figure 
surf(x,y,new _ TOTthick','EdgeColor','none') %Figure 5 is the ONL thickness 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Total Thickness (microns)'); 
title('Outer Retinal Thickness (BrM-ONL)','FontSize',20); 
caxis([O 275]); 
colorbar; 
xlim([O 6000]); 
ylim([O 990]); 
axis equal; 
view(2); 
print(' -dti ff, '-r600', 'MSG _modeling_ 00 1_ Outer_ Retinal_ Thickness'); 
9.2.2 MSG_OOIJor_heatmap_colors.m 
%Analysis m-file called "OctColorFinder" 
function MSG _ 00 1_ for_ heatmap _script( image_ file) 
global ONL_top IS_top OS_top RPE_bottom BRM_bottom slice_number 
X= imread(image_file, jpg'); % imports image and creates X vector 
[d1 ,d2,d3] = size(X);% determines height of image in pixels (must be less than width) 
ifd1 > d2 
image_height = d2; 
else 
image_height = d1 ; 
end 
% begin scanning at the right side of the image, one pixel at a time for blue (cuts off 5 
pixels) 
for column= (length(X)):-2:(length(X)-2047) 
row= 1; 
while row <= image_ height 
ifX(row,column,1)<20 && X(row,column,2)<20 && X(row,column,3)>240% 
BLUE 
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ONL _top( ( ( column-(length(X)-2048) )/2),slice _number) = row; 
row = image _height + 1; 
else 
row=row+1; 
end 
end 
end 
% begin scanning at the right side of the image, one pixel at a time for green 
for column= (length(X)):-2:(length(X)-2047) 
row= 1; 
while row <= image_ height 
ifX(row,column,1)<20 && X(row,column,2)>240 && X(row,column,3)<20 % 
GREEN 
IS_top(((column-(length(X)-2048))/2),slice_ number)= row; 
row = image_ height + 1; 
else 
row=row+1; 
end 
end 
end 
% begin scanning at the right side of the image, one pixel at a time for red 
for column = (length(X)):-2:(length(X)-2047) 
row= 1; 
while row <= image_ height 
ifX(row,column,1)>230 && X(row,column,2)<20 && X(row,column,3)<20 % 
RED 
OS _top((( column-(length(X)-2048))/2),slice _number)= row; 
row = image _height + 1; 
else 
row=row+1; 
end 
end 
end 
% begin scanning at the right side of the image, one pixel at a time for magenta 
for column= (length(X)):-2:(length(X)-2047) 
row= 1; 
while row <= image_ height 
ifX(row,column,1)> 175 && X(row,column,1)<225 && X(row,column,2)<20 && 
X(row,column,3)> 175 && X(row,column,3)<225% MAGENTA 
RPE _bottom( ( ( column-(length(X)-2048) )/2),slice _number) = row; 
row = image_ height + 1; 
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else 
row=row+l; 
end 
end 
end 
% begin scanning at the right side of the image, one pixel at a time for Cyan 
for column= (length(X)):-2:(length(X)-2047) 
row= 1; 
while row <= image_ height 
ifX(row,column,1)<20 && X(row,column,2)>200 && X(row,column,2)<240 && 
X(row,column,3)>210 && X(row,column,3)<240% CYAN VALUE 
BRM _bottom( ( ( column-(length(X)-2048) )/2),slice _number) = row; 
row = image_ height + 1; 
else 
row=row+l; 
end 
end 
end 
slice_ number = slice_ number + 1; 
9.3 Appendix C: MATLAB Code for Auto-segmentation Geometry 
9.3.1 Retinal_Morphology.m 
close all; 
clear all; 
load('C: \modeling_ data \Auto_ traced\MSG _ 00 1_ auto\ TIFFs'); 
timel =thicknessMaps; 
clear thicknessMaps; 
load('C:\modeling_data\Auto_traced\MSG_002_auto\TIFFs'); 
time2=thicknessMaps; 
clear thicknessMaps; 
figure; 
surf(time1(: ,:,9),'EdgeColor','none') 
xlabel('Along OCT dimension (tens of microns)'); 
ylabel('Slice dimension (tens of microns)'); 
zlabel('ILM -Choroid Thickness (microns)'); 
title('Time 1 Before Alignment','FontSize',20); 
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caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
figure; 
surf(time2(:,:,9),'EdgeColor','none') 
xlabel('Along OCT dimension (tens of microns)'); 
ylabel('Slice dimension (tens of microns)'); 
zlabel('ILM-Choroid Thickness (microns)'); 
title('Time 2 Before Alignment','FontSize',20); 
caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
%manually input angle of rotation 
time2=imrotate(time2,-5,'bilinear'); 
figure; 
surf(time2(:,:,9),'EdgeColor','none') 
xlabel('Along OCT dimension (tens of microns)'); 
ylabel('Slice dimension (tens of microns)'); 
zlabel('ILM-Choroid Thickness (microns)'); 
title('Time 2 After Rotation','FontSize',20); 
caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
%% 
%Manually input foveal center for each time point (after rotation for time 2) 
tl_ center _row=219; 
tl _ center_ column=296; 
t2 _center _row=244; 
t2 _center_ column=31 0; 
time1_ crop=zeros(30 1,301 ,9); 
time2 _ crop=zeros(30 1,3 01 ,9); 
row_ count= 1; 
for row=(tl_center_row-150):(t1_center_row+ 150) 
col_ count= 1; 
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for column=(t1_ center_column-150):(t1_ center_ column+ 150) 
time 1_ crop(row _count, col_ count,:)=time1 (row,column,:); 
col_ count=col_ count+ 1; 
end 
row_ count=row _count+ 1; 
end 
row_ count= 1; 
for row=(t2 _center _row-150):(t2 _center _row+ 150) 
col_ count= 1; 
for column=(t2 _center_ column-150):(t2 _center_ column+ 150) 
time2 _crop( row_ count, col_ count,: )=time2(row ,column,:); 
col_ count=col_ count+ 1; 
end 
row_ count=row _count+ 1; 
end 
figure; 
surf(O: 10:3000,0: 10:3000,time1_ crop(: ,:,9),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ILM -Choroid Thickness (microns)'); 
title('Time 1 After Crop','FontSize',20); 
caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
figure; 
surf(O: 10:3000,0:1 0:3000,time2 _ crop(:,:,9),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ILM -Choroid Thickness (microns)'); 
title('Time 2 After Crop','FontSize',20); 
caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
%Plot Drusen Thickness at Time 1 
a1=figure; 
surf(O: 10:3000,0:1 0:3000,time1_ crop(:,:,8),'EdgeCo1or','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('S1ice dimension (microns)'); 
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zlabel('Drusen( microns)'); 
title('Drusen at Time 1 ','FontSize',20); 
caxis([O 90]); 
axis equal; 
colorbar; 
view(2); 
print(a1 , '-dtiff,'-r300', 'MSG_001_Drusen_tl'); 
%Plot Drusen Thickness at Time 2 
a2=figure; 
surf(O: 10:3000,0:1 0:3000,time2 _ crop(:,:,8),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Drusen (microns)'); 
title('Drusen at Time 2','FontSize',20); 
caxis([O 90]); 
axis equal; 
colorbar; 
view(2); 
print(a2, '-dtiff,'-r300', 'MSG_001_Drusen_t2'); 
%Plot Change in drusen thickness between Time 1 & Time 2 
a3=figure; 
surf(O: 10:3000,0:1 0:3000,(time2 _ crop(:,:,8)-time 1_ crop(:,:,8)),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Change in Drusen size(microns)'); 
title('Change in Drusen size','FontSize',20); 
caxis([ -50 50]); 
axis equal; 
colorbar; 
view(2); 
print(a3, '-dtiff,'-r300', 'MSG _ 001_Drusen _ Diff); 
%Plot ONL Thickness at Time 1 
a4=figure; 
surf(O: 10:3000,0:1 0:3000,time1_ crop(:,:,5),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thickness (microns)'); 
title('ONL Thickness at Time 1 ','FontSize',20); 
caxis([O 150]); 
axis equal; 
colorbar; 
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view(2); 
print(a4, '-dtiff,'-r300', 'MSG_001_0NL_t1'); 
%Plot ONL Thickness at Time 2 
a5=figure; 
surf(0:10:3000,0:10:3000,time2_crop(: ,:,5),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thickness (microns)'); 
title('ONL Thickness at Time 2','FontSize',20); 
caxis([O 150]); 
axis equal; 
colorbar; 
view(2); 
print(a5, '-dtiff,'-r300', 'MSG_001_0NL_t2'); 
%Plot ONL Thinning 
a6=figure; 
ONL _ diff=time1_ crop(: ,:,5)-time2 _ crop(: ,:,5); 
surf(O: 10:3000,0:1 0:3000,0NL _ diff,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thinning (microns)'); 
title('ONL Thinning Only from T1 to T2','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
print(a6, '-dtiff,'-r300', 'MSG_001_0NL_Thinning'); 
%Plot ONL Thickening 
a7=figure; 
ONL_difi_opposite=time2_crop(:,: ,5)-time1_crop(: ,:,5); 
surf(O: 10:3000,0:1 0:3000,0NL _ diff_ opposite,'EdgeColor','none') 
xlabei('Aiong OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thickening (microns)'); 
title('ONL Thickening Only from T1 to T2','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
print( a7, '-dtiff ,'-r300', 'MSG _ 00 1_ ONL _Thickening'); 
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%Plot ONL Change between Time 1 & Time 2 
a8=figure; 
surf(O: 10:3000,0: 10:3000,(time2 _ crop(:,: ,5)-timel_ crop(:,:,5)),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Change in ONL thickness (microns)'); 
title('ONL Change from Tl to T2','FontSize',20); 
caxis([ -50 50]); 
axis equal; 
colorbar; 
view(2); 
print(a8, '-dtiff,'-r300', 'MSG_OOl_ONL_Diff); 
%Plot (ONL + OPL) Thinning 
a9=figure; 
ONL _ diff=( time 1_ crop(:,:, 4 )+time 1_ crop(:,: ,5) )-( time2 _crop(:,:, 4 )+time2 _crop(:,: ,5)); 
surf(O: 10:3000,0:1 0:3000,0NL _ diff,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thinning (microns)'); 
title('ONL Thinning Only from Tl to T2','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
print(a9, '-dtiff,'-r300', 'MSG_OOl_ONL+OPL_Thinning'); 
%Plot (ONL + OPL) Thickening 
al O=figure; 
ONL _ diff_ opposite=(time2 _ crop(:,:,4)+time2 _ crop(:,:,5))-
(timel_ crop(:,:,4)+timel_ crop(:,:,5)); 
surf(O: 10:3000,0: 10:3000,0NL _ diff_ opposite,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL Thickening (microns)'); 
title('ONL Thickening Only from Tl to T2','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
print(alO, '-dtiff,'-r300', 'MSG_OOl_ ONL+OPL _Thickening'); 
%Plot (ONL + OPL) Change with+/- range 
all =figure; 
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ONL_diff=(time2_crop(:,:,4)+time2_crop(:,:,5))-(time1_crop(:,:,4)+time1_crop(:,: ,5)); 
surf(O: 10:3000,0:1 0:3000,0NL _ diff,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Change in ONL+OPL (microns)'); 
title('ONL+OPL Change from T1 to T2','FontSize',20); 
caxis([ -50 50]); 
axis equal; 
colorbar; 
view(2); 
print(all, '-dtiff,'-r300', 'MSG_001_0NL+OPL_Diff); 
%Plot (ONL + OPL) Thickness at time 1 
a12=figure; 
surf(O: 10:3000,0:1 0:3000,(time 1_ crop(:,:,4)+time 1_ crop( :,:,5)),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL+OPL Thickness (microns)'); 
title('ONL+OPL Thickness at Time 1 ','FontSize',20); 
caxis([50 150]); 
axis equal; 
%colormap(flipud( colormap) ); 
colorbar; 
view(2); 
print(a12, '-dtiff,'-r300', 'MSG_001_0NL+OPL_t1'); 
%Plot (ONL + OPL) Thickness at time 2 
a 13=figure; 
surf(O: 10:3000,0:1 0:3000,(time2 _ crop(:,:,4)+time2 _ crop(: ,:,5)),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('ONL+OPL Thickness (microns)'); 
title('ONL+OPL Thickness at Time 2','FontSize',20); 
caxis([50 150]); 
axis equal; 
colorbar; 
view(2); 
print(a13, '-dtiff,'-r300', 'MSG_001_0NL+OPL_t2'); 
% Reformat data into Global Mapper/COMSOL XYZ points 
x _ coord=O: 1 0:3000; 
y_coord=O: 10:3000; 
time1_RPE=zeros(301 *301,3); 
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timel_OS=zeros(301 *301 ,3); 
timel_IS=zeros(301 *301 ,3); 
timel_ONL=zeros(301 *301 ,3); 
timel_ OPL=zeros(301 *301 ,3); 
for iterate! =1:301 
for iterate2= 1 :301 
timel_ RPE((iteratel-1 )*301 +iterate2,1 )=x _ coord(iteratel ); 
timel_ RPE((iterate 1-1 )*301 +iterate2,2)=y _ coord(iterate2); 
time 1_ RPE( (iterate 1-1) *30 1 +iterate2,3 )=time 1_ crop(iterate2,iterate 1 ,8); 
timel_ OS((iteratel-1)*301 +iterate2, 1 )=x _ coord(iteratel ); 
timel_ OS((iteratel-1 )*301 +iterate2,2)=y _ coord(iterate2); 
timel_ OS((iteratel-
1 )*30 1 +iterate2,3)=time 1_ crop(iterate2,iterate 1, 7)+time 1_ crop(iterate2,iterate 1 ,8); 
timel_ IS((iteratel-1 )*301 +iterate2, l)=x _ coord(iteratel ); 
time l_IS((iteratel-1 )*301 +iterate2,2)=y _ coord(iterate2); 
time 1 IS( (iterate 1-
1 )*30 1 +iterate2,3)=time 1_ crop(iterate2,iterate 1 ,6)+time 1_ crop(iterate2,iterate 1, 7)+time 1 
_ crop(iterate2,iterate 1 ,8); 
timel_ ONL((iteratel-1 )*301 +iterate2, l)=x _ coord(iteratel ); 
time1_ ONL((iterate1-1)*301 +iterate2,2)=y _coord(iterate2); 
time 1_ ONL( (iterate 1-
1 )*30 1 +iterate2,3 )=time 1_ crop(iterate2,iterate 1 ,5)+time 1_ crop(iterate2,iterate 1 ,6)+time 1 
_ crop(iterate2,iterate 1, 7)+time 1_ crop(iterate2,iterate 1 ,8); 
time1_ OPL((iterate1-1 )*301 +iterate2, 1 )=x _ coord(iterate1 ); 
time1_ OPL((iteratel-1 )*301 +iterate2,2)=y _ coord(iterate2); 
time1_ OPL((iterate1-
1 )*30 1 +iterate2,3)=time 1_ crop(iterate2,iterate1 ,4)+time 1_ crop(iterate2,iterate 1 ,5)+time 1 
_ crop(iterate2,iteratel ,6)+timel_ crop(iterate2,iterate 1, 7)+time 1_ crop(iterate2,iterate1 ,8); 
end 
end 
%% 
% Save matricies for Global Mapper Import 
fid=fopen('MSG_001_RPE_ 4_DEM.txt','w'); 
fprintf( fid, '%f %f %f\n', time 1_ RPE'); 
fclose(fid); 
fid=fopen('MSG _ 00 1_ OS_ 4_ DEM. txt','w'); 
fprintf(fid,'%f %f %f\n',timel_ OS'); 
fclose( fid); 
fid=fopen('MSG _ 00 1_ IS_ 4 _ DEM. txt', 'w'); 
fprintf(fid,'%f %f %f\n',time 1_ IS'); 
fclose(fid); 
fid=fopen('MSG_001_ ONL_ 4_DEM.txt','w'); 
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fprintf(fid,'%f %f %f\n',time1_ ONL'); 
fclose( fid); 
fid=fopen('MSG_001_0PL_ 4_DEM.txt','w'); 
fprintf(fid,'%f %f %f\n',time1_ OPL'); 
fclose(fid); 
OS=time1_ OS; 
IS=time 1_ IS; 
RPE=time 1_ RPE; 
ONL=time1_ ONL; 
OPL=time1_ OPL; 
IS_ uniform_ 20=zeros(length(OS(:, 1 )),3); 
IS_ moved_ to junction=zeros(length( OS(:, 1) ),3); 
IS _proportional=zeros(length( OS(:, 1) ),3 ); 
% Create a new IS layer that is uniformly 20um-thick above the OS 
for counter= l:length(OS(:,1)) 
IS_ uniform_ 20( counter, 1 )=OS( counter, 1 ); 
IS_ uniform _20( counter,2)=0S( counter,2); 
IS uniform 20(counter,3)=0S(counter,3)+20; 
- -
end 
dlmwrite('MSG_ 001_IS_uni_ 4_DEM.txt',IS _uniform_ 20,' '); 
%Create a new IS boundary that is proportional to the ONL+OPL thickness 
% such that the maximum IS thickness is 20um 
IS_ 20max=zeros(length(OS(:, 1)),3); 
ONL _ OPL=ONL+OPL; 
max_thick=max(ONL_OPL(: ,3)); 
IS_ test=zeros(length(OS(:, 1) ),3 ); 
for counter= 1:length(OS(:,1)) 
IS_ 20max( counter, 1 )=OS( counter, 1 ); 
IS_ 20max( counter,2)=0S( counter,2); 
IS_20max(counter,3)=0S(counter,3)+(20*(0NL_OPL(counter,3)/max_thick)); 
% IS_ test( counter, 1 )=OS( counter, 1 ); 
% IS test( counter,2)=0S( counter,2); 
% IS_test(counter,3)=(20*(0NL_OPL(counter,3)/max_thick)); 
end 
dlmwrite('MSG_001_IS_20max_ 4_DEM.txt',IS_20max,' '); 
%Create a new IS boundary that is proportional to the ONL+OPL thickness, 
% but with a maximum thickness of 20um 
for counter= 1:length(OS(:,1)) 
IS _proportional( counter, 1 )=OS( counter, 1 ); 
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IS _proportional( counter,2)=0S( counter,2); 
if(OPL(counter,3)+0NL(counter,3)) > 100 
IS _proportional( counter,3)= OS( counter,3)+20; 
else 
IS_proportional(counter,3)=0S(counter,3)+0.2*(0NL(counter,3)+0PL(counter,3)); 
end 
end 
dlmwri te('MSG _ 00 l_IS _limited _proportional_ 4 _ D EM. txt' ,IS _proportional,' '); 
%% 
%Create a new IS boundary that is proportional (0.4x)to the OS thickness, 
% with a maximum thickness of 20um 
for counter= l:length(OS(:,l)) 
IS _proportional_ OS( counter, 1 )=OS( counter, 1 ); 
IS _proportional_ OS( counter,2)=0S( counter,2); 
if OS( counter,3) > 50 
IS _proportional_ OS( counter,3)= OS( counter ,3 )+ 20; 
else 
IS _proportional_ OS( counter,3)=0S( counter,3)+0.4 *(OS( counter,3)); 
end 
end 
dlmwrite('MSG_014_IS_pro_ OS_DEM.txt',IS _proportional_ OS,''); 
%Plot "Above" Thickness at Tl (ONL+OPL) 
blO=figure; 
above=(timel_ crop(: ,:,4)+timel_ crop(: ,: ,5)); 
surf(O: 10:3000,0:1 0:3000,above,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)') ; 
ylabel('Slice dimension (microns)'); 
zlabel('Above Thickness (microns)'); 
title('ONL + OPL at Time 1 ','FontSize',20); 
caxis([O 150]); 
axis equal; 
colorbar; 
view(2); 
print(blO, '-dtiff,'-r300', 'MSG_OOl_Above2'); 
%Plot "Below" Thickness at Tl (RPE+OS) 
b 11 =figure; 
below=(timel_ crop(:, :, 7)+timel_ crop( :,:,8)); 
surf(O: 10:3000,0:1 0:3000,below,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)') ; 
ylabel('Slice dimension (microns)'); 
zlabel('Below Thickness (microns)'); 
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title('RPE +OS at Time 1 ','FontSize',20); 
caxis([O 150]); 
axis equal; 
colorbar; 
view(2); 
print(b11, '-dtiff,'-r300', 'MSG_001_Below'); 
%Plot IS Thickness at T1 
b12=figure; 
middle=(time1 crop(:,: ,6)); 
surf(O: 10:3000,0:1 0:3000,middle,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Below Thickness (microns)'); 
title('IS at Time 1 ','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
print(b12, '-dtiff,'-r300', 'MSG_001_Middle'); 
%Plot Full Thickness at Tl 
b13=figure; 
alls=middle + above + below; 
surf(O: 10:3000,0:1 0:3000,alls,'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
zlabel('Below Thickness (microns)'); 
title('Whole at Time 1 ','FontSize',20); 
caxis([O 300]); 
axis equal; 
colorbar; 
view(2); 
print(b13, '-dtiff,'-r300', 'MSG_OOl_All'); 
%% 
%Plot IS Thickness at Tl 
b14=figure; 
surf(O: 10:3000,0:1 0:3000,timel_ crop(:, :,4)+timel_ crop(:,:,S)+timel_ crop(: ,:,6)+timel_ c 
rop(: ,: , 7)+time 1_ crop(: ,: ,8),'EdgeColor' ,'none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%zlabel('Below Thickness (microns)'); 
title('Outer Retinal Thickness','FontSize',20); 
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caxis([O 300]); 
axis equal; 
colorbar; 
view(2); 
print(b14, '-dtiff,'-r300', 'Outer_Retina_Figure'); 
%Plot IS Thickness at T1 
b 15=figure; 
surf(O: 10:3000,0:1 0:3000,time 1_ crop(:,:,8),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%zlabel('RPE & Drusen Thickness (microns)'); 
title('RPE & Drusen Thickness','FontSize',20); 
caxis([O 90]); 
axis equal; 
colorbar; 
view(2); 
print(b15, '-dtiff,'-r300', 'RPE_Figure'); 
b 16=figure; 
surf(O: 10:3000,0:1 0:3000,time 1_ crop(:,:, 7),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%zlabel('RPE & Drusen Thickness (microns)'); 
title('Outer Segment Thickness','FontSize',20); 
caxis([O 50]); 
axis equal; 
colorbar; 
view(2); 
print(b 16, '-dtiff ,'-r300', 'OS_ Figure'); 
b 1 7=figure; 
surf(O: 10:3000,0:1 0:3000,time1_ crop(:,:,6),'EdgeColor','none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%z1abe1('RPE & Drusen Thickness (microns)'); 
title('Inner Segment Thickness','FontSize',20); 
caxis([O 40]); 
axis equal; 
colorbar; 
view(2); 
print(b17, '-dtiff,'-r300', 'IS_Figure'); 
b 18=figure; 
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surf(O: 10:3000,0:1 0:3000,time1_ crop(: ,:,4)+time 1_ crop( :,:,5),'EdgeCo1or', 'none') 
xlabel('Along OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%zlabe1('RPE & Drusen Thickness (microns)'); 
title('ONL & OPL Thickness','FontSize',20); 
caxis([O 150]); 
axis equal; 
colorbar; 
view(2); 
print(b18, '-dtiff,'-r300', 'ONL_OPL_Figure'); 
b 19=figure; 
surf(O: 10:3000,0:1 0:3000,time1_ crop(:, :,9),'EdgeColor','none') 
xlabe1('A1ong OCT dimension (microns)'); 
ylabel('Slice dimension (microns)'); 
%zlabel('RPE & Drusen Thickness (microns)'); 
title('Full Retinal Thickness','FontSize',20); 
caxis([O 450]); 
axis equal; 
colorbar; 
view(2); 
print(b 19, '-dtiff,'-r300', 'Full_ Retina _Figure'); 
9.3.2 Minimum 02 Concentration.m 
%%Makes a 2D heatmap for the minimum concentration corresponding to a particular x-
y value 
load('C: \Users \Kevin \Documents \Modeling\modeling_ data \MSG _ 00 1_ 002\o2 _cone_ MS 
G _ 00 1. txt') 
MSG _ 00 1_ COMSOL _ output=o2 _cone_ MSG _ 001 ; 
oxygen=ones( 150, 150); 
for row=1 :450000 
if 
oxygen((MSG _ 00 1_ COMSOL _output( row, 1 )+ 1 0)/20,(MSG _ 00 1_ COMSOL _ output(ro 
w,2)+10)120) > MSG_001_COMSOL_output(row,4) 
oxygen((MSG_001_COMSOL_output(row,1)+10)120,(MSG_001_COMSOL_output(ro 
w,2)+10)/20) = MSG_001_COMSOL_output(row,4); 
end 
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end 
oxygen=oxygen.*573.833;% Translate uM oxygen into pp02 
min_con=rot90(oxygen,3); % Rotate back to original orientation (COMSOL changes 
rows & columns) 
figure; 
surf(0:20:2980,0 :20:2980,min _con, 'EdgeColor', 'none') 
xlabel('Distance (microns)'); 
ylabel('Distance, (microns)'); 
zlabel('Partial Pressure of Oxygen (mmHg)'); 
title('Predicted Partial Pressure of Oxygen (mmHg)','FontSize',20); 
caxis([O 5]); 
axis equal; 
colormap( flipud( colormap) ); 
colorbar; 
view(2); 
figure; 
surf(0:20:2980,0:20:2980,min_con,'EdgeColor','none') 
xlabel('Distance (microns)'); 
ylabel('Distance, (microns)'); 
zlabel('Partial Pressure of Oxygen (mmHg)'); 
title('Predicted Partial Pressure of Oxygen (mmHg)','FontSize',20); 
caxis([O 1 0]); 
axis equal; 
colormap( flipud( colormap)); 
colorbar; 
view(2); 
figure; 
surf(O :20 :2980,0:20:2980,min _ con,'EdgeColor', 'none'); 
xlabel('Distance (microns)'); 
ylabel('Distance, (microns)'); 
zlabel('Partial Pressure of Oxygen (mmHg)'); 
title('Predicted Partial Pressure of Oxygen (mmHg)','FontSize',20); 
caxis([O 15]); 
axis equal; 
colormap(flipud( colormap )); 
colorbar; 
view(2); 
figure; 
surf(0:20:2980,0:20:2980,min_con,'EdgeColor','none') 
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xlabel('Distance (microns)'); 
ylabel('Distance, (microns)'); 
zlabel('Partial Pressure of Oxygen (mmHg)'); 
title('Predicted Partial Pressure of Oxygen (mmHg)','FontSize',20); 
caxis([O 20]); 
axis equal; 
colormap( flipud( colormap) ); 
colorbar; 
view(2); 
%% Downsampling original thinning grid 
for x_samp=1: 150 
for y_samp=1:150 
new_ ONL(x _samp,y _samp )=ONL _ diff((1 +(2*x _ samp-1)),(1 +(2*y _samp-1))); 
end 
end 
figure ; 
surf(0:20:2980,0:20:2980,new _ ONL,'EdgeColor','none') 
xlabel('Distance (microns)'); 
ylabel('Distance, (microns)'); 
zlabel('ONL Thinning (mol/m3)'); 
title('ONL Thinning Between Time 1 & 2','FontSize',20); 
caxis([O 30]); 
axis equal; 
colorbar; 
view(2); 
% Scatter Plot of oxygen vs. ONL thinning 
figure; 
hold on; 
forx axis=1:150 
for y_axis=1:150 
ifnew_ONL(x_axis,y_axis) > 0 
plot( min_ con(x _ axis,y _ axis),new _ ONL(x _ axis,y _axis),'.','MarkerSize', 12); 
end 
end 
end 
xlabel('Predicted Oxygen Partial Pressure (mmHg)','FontSize',20); 
ylabel('ONL Thinning (microns)','FontSize',20); 
title('Correlation ofONL Thinning with Oxygen Concentration','FontSize',20); 
%%Make graph to compare ONL Thinning with Drusen Height 
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ONL transfer=time2 crop(:,:,5); %new 11-21-13 
- -
forx_samp=1:150 
for y_samp=1:150 
new _RPE(x_samp,y_samp)=time1_crop((1 +(2*x _samp-1)),(1 +(2*y _samp-1))); 
ONL _ only(x_samp,y _samp )=ONL _transfer( (I +(2*x _samp-1 )),(1 +(2*y _samp-1 ))); 
%new 11-21-13 
end 
end 
%Scatter plot of drusen height vs. ONL thinning between T1 & T2 
figure; 
hold on; 
for x axis=1 :150 
for y_axis=1 :150 
ifnew_ONL(x_axis,y_axis) > 0 
plot( new_ RPE(x _ axis,y _ axis),new _ ONL(x _ axis,y _ axis),'.','MarkerSize', 12); 
end 
end 
end 
xlabel('Drusen Height','FontSize',20); 
ylabel('ONL Thinning (microns)','FontSize',20); 
title('Correlation ofONL Thinning with Drusen Height','FontSize',20); 
% Scatter plot of drusen height vs. ONL thickness at T2 
figure; 
hold on; 
for x axis=1: 150 
for y _axis= 1:150 
ifONL_only(x_axis,y_axis) > 0 
plot( new_ RPE(x _ axis,y _ axis),ONL _ only(x _ axis,y _axis),'.','MarkerSize', 12); 
end 
end 
end 
xlabel('Drusen Height','FontSize',20); 
ylabel('ONL Thickiness at Time 2 (microns)','FontSize',20); 
title('Correlation of Final ONL Thickness with Drusen Height','FontSize',20); 
%% 
% Scatter plot of drusen height vs. ONL thickness at T2 
figure; 
hold on; 
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for x axis= l:l50 
for y _axis= 1: 150 
ifONL_only(x_axis,y_axis) > 0 
plot( min_ con(x _ axis,y _ axis),ONL _ only(x _ axis,y_ axis),' .','MarkerSize', 12); 
end 
end 
end 
xlabel('Partial Pressure of Oxygen', 'F ontSize' ,20); 
ylabel('ONL Thickness at Time 2 (microns)','FontSize',20); 
title('Correlation of Final ONL Thickness with Drusen Height','FontSize',20); 
170 
10. BIBLIOGRAPHY 
1. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD, 
Resnikoff S. 2002 Global update of available data on visual impairment: a 
compilation of population-based prevalence studies. Ophthalmic Epidemiology 
2004;11 :67-115. 
2. Congdon N, O'Colmain B, Klaver CC, Klein R, Muiioz B, Friedman DS, Kempen J, 
Taylor HR, Mitchell P (Eye Diseases Prevalence Research Group). Causes and 
prevalence of visual impairment among adults in the United States. Archives of 
Ophthalmology 2004;122:477-85. 
3. Nita M, Strzalka-Mrozik B, Grzybowski A, Romaniuk W, Mazurek U. Ophthalmic 
transplantology: posterior segment of the eye - Part II, Medical Science Monitor 
2012;18:RA97-103. 
4. Wang JJ, Rochtchina E, Lee AJ, Chia EM, Smith W, Cumming RG, Mitchell P. 
Ten-year incidence and progression of age-related maculopathy: the Blue 
Mountains Eye Study. Ophthalmology 2007;114:92-8 
5. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. 
Progress in Retinal and Eye Research 2007;26:516-54. 
6. Shiragami C, Matsuo T, Shiraga F, Matsuo N. Transplanted and repopulated retinal 
pigment epithelial cells on damaged Bruch's membrane in rabbits. British Journal 
of Ophthalmology 1998;82: 1056-62. 
7. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Bulder PG, de Jong 
PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the 
choroid in aging. Investigative Ophthalmology & Visual Science 1994;35:2857-64. 
8. Curcio CA, Johnson M. Structure, function, and pathology of Bruch's membrane. 
Ryan SJ, editor. Retina: Expert Consult Premium Edition. China: Elsevier; 
2013 :465-81. 
9. Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch's 
membrane. A histochemical and morphologic study. Ophthalmology 1990;97:171-
8. 
10. Singh S, Woerly S, Mclaughlin BJ. Natural and artificial substrates for retinal 
pigment epithelial monolayer transplantation. Biomaterials 2001;22:3337-43. 
11. Christiansen AT, Tao SL, Smith M, Wnek GE, Prause JU, Young MJ, Klassen H, 
Kaplan HJ, la Cour M, Kiilgaard JF. Subretinal implantation of electrospun, short 
171 
nanowire, and smooth poly(~::-caprolactone) scaffolds to the subretinal space of 
porcine eyes. Stem Cells International2012;2012:454295. 
12. Strauss 0. The retinal pigment epithelium in visual function. Physiological Reviews 
2005;85:845-81. 
13. Ferris FL, Davis MD, Clemons TE, Lee L Y, Chew EY, Lindblad AS, Milton RC, 
Bressler SB, Klein R, Age-Related Eye Disease Study (AREDS) Research Group. 
A simplified severity scale for age-related macular degeneration: AREDS report no. 
18. Archives of Ophthalmology 2005; 123:1570-4. 
14. McHugh KJ, Saint-Geniez M, Tao SL. Topographical control of ocular cell types 
for tissue engineering. Journal of Biomedical Materials Research Part B: Applied 
Biomaterials 2013; 101:1571-84. 
15. Smith G, Pierscionek BK. The optical structure of the lens and its contribution to 
the refractive status of the eye. Ophthalmic & Physiological Optics 1998;18:21-9. 
16. Tessier-Lavigne M. Visual processing by the retina. Kandel ER, Schwartz JH, 
Jessell TM, editors. Principles ofNeural Science, 4th ed. New York, NY: McGraw-
Hill Companies, 2000:507-22. 
17. Provis JM, Dubis AM, Maddess T, Carroll J. Adaptation of the central retina for 
high acuity vision: cones, the fovea and the avascular zone. Progress in Retinal and 
Eye Research 2013;35:63-81. 
18. Korenbrot JI. Speed, sensitivity, and stability of the light response in rod and cone 
photoreceptors: facts and models. Progress in Retinal and Eye Research 
2012;31 :442-66. 
19. Anderson B Jr, Saltzman HA. Retinal oxygen utilization measured by hyperbaric 
blackout. Archives of Ophthalmology 1964;72:792-5. 
20. Ames A 3rd. Energy requirements of CNS cells as related to their function and to 
their vulnerability to ischemia: a commentary based on studies on retina. Canadian 
Journal of Physiology and Pharmacology 1992;70:Sl58-64. 
21. Sterling P. How retinal circuits optimize the transfer of visual information. Werner 
JS, Chalupa LM, editors. Cambridge, MA: MIT Press, 2004:234-59. 
22. Dartnall HJA, Bowmaker JK, Mollon JD. Human visual pigments: 
microspectrophotometric results from the eyes of seven persons. Proceedings of the 
Royal Society of London Series B: Biological Sciences 1983;220: 115-30. 
23 . Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor 
topography. Journal of Comparative Neurology 1990;292:497-523. 
172 
24. Gao H, Hollyfield JG. Aging of the human retina: differential loss of neurons and 
retinal pigment epithelial cells. Investigative Ophthalmology & Visual Science 
1992;33:1-17. 
25 . Steinberg RH. Interactions between the retinal pigment epithelium and the neural 
retina. Documenta Ophthalmologica 1985;60:327-46. 
26. Kevany BM, Palczewski K. Phagocytosis of retinal rod and cone photoreceptors. 
Physiology (Bethesda, MD) 2010;25:8-15. 
27. Palczewski K, Chemistry and Biology of Vision, Journal of Biological Chemistry, 
2012, 287, 1612-9. 
28. Becerra SP, Fariss RN, Wu YQ, Montuenga LM, Wong P, Pfeffer BA. Pigment 
epithelium-derived factor in the monkey retinal pigment epithelium and 
interphotoreceptor matrix: apical secretion and distribution. Experimental Eye 
Research 2004;78:223-34. 
29. Amaral J, Becerra SP. Effects of human recombinant PEDF protein and PEDF-
derived peptide 34-mer on choroidal neovascularization. Investigative 
Ophthalmology & Visual Science 201 0;51: 1318-26. 
30. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, 
Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO. Polarized 
vascular endothelial growth factor secretion by human retinal pigment epithelium 
and localization of vascular endothelial growth factor receptors on the inner 
choriocapillaris. Evidence for a trophic paracrine relation. The American Journal of 
Pathology 1999;155:421-8. 
31. Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA. The dynamic nature of 
Bruch's membrane. Progress in Retinal and Eye Research 2010;29: 1-18. 
32. Turowski P, Adamson P, Sathia J, Moss SE, Aylward GW, Hayes MJ, Kanuga N, 
Greenwood J. Basement membrane-dependent modification of phenotype and gene 
expression in human retinal pigment epithelial ARPE-19 cells. Investigative 
Ophthalmology & Visual Science 2014;45:2786-94. 
33. Provis JM, Penfold PL, Cornish EE, Sandercone TM, Madigan MC. Anatomy and 
development of the macula: specialization and the vulnerability to macular 
degeneration. Clinical & Experimental Optometry 2005 ;88 :269-81. 
34. Yu DY, Cringle SJ. Retinal degeneration and local oxygen metabolism. 
Experimental Eye Research, 2005;80:745-51. 
35. Nickla DL, Wallman J. The multifunctional choroid. Progress in Retinal and Eye 
Research 2010;29:144-68. 
173 
36. Friedman DS, O'Colmain BJ, Mufioz B, Tomany SC, McCarty C, de Jong PT, 
Nemesure B, Mitchell P, Kempen J (Eye Disease Prevalence Research Group). 
Prevalence of age-related macular degeneration in the United States. Archives of 
Ophthalmology 2004;122:564-72. 
37. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of 
cigarette smoking and age-related macular degeneration in women. JAMA : the 
Journal of the American Medical Association 1996;276:1141-6. 
38. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen 
S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: pooled 
findings from three continents. Ophthalmology 2001;108:697-704. 
39. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, 
Pleil A, Mitchell P. Clinical risk factors for age-related macular degeneration: a 
systematic review and meta-analysis. BMC Ophthalmology 2010;10:31. 
40. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, Zack DJ, 
Arakawa S, Cipriani V, Ripke S, Igo RP Jr, Buitendijk GH, Sim X, Weeks DE, 
Guymer RH, Merriam JE, Francis PJ, Hannum G, Agarwal A, Armbrecht AM, 
Audo I, Aung T, Barile GR, Benchaboune M, Bird AC, Bishop PN, Branham KE, 
Brooks M, Brucker AJ, Cade WH, Cain MS, Campochiaro PA, Chan CC, Cheng 
CY, Chew EY, Chin KA, Chowers I, Clayton DG, Cojocaru R, Conley YP, Comes 
BK, Daly MJ, Dhillon B, Edwards AO, Evangelou E, Fagemess J, Ferreyra HA, 
Friedman JS, Geirsdottir A, George RJ, Gieger C, Gupta N, Hagstrom SA, Harding 
SP, Haritoglou C, Heckenlively JR, Holz FG, Hughes G, Ioannidis JP, Ishibashi T, 
Joseph P, Jun G, Kamatani Y, Katsanis N, N Keilhauer C, Khan JC, Kim IK, 
Kiyohara Y, Klein BE, Klein R, Kovach JL, Kozak I, Lee CJ, Lee KE, Lichtner P, 
Lotery AJ, Meitinger T, Mitchell P, Mohand-Said S, Moore AT, Morgan DJ, 
Morrison MA, Myers CE, Naj AC, Nakamura Y, Okada Y, Orlin A, Ortube MC, 
Othman MI, Pappas C, Park KH, Pauer GJ, Peachey NS, Poch 0 , Priya RR, 
Reynolds R, Richardson AJ, Ripp R, Rudolph G, Ryu E, Sahel JA, Schaumberg 
DA, Scholl HP, Schwartz SG, Scott WK, Shahid H, Sigurdsson H, Silvestri G, 
Sivakumaran TA, Smith RT, Sobrin L, Souied EH, Stambolian DE, Stefansson H, 
Sturgill-Short GM, Takahashi A, Tosakulwong N, Truitt BJ, Tsironi EE, 
Uitterlinden AG, van Duijn CM, Vijaya L, Vingerling JR, Vithana EN, Webster 
AR, Wichmann HE, Winkler TW, Wong TY, Wright AF, Zelenika D, Zhang M, 
Zhao L, Zhang K, Klein ML, Hageman GS, Lathrop GM, Stefansson K, Allikmets 
R, Baird PN, Gorin MB, Wang JJ, Klaver CC, Seddon JM, Pericak-Vance MA, 
Iyengar SK, Yates JR, Swaroop A, Weber BH, Kubo M, Deangelis MM, Leveillard 
T, Thorsteinsdottir U, Haines JL, Farrer LA, Heid IM, Abecasis GR (AMD Gene 
Consortium). Seven new loci associated with age-related macular degeneration. 
Nature Genetics 2013;45:433-9. 
174 
41. Biames M, Mones J, Alonso J, Arias L. Update on geographic agrophy in age-
related macular degeneration. Optometly and Vision Science 2011;88:881-9. 
42. Pauleikhoff D, Barondes MJ, Minassian D, Chrisholm IH, Bird AC. Drusen as risk 
factors in age-related macular disease. American Journal of Ophthalmology 
1990;109:38-43. 
43 . Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins 
RF. An integrated hypothesis that considers drusen as biomarkers of immune-
mediated processes at the RPE-Bruch's membrane interface in aging and age-
related macular degeneration. Progress in Retinal and Eye Research 2001;20:705-
32. 
44. Umeda S, Suzuki MT, Okamoto H, Ono F, Mizota A, Terao K, Yoshikawa Y, 
Tanaka Y, Iwata T. Molecular composition of drusen and possible involvement of 
anti-retinal autoimmunity in two different forms of macular degeneration m 
cynomolgus monkey (Macaca fascicularis). FASEB Journal2005;19:1683-5. 
45. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. 
Pharmacological Reports 2006;58:353-63. 
46. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA. Impaired RPE 
survival on aged submacular human Bruch's membrane. Experimental Eye 
Research 2005;80:235-48. 
47. Zarbin MA. Current concepts in the pathogenesis of age-related macular 
degeneration. Archives of Ophthalmology 2004;122:598-614. 
48. Moore DJ, Clover GM. The effect of age on the macromolecular permeability of 
human Bruch's membrane. Investigative Ophthalmology & Visual Science 
2001;42:2970-5 . 
49. Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH. Autophagy and 
exosomes in the aged retinal pigment epithelium: possible relevance to drusen 
formation and age-related macular degeneration. PLoS One 2009;4:e4160. 
50. Verner-Cole EA, Davis SJ, Lauer AK. Aflibercept for the treatment of neovascular 
age-related macular degeneration. Drugs of Today (Barcelona, Spain) 2012;48:317-
29. 
51. Sarks S, Arnold J, Killingsworth M, Sarks J. Early drusen formation in the normal 
and aging eye and their relation to age related maculopathy: a clinicopathological 
study. British Journal of Ophthalmology 1999;83:358-68. 
52. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda 
SR, Beckman Initiative for Macular Research Classification Committee. Clinical 
175 
classification of age-related macular degeneration. Ophthalmology 2013;120:844-
51. 
53. Adhi M, Duker JS. Optical coherence tomography--current and future applications. 
Current Opinion in Ophthalmology 2013;24:213-21. 
54. Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: diagnosis and 
management. British Medical Bulletin 2008;85: 127-49. 
55. Nittala MG, Ruiz-Garcia H, Sadda SR. Accuracy and reproducibility of automated 
drusen segmentation in eyes with non-neovascular age-related macular 
degeneration. Investigative Ophthalmology & Visual Science 2012;53:8319-24. 
56. Freeman SR, Kozak I, Cheng L, Bartsch DU, Mojana F, Nigam N, Brar M, Yuson 
R, Freeman WR. Optical coherence tomography-raster scanning and manual 
segmentation in determining drusen volume in age-related macular degeneration. 
Retina 2010;30:431-5. 
57. Farsiu S, Chiu SJ, O'Connell RV, Folgar FA, Yuan E, Izatt JA, Toth CA, Age-
Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence 
Tomography Study Group. Quantitative classification of eyes with and without 
intermediate age-related macular degeneration using optical coherence tomography. 
Ophthalmology 2014; 121:162-72. 
58. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): 
relationships between the photoreceptor/retinal pigment epitheliurn/Bruch's 
rnernbrane/choriocapillaris complex. Molecular Aspects of Medicine 2012;33:295-
317. 
59. McUsic AC, Larnba DA, Reh TA. Guiding the morphogenesis of dissociated 
newborn mouse retinal cells and hES cell-derived retinal cells by soft lithography-
patterned rnicrochannel PLGA scaffolds. Biomaterials 2012;33 :1396-405. 
60. Kador KE, Goldberg JL. Scaffolds and stern cells: delivery of cell transplants for 
retinal degenerations. Expert Review of Ophthalmology 2012;7:459-70. 
61. Ong JM, da Cruz L. A review and update on the current status of stern cell therapy 
and the retina. British Medical Bulletin 2012;102:133-46. 
62. Stanzel BV, Liu Z, Sornboonthanakij S, Wongsawad W, Brinken R, Eter N, Comeo 
B, Holz FG, Temple S, Stem JH, Blenkinsop T A. Human RPE stern cells grown 
into polarized RPE rnonolayers on a polyester matrix are maintained after grafting 
into rabbit subretinal space. Stem Cell Reports 20 14;2:64-77. 
176 
63. Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, Hinton DR. A protocol for the 
culture and differentiation of highly polarized human retinal pigment epithelial 
cells. Nature Protocols 2009;4:662-73. 
64. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, Yoshimura N, 
Takahashi M. Generation of retinal cells from mouse and human induced 
pluripotent stem cells. Neuroscience Letters 2009; 458:126-31. 
65. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick 
RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for 
macular degeneration: a preliminary report. Lancet 2012;379:713-20. 
66. Seiler MJ, Aramant RB. Cell replacement and visual restoration by retinal sheet 
transplants. Progress in Retinal and Eye Research 20 12;31 :661-87. 
67. Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells 
seeded onto layers of human Bruch's membrane. Investigative Ophthalmology & 
Visual Science 1999;40:467-76. 
68 . Cai H, Del Priore LV. Bruch membrane aging alters the gene expression profile of 
human retinal pigment epithelium. Current Eye Research 2006;31: 181-9. 
69. Sun K, Cai H, Tezel TH, Paik D, Gaillard ER, Del Priore LV. Bruch's membrane 
aging decreases phagocytosis of outer segments by retinal pigment epithelium. 
Molecular Vision 2007;13:2310-9. 
70. Hynes SR, Lavik EB. A tissue-engineered approach towards retinal repair: 
Scaffolds for cell transplantation to the subretinal space. Graefe's Archive for 
Clinical and Experimental Ophthalmology 2010;248:763-78. 
71. Capeans C, Pineiro A, Pardo M, Sueiro-Lopez C, Blanco MJ, Dominguez F, 
Sanchez-Salorio M. Amniotic membrane as support for human retinal pigment 
epithelium (RPE) cell growth. Acta Ophthalmologica Scandinavica 2003;81:271-7. 
72. Giordano GG, Thomson TC, Ishaug SL, Mikos AG, Cumber S,Garcia CA, Lahiri-
Munir D. Retinal pigment epithelium cells cultured on synthetic biodegradable 
polymers. Journal of Biomedical Materials Research 1997;34:87-93. 
73. Lu B, Zhu D, Hinton D, Humayun MS, Tai YC. Mesh-supported submicron 
parylene-C membranes for culturing retinal pigment epithelial cells. Biomedical 
Microdevices 2012;14:659-67. 
74. Thomson HA, Treharne AJ, Walker P, Grosse! MC, Lotery AJ. Optimisation of 
polymer scaffolds for retinal pigment epithelium (RPE) cell transplantation. British 
Journal of Ophthalmology 2011;95:563-8. 
177 
7 5. Gunatillake P A, Adhikari R. Biodegradable synthetic polymers for tissue 
engineering. European Cells & Materials 2003;5:1-16. 
76. Sabir MI, Xu X, Li L. A review on biodegradable polymeric materials for bone 
tissue engineering applications. Journal of Materials Science 2009;44:5713-24. 
77. Kohn J, Abramson S, Langer R. Bioresorbable and bioerodible materials. Ratner 
BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: An 
Introduction to Materials in Medicine, 2nd ed. Boston, MA: Elsevier Academic 
Press, 2004:115-26. 
78. Tao S, Young C, Redenti S, Zhang Y, Klassen H, Desai T, Young MJ. Survival, 
migration and differentiation of retinal progenitor cells transplanted on micro-
machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab on a 
Chip 2007;7:695-701. 
79. Montezuma SR, Loewenstein J, Scholz C, Rizzo JF 3rd. Biocompatibility of 
materials implanted into the subretinal space of Yucatan pigs. Investigative 
Ophthalmology & Visual Science 2006;47:3514-22. 
80. Redenti S, TaoS, Yang J, Gu P, Klassen H, Saigal S, Desai T, Young MJ. Retinal 
tissue engineering using mouse retinal progenitor cells and a novel biodegradable, 
thin-film poly(e-caprolactone) nanowire scaffold. Journal of Ocular Biology, 
Diseases, and Informatics 2008; 1:19-29. 
81. McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(E-caprolactone) scaffolds for 
retinal pigment epithelium transplantation. Investigative Ophthalmology & Visual 
Science 2014;55:1754-62. 
82. Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H, Langer R, Young 
MJ. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) 
composites for expansiOn and subretinal transplantation. Biomaterials 
2009;30:3405-14. 
83. Pachence JM, Bohrer MP, Kohn J. Biodegradable Polymers. Lanza R, Langer R, 
Vacanti J, editors. Principles of Tissue Engineering, 3rd ed. Burlington, MA: 
Elsevier Academic Press; 2007:323-40. 
84. Saint-Geniez M, Tao SL, Tucker BT, Borenstein JT, Herman IM, D 'Amore PA, 
Young MJ. Retina Reconstruction. Ducheyne P, Healy K, Hutmacher DE, Grainger 
DW, Kirkpatrick CJ, editors. Comprehensive Biomaterials. Waltham, MA: 
Elsevier, 2011:500-16. 
178 
85. Salgado CL, Sanchez EM, Zavaglia CA, Granja PL. Biocompatibility and 
biodegradation of polycaprolactone-sebacic acid blended gels. Journal of 
Biomedical Materials Research Part A 2012;100:243-51. 
86. Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the 
choroid in the normal and detached retina. Investigative Ophthalmology & Visual 
Science 2000;41:3117 -23. 
87. Stefansson E, Geirsd6ttir A, Sigurdsson H. Metabolic physiology in age related 
macular degeneration. Progress in Retinal and Eye Research 2011;30:72-80. 
88. Lim JM, Byun S, Chung S, Park TH, Seo JM, Joo CK, Chung H, Cho DI. Retinal 
pigment epithelial cell behavior is modulated by alterations in focal cell-substrate 
contacts. Investigative Ophthalmology & Visual Science 2004;45:4210-6. 
89. Gragoudas ES, Chandra SR, Friedman E, Klein ML, Van Brskirk M. Disciform 
degeneration of the macula. II. pathogenesis. Archives of Ophthalmology 
1976;94:755-7. 
90. Moore DJ, Hussain AA, Marshall J. Age-related vanatwn in the hydraulic 
conductivity of Bruch's membrane. Investigative Ophthalmology & Visual Science 
1995;36: 1290-7. 
91. Warburg 0. The chemical constitution of respiration ferment. Science 1928;68:437-
43. 
92. Ames A 3rd. CNS energy metabolism as related to function. Brain Research 
Reviews 2000;34:42-68. 
93. Okawa H, Sampath AP, Laughlin SB, Fain GL. ATP consumption by mammalian 
rod photoreceptors in darkness and in light. Current Biology 2008;18:1917-21. 
94. Panfoli I, Dalzia D, Ravera S, Morelli AM, Traverso CE. Extra-mitochondrial 
aerobic metabolism in retinal rod outer segments: New perspectives in 
retinopathies. Medical Hypotheses 2012;78:423-7. 
95. Braun RD, Linsenmeier RA, Goldstick TK. Oxygen consumption in the inner and 
outer retina of the cat. Investigative Ophthalmology & Visual Science 1995;36:542-
54. 
96. Ahmed J, Braun RD, Dunn RJ, Linsenmeier RA. Oxygen distribution in the 
macaque retina. Investigative Ophthalmology & Visual Science 1993 ;34: 516-21 . 
97. Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina 
during normoxia and hypoxemia. Journal of General Physiology 1992;99: 177-97. 
179 
98. Alm A, Bill A. The oxygen supply to the retina. I: effect of changes in intraocular 
and arterial blood pressures, and in arterial P 02 and P C02 on the oxygen tension 
in the vitreous body of the cat. Acta Physiologica Scandinavica 1972;84:261-74. 
99. Linsenmeier RA. Electrophysiological consequences of retinal hypoxia. Graefe 's 
Archive for Clinical and Experimental Ophthalmology 1990;228:143-50. 
100. Pittman RN. Regulation of Tissue Oxygenation. San Rafael, CA: Morgan & 
Claypool Publishers, 2011. 
101. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and P02 gradients in 
solid tumors in vivo: high-resolution measurements reveal a lack of correlation. 
Nature Medicine 1997;3:177-82. 
102. Yu DY, Cringle SJ, Alder VA, Su EN. Intraretinal oxygen distribution in the rat 
with graded systemic hyperoxia and hypercapnia. Investigative Ophthalmology & 
Visual Science 1999;40:2082-7. 
103. Wang S, Linsenmeier RA. Hyperoxia 
detached feline retina. Investigative 
2007;48: 1335-41. 
Improves oxygen consumption m the 
Ophthalmology & Visual Science 
104. Birol G, Wang S, Budzynski E, Wangsa-Wirawan ND, Linsenmeier RA. Oxygen 
distribution and consumption in the macaque retina. American Journal of 
Physiology: Heart and Circulatory Physiology 2007;293:696-704. 
105. Alder VA, Cringle SJ. P02 profiles and oxygen consumption in cat retina with an 
occluded retinal circulation. Investigative Ophthalmology & Visual Science 
1990;31: 1029-34. 
106. Braun RD, Linsenmeier RA. Retinal oxygen tension and electro retinogram during 
arterial occlusion in the cat. Investigative Ophthamology & Visual Science 
1995 ;36:523-41. 
107. Noell WK. Visual cell effects of high oxygen pressures. Federation Proceedings 
1955;14: 107-8. 
108. Linsenmeier RA. Effects of light and darkness on oxygen distribution and 
consumption in the cat retina. Journal of General Physiology 1986;88:521-42. 
109. Feigl B. Age-related maculopathy - linking aetiology and pathophysiological 
changes to the ischaemia hypothesis. Progress in Retinal and Eye Research 
2009;28:63-86. 
110. Arden GB, Sidman RL, Arap W, Schlingemann RO. Spare the rod and spoil the 
eye. British Journal of Ophthalmology 2005;89:764-9. 
180 
111. Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. 
Supplemental oxygen improves diabetic macular edema: a pilot study. Investigative 
Ophthalmology & Visual Science 2004;45:617-24. 
112. Pfoff DS, Thorn SR. Preliminary report on the effect of hyperbaric oxygen on 
cystoid macular edema. Journal of Cataract and Refractive Surgery 1987;13:136-
40. 
113. Lewis GP, Talaga KC, Linberg KA, Avery RL, Fisher SK. The efficiency of 
delayed oxygen therapy in the treatment of experimental retinal detachment. 
American Journal of Ophthalmology 2004;137:1085-95. 
114. Mervin K, Valter K, Maslim J, Lewis G, FisherS, Stone 1. Limiting photoreceptor 
death and deconstruction during experimental retinal detachment: the value of 
oxygen supplementation. American Journal of Ophthalmology 1999;128:155-64. 
115. Sakai T, Lewis GP, Lindberg KA, Fisher SK. The ability of hyperoxia to limit the 
effects of experimental detachment in cone-dominated retina. Investigative 
Ophthalmology & Visual Science 2001;42:3264-73. 
116. Weiss JN. Hyperbaric oxygen therapy and age-related macular degeneration. 
Undersea & Hyperbaric Medicine 2010;37:101-5. 
117. Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea 
determines visual outcomes in resolved central serous chorioretinopathy. American 
Journal of Ophthalmology 2009; 148:105-10. 
118. Wong-Riley MT. Energy metabolism of the visual system. Eye and Brain 
2010;2:99-116. 
119. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, WolfRL, Mullins 
RF, Hageman GS. Decreased thickness and integrity of the macular elastic layer of 
Bruch's membrane correspond to the distribution of legions associated with age-
related macular degeneration. American Journal of Pathology 2005; 166:241-51. 
120. Baffi J, Byrnes G, Chan CC, Csaky KG. Choroidal neovascularization in the rat 
induced by adenovirus mediated expression of vascular endothelial growth factor. 
Investigative Ophthalmology & Visual Science 2000;41 :3582-9. 
121. Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, 
Cideciyan AV, Jacobson SG, Wilson JM, Bennett J. Nonhuman primate models for 
diabetic ocular neovascularization using AA V2-mediated overexpression of 
vascular endothelial growth factor. Diabetes 2005;54:1141-9. 
122. Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, Le YZ, Ge 1, Ma JX. Impacts of 
hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal 
181 
neovascularization. Investigative Ophthalmology & Visual Science 2012;53:6197-
206. 
123. Wang M, Munch IC, Hasler PW, Priinte C, Larsen M. Central serous 
chorioretinopathy. Acta Ophthalmologica 2008;86: 126-45. 
124. Rotsos TG, Moschos MM. Cystoid macular edema. Clinical Ophthalmology 
(Auckland, N.Z.) 2008;2:919-30. 
125. McHugh KJ, Tao SL, Saint-Geniez M. A novel porous scaffold fabrication 
technique for epithelial and endothelial tissue engineering. Journal of Materials 
Science: Materials in Medicine 2013; 24:1659-70. 
126. Ayres CE, Jha BS, Meredith H, Bowman JR, Bowlin, GL, Henderson SC, Simpson 
DG Measuring fiber alignment in electrospun scaffolds: a user's guide to the 2D fast 
Fourier transform approach. Journal of Biomaterials Science: Polymer Edition 
2008; 19:603-21. 
127. Lee CJ, Vroom JA, Fishman HA, Bent SF. Determination of human lens capsule 
permeability and its feasibility as a replacement for Bruch's membrane. 
Rio materials 2006;27: 1670-8. 
128. von der Mark K, Park J, BauerS, Schmuki P. Nanoscale engineering ofbiomimetic 
surfaces: cues from the extracellular matrix. Cell and Tissue Research 
2010;339: 131-53. 
129. Zhu Y, Gao C, Liu X, Shen J. Surface modification ofpolycaprolactone membrane 
via aminolysis and biomacromolecule immobilization for promoting 
cytocompatibility of human endothelial cells. Biomacromolecules 2002;3: 1312-9. 
130. Causa F, Battista E, Della Moglie R, Guarnieri D, Iannone M, Netti PA. Surface 
investigation on biomimetic materials to control cell adhesion: the case of RGD 
conjugation on PCL. Langmuir 2010;26:9875-84. 
131. Wegener J, Abrams D, Willenbrink W, Galla HJ, Janshoff A. Automated multi-well 
device to measure transepithelial electrical resistance under physiological 
conditions. BioTechniques 2004;37:590-7. 
132. Tsang SH, Bums ME, Calvert PD, Gouras P, Baylor DA, Goff SP, Arshavsky VY. 
Role of the target enzyme in deactivation of photoreceptor G protein in vivo. 
Science 1998;282:117-21. 
133. Chiu SJ, Li XT, Nicholas P, Toth CA, Izatt JA, Farsiu S. Automatic segmentation 
of seven retinal layers in SDOCT images congruent with expert manual 
segmentation. Optics Express 2010;18:19413-28. 
182 
134. Schindler M, Nur-E-Kamal A, Ahmed I, Kamal J, Liu HY, Amor N, Ponery AS, 
Crockett DP, Grafe TH, Chung HY, Weik T, Jones E, Meiners S. Living in three 
dimensions: 3D nanostructured environments for cell culture and regenerative 
medicine. Cell Biochemistry and Biophysics 2006;45 :215-27. 
135. Carletti E, Endogan T, Hasirci N, Hasirci V, Maniglio D, Motta A, Migliaresi C. 
Microfabrication of PDLLA scaffolds. Journal of Tissue Engineering and 
Regenerative Medicine 2011 ;5: 569-77. 
136. Dado D, Levenberg S. Cell-scaffold mechanical interplay within engineered tissues. 
Seminars in Cell & Developmental Biology 2009;20:656-64. 
137. McCullen SD, Ramaswamy S, Clarke LI, Gorga RE. Nanofibrous composites for 
tissue engineering applications. Wiley Interdisciplinary Reviews: Nanomedicine and 
Nanobiotechnology 2009; 1:369-90. 
138. Nemir S, West JL. Synthetic materials in the study of cell response to substrate 
rigidity. Annals of Biomedical Engineering 2010;38:2-20. 
139. Hutmacher DW. Scaffold design and fabrication technologies for engineering 
tissues-state of the art and future perspectives. Journal of Biomaterials Science: 
Polymer Edition 2001;12:107-24. 
140. Sachlos E, Czemuszak JT. Making tissue engineering scaffolds work. Review: the 
application of solid freeform fabrication technology to the production of tissue 
engineering scaffolds. European Cells & Materials 2003 ;5:29-40. 
141. Zhang R, Ma PX. Synthetic nano-fibrillar extracellular matricies with predesigned 
macroporous architectures. Journal of Biomedical Materials Research 
2000;52:430-8. 
142. Wiesmann HP, Lammers L. Scaffold structure and fabrication. Fundamentals of 
Tissue Engineering and Regenerative Medicine. Meyer U, Meyer T, Handschel J, 
Wiesmann, editors. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2009: 
539-49. 
143. Amini AR, Adams DJ, Laurencin CT, Nukavarapu SP. Optimally porous and 
biomechanically compatible scaffolds for large-area bone regeneration. Tissue 
Engineering Part A 2012;18:1376-88. 
144. Ashkenas J, Muschler J, Bissell MJ. The extracellular matrix in epithelial biology: 
shared molecules and common themes in distant phyla. Developmental Biology 
1996; 180:433-44. 
145. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue 
engineering applications: a review. Tissue Engineering 2006;12:1197-211. 
183 
146. Prabhakaran MP, Ghasemi-Mobarakeh L, Jin G, Ramakrishna S. Electrospun 
conducting polymer nanofibers and electrical stimulation of nerve stem cells. 
Journal of Bioscience and Bioengineering 2011;112:501-7. 
147. Di Martino A, Liverani L, Rainer A, Salvatore G, Trombetta M, Denaro V. 
Electrospun scaffolds for bone tissue engineering. Musculoskeletal Surgery 
2011;95:69-80. 
148. Valmikinathan CM, Hoffman J, Yu X. Impact of scaffold micro and macro 
architecture on Schwarm cell proliferation under dynamic conditions in a rotating 
wall vessel bioreactor. Materials Science & Engineering C: Materials for 
Biological Applications 2011 ;31 :22-9. 
149. Del Gaudio C, Grigioni M, Bianco A, De Angelis G. Electrospun bioresorbable 
heart valve scaffold for tissue engineering. International Journal of Artificial 
Organs 2008;31:68-75. 
150. James R, Toti US, Laurencin CT, Kumbar SG. Electrospun nanofibrous scaffolds 
for engineering soft connective tissues. Methods in Molecular Biology (Clifton, 
NJ) 2011;726:243-58. 
151. Jin G, Prabhakaran MP, Ramakrishna S. Stem cell differentiation to epidermal 
lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta 
Biomaterialia 2011 ;7: 112-22. 
152. Nisbet DF, Forsythe JS, Shen W, Finkelstein DI, Home MK. Review paper: A 
review of the cellular response on electrospun nanofibers for tissue engineering. 
Journal of Biomaterials Applications 2009;24:7-29. 
153. Soliman S, Sant S, Nichol JW, Khabiry M, Traversa E, Khadernhosseini A. 
Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and 
packing density. Journal of Biomedical Materials Research Part A 2011 ;96 :566-7 4. 
154. Kwon IK, Kidoaki S, Matsuda T. Electrospun nano- to microfiber fabrics made of 
biodegradable copolyesters: structural characteristics, mechanical properties and 
cell adhesion potential. Biomaterials 2005;26:3929-39. 
155. Okay 0. General properties of hydrogels. Gerlach G, Arndt KF, editors. Hydrogel 
Sensors and Actuators. New York, NY: Springer-Verlag Berlin Heidelberg; 2009: 
1-14. 
156. Apel P. Track etching technique in membrane technology. Radiation Measurements 
2001;34:559-66. 
157. Desai TA. Micro- and nanoscale structures for tissue engmeenng constructs. 
Medical Engineering & Physics 2000;22:595-606. 
184 
158. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue 
engineering. Part I. Traditional Factors. Tissue Engineering 2001;7:679-89. 
159. Patel H, Bonde M., Srinivasan G. Biodegradable polymer scaffold for tissue 
engineering. Trends in Biomaterials & Artificial Organs 2011 ;25 :20-9. 
160. Lu L, Mikos AG. The importance of new processing techniques m tissue 
engineering. MRS Bulletin: Materials Research Society 1996;21 :28-32. 
161. Cima LG, Vacanti JP, Vacanti C, Ingber D, Mooney D, Langer R. Tissue 
engineering by cell transplantation using degradable polymer substrates. Journal of 
Biomechanical Engineering 1991; 113:143-51 . 
162. Ratner BD, Hoffman AS, Schoen FJ, Lemons LE. Biomaterials Science: An 
Introduction to Materials in Medicine. 2nd ed. New York, NY: Elsevier Academic 
Press, 2004. 
163. Carletti E, Motta A, Migliaresi C. Scaffolds for tissue engineering and 3D cell 
culture. Methods in Molecular Biology (Clifton, NJ) 2011;695: 17-39. 
164. Sodha S, Wall K, Redenti S, Klassen H, Young MJ, Tao SL. Microfabrication of a 
three-dimensional polycaprolactone thin-film scaffold for retinal progenitor cell 
encapsulation. Journal of Biomaterials Science: Polymer Edition 2011 ;22:443-56. 
165. Andersson AS, Backhed F, Von Euler A, Richter-Dahlfors A, Sutherland D, 
Kasemo B. Nanoscale features influence epithelial cell morphology and cytokine 
production. Biomaterials 2003;24:3428-36. 
166. Flemming RG, Murphy CJ, Abrams GA, Goodman SL, Nealy PF. Effects of 
synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 
1999;20:573-88. 
167. Teixeira AI, Abrams GA, Bertics PJ, Murphy CJ, Nealy PF. Epithelial contact 
guidance on well-defined micro- and nanostructured substrates. Journal of Cell 
Science 2003;116: 1881-92. 
168. Figallo E, F1aibani M, Zavan B, Abatangelo G, Elvassore N. Micropattemed 
biopolymer 3D scaffold for static and dynamic culture of human fibroblasts. 
Biotcehnology Progress 2007 ;23 :210-6. 
169. Jackman RJ, Duffy DC, Chemiavskaya 0 , Whitesides GM. Using elastomeric 
membranes as dry resists and for dry liftoff. Langmuir 1999; 15:2973-84. 
170. Vozzi G, Flaim C, Ahluwalia A, Bhatia S. Fabrication ofPLGA scaffolds using soft 
lithography and microsyringe deposition. Biomaterials 2003;24:2533-40. 
185 
171. Delamarche E, Schmid H, Michel B, Biebuyck H. Stability of molded 
polydimethylsiloxane microstructures. Advanced Materials 1997;9:741-6. 
172. Qin D, Xia Y, Whitesides GM. Soft lithography for micro- and nanoscale 
patterning. Nature Protocols 2010;5:491-502. 
173. Hussain AA, Starita C, Hodgetts A, Marshall J. Macromolecular diffusion 
characteristics of ageing human Bruch's membrane: implications for age-related 
macular degeneration (AMD). Experimental Eye Research 2010;90:703-10. 
174. Okamoto S, Takahashi M. Induction of retinal pigment epithelial cells from monkey 
iPS cells. Investigative Ophthalmology & Visual Science 2011;52:8785-90. 
175. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, Rajala K, Onnela N, Narkilahti S, 
Suuronen R, Hyttinen J, Uusitalo H, Skottman H. Toward the defined and xeno-free 
differentiation of functional human pluripotent stem cell-derived retinal pigment 
epithelial cells. Molecular Vision 2011;17:558-75. 
176. Marmor MF. Retinal pigment epithelium. Yanoff M, Duker JS, editors. 
Ophthalmology: Expert Consult Premium Edition, 3rd ed. China: Mosby Elsevier, 
2008:515-7. 
177. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, 
distribution, and correlations in normal human eyes. American Journal of 
Ophthalmology 1996; 121: 181-9. 
178. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density 
and apoptosis proportion in situ. Investigative Ophthalmology & Visual Science 
2002;43 :3312-8. 
179. Bok D. The retinal pigment epithelium: a versatile partner in vision. Journal of Cell 
Science: Supplement 1993; 17: 189-95. 
180. Marmor MF. Control of subretinal fluid: experimental and clinical studies. Eye 
(London, England) 1990;4:340-4. 
181. Gu X, Neric NJ, Crabb JS, Crabb JW, Bhattacharya SK, Rayborn ME, Hollyfield 
JG, Bonilha VL. Age-related changes in the retinal pigment epithelium (RPE). 
PLoS One 2012;7:e38673. 
182. Sonoda S, Sreekumar PG, Kase S, Spee C, Ryan SJ, Kannan R, Hinton DR. 
Attainment of polarity promotes growth factor secretion by retinal pigment 
epithelial cells: relevance to age-related macular degeneration. Aging (Albany, New 
York) 2009;2:28-42. 
186 
183. Kokkinopoulos I, Shahabi G, Colman A, Jeffery G. Mature peripheral RPE cells 
have an intrinsic capacity to proliferate; a potential regulatory mechanism for age-
related cell loss. PLoS One 2011;6:el8921. 
184. Geisen P, McColm JR, King BM, Hartnett ME. Characterization of barrier 
properties and inducible VEGF expression of several types of retinal pigment 
epithelium in medium-term culture. Current Eye Research 2006;31 :739-48. 
185. Gamm DM, Melvan JN, Shearer RL, Pinilla I, Sabat G, Svendsen CN, Wright LS. 
A novel serum-free method for culturing human prenatal retinal pigment epithelial 
cells. Investigative Ophthalmology & Visual Science 2008;49:788-99. 
186. Peng S, Rao VS, Adelman RA, Rizzolo LJ. Claudin-19 and the barrier properties of 
the human retinal pigment epithelium. Investigative Ophthalmology & Visual 
Science 2011 ;52:1392-403. 
187. Zech JC, Pouvreau I. Cotinet A, Goureau 0 , Le Varlet B, de Kozak Y. Effect of 
cytokines and nitric oxide on tight junctions in cultured rat retinal pigment 
epithelium. Investigative Ophthalmology & Visual Science 1998;39: 1600-8. 
188. Maminishkis A, Chen S, Jalickee S, Banzon T, Shi G, Wang FE, Ehalt T, Hammer 
JA, Miller SS. Confluent monolayers of cultured human fetal retinal pigment 
epithelium exhibit morphology and physiology of native tissue. Investigative 
Ophthalmology & Visual Science 2006;47:3612-24. 
189. Newsome DA, Dobard EP, Liles MR, Oliver PD. Human retinal pigment 
epithelium contains two distinct species of superoxide dismutase. Investigative 
Ophthalmology & Visual Science 1990;31:2508-13. 
190. Ablonczy Z, Dahrouj M, Tang PH, Liu Y, Sambamurti K, Marmorstein AD, 
Crosson CE. Human retinal pigment epithelium cells as functional models for the 
RPE in vivo. Investigative Ophthalmology & Visual Science 2011;52:8614-8620. 
191. McKay BS, Goodman B, Falk T, Sherman SJ. Retinal pigment epithelial cell 
transplantation could provide trophic support in Parkinson's disease: results from an 
in vitro model system. Experimental Neurology 2006;201:234-43. 
192. Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S, Ogura T, 
Mizusawa H, Imai T, Miyasaka N, Nanki T. Serum level of soluble 
CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, 
which is correlated with disease activity. Arthritis Research & Therapy 
2012;14:R48. 
193. Takahashi K, Ohara M, Sasai T, Homma H, Gagasawa K, Takahashi T, Yamashina 
M, Ishii M, Fujiwara F, Kajiwara T, Taneichi H, Takebe N, Satoh J. Serum CXCL1 
187 
concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity 
of anti-islet autoimmune activity. Diabetes/Metabolism Research and Reviews 
2011;27:830-3. 
194. Cao S, Walker GB, Wang X, Cui JZ, Matsubara JA. Altered cytokine profiles of 
human retinal pigment epithelium: oxidant injury and replicative senescence. 
Molecular Vision 2013;19:718-28. 
195. Nagineni CN, Kutty V, Detrick B, Hooks JJ. Expression of PDGF and their 
receptors in human retinal pigment epithelial cells and fibroblasts: regulation by 
TGF-beta. Journal of Cellular Physiology 2005;203:35-43. 
196. Fisher RF. The influence of age on some ocular basement membranes. Eye 
(London, England) 1987;1:184-9. 
197. Chan WH, Hussain AA, Marshall J. Youngs modulus of Bruch's membrane: 
implications for AMD. Investigative Ophthalmology & Visual Science 
2007;48:ARVO E-Abstract 2187-B796. 
198. Zayas-Santiago A, Marmorstein AD, Marmorstein L Y. Relationship of Stokes 
radius to the rate of diffusion across Bruch's membrane. Investigative 
Ophthalmology & Visual Science 2011;52:4907-4913. 
199. Abbott, A. Cell culture: biology's new dimension. Nature 2003;424:870-2. 
200. Hoque ME, San WY, Wei F, LiS, Huang MH, Vert M, et al. Processing of 
polycaprolactone and polycaprolactone-based copolymers into 3D scaffolds, and 
their cellular responses. Tissue Eng Part A 2009;15:3013-24. 
201. Liu Y, Li X, Qu X, Zhu L, He J, Zhao Q, et al. The fabrication and cell culture of 
three-dimensional rolled scaffolds with complex micro-architectures. Biofabrication 
2012,4:015004. 
202. Tarawneh AM, Wettergreen M, Liebschner MA. Computer-aided tissue 
engineering: benefiting from the control over scaffold micro-architecture. Methods 
in Molecular Biology (Clifton, N.J) 2012;868:1-25. 
203 . Santos E, Hernandez RM, Pedraz JL, Orive G. Novel advances in the design of 
three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. 
Trends in Biotechnology 2012;30:331-41. 
204. Horst M, Madduri S, Gobet R, Sulser T, Milleret V, Hall H, Atala A, Eberli D. 
Engineering functional bladder tissues. Journal of Tissue Engineering and 
Regenerative Medicine 2013;7:515-22. 
188 
205. Parenteau N. Skin: the first tissue-engineered products. Scientific American 
1999;280:83-4. 
206. Proud D, Leigh R. Epithelial cells and airway diseases. Immunological Reviews 
2011 ;242: 186-204. 
207. Wilson PD. Epithelial cell polarity and disease. American Journal of Physiology 
1997;272:F434-42. 
208. Zouiten-Mekki L, Serghini M, Fekih M, Kallel L, Matri S, Ben Mustapha N, 
Boubaker J, Filali A. Epithelial cell in intestinal homeostasis and inflammatory 
bowel diseases. Medecine Sciences 2013;29:1145-50. 
209. McBane JE, Sharifpoor S, Labow RS, Ruel M, Suuronen EJ, Santerre JP. Tissue 
engineering a small diameter vessel substitute: engineering constructs with select 
biomaterials and cells. Current Vascular Pharmacology 2012;10:347-60. 
210. McGuigan AP, Sefton MV. The influence of biomaterials on endothelial cell 
thrombogenicity. Biomaterials 2007 ;28 :254 7-71. 
211. Yang J, Motlagh D, Webb AR, Ameer GA. Novel biphasic elastomeric scaffold for 
small-diameter blood vessel tissue engineering. Tissue Engineering 2005; 11:1876-
86. 
212. Lee SJ, Liu J, Oh SH, Soker S, Atala A, Yoo JJ. Development of a composite 
vascular scaffolding system that withstands physiological vascular conditions. 
Biomaterials 2008;29:2891-8. 
213 . Thomas V, Donahoe T, Nyairo E, Dean DR, Vohra YK. Electrospinning ofBiosyn-
based tubular conduits: Structural, morphological, and mechanical 
characterizations. Acta Biomaterialia 2011 ;7 :2070-9. 
214. Williams C, Xie AW, Yamato M, Okano T, Wong JY. Stacking of aligned cell 
sheets for layer-by-layer control of complex tissue structure. Biomaterials 
2011 ;32:5625-32. 
215. Wu H, Fan J, Chu CC, Wu J. Electrospinning of small diameter 3-D nanofibrous 
tubular scaffolds with controllable nanofiber orientations for vascular grafts. 
Journal of Materials Science: Materials in Medicine 2010;21:3207-15. 
216. Khan OF, Sefton MV. Endothelialized biomaterials for tissue engmeenng 
applications in vivo. Trends in Biotechnology 2011;29:379-87. 
217. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR. 
MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability 
screening. Journal of Pharmaceutical Sciences 1999;88:28-33 . 
189 
218. Viiji M, Hill DJ. In vitro models of infection IT--human umbilical vein endothelial 
cells (HUVECs) system. Methods in Molecular Medicine 2003;71 :297-314. 
219. Heath DE, Lannutti JJ, Cooper SL. Electrospun scaffold topography affects 
endothelial cell proliferation, metabolic activity, and morphology. Journal of 
Biomedical Materials Research Part A 2010;94:1195-204. 
220. Del Gaudio C, Fioravanzo L, Folin M, Marchi F, Ercolani E, Bianco A. Electrospun 
tubular scaffolds: On the effectiveness of blending pol(E-caprolactone) with poly(3-
hydroxybutyrate-co-3-hydroxyvalerate ). Journal of Biomedical Materials Research 
Part B: Applied Biomaterials 2012;100B:1883-98. 
221. Wang X, Heath DE, Cooper SL. Endothelial cell adhesion and proliferation to 
PEGylated polymers with covalently linked RGD peptides. Journal of Biomedical 
Materials Research Part A 2012;100:794-801. 
222. Zhang M, Wang K, Wang Z, Xing B, Zhao Q, Kong D. Small-diameter tissue 
engineered vascular graft made of electrospun PCL/lecithin blend. Journal of 
Materials Science: Materials in Medicine 2012;23:2639-48. 
223. Hajialai H, Shahgasempour S, Naimi-Jamal MR, Peirovi H. Electrospun 
PGA/gelatin nanofibrous scaffolds and their potential in vascular tissue 
engineering. International Journal ofNanomedicine 2011;6:2133-41. 
224. Hsia HC, Nair MR, Mintz RC, Corbett SA. The fiber diameter of synthetic 
bioresorbable extracellular matrix influences human fibroblast morphology and 
fibronectin matrix assembly. Plastic and Reconstructive Surgery 2011; 127:2312-20. 
225. Vaquette C, Cooper-White JJ. Increasing electrospun scaffold pore size with 
tailored collectors for improved cell penetration. Acta Biomaterialia 2011 ;7:2544-
57. 
226. McMillan JR, Akiyama M, Tanaka M, Yamamoto S, Goto M, Abe R, Sawamura D, 
Shimomura M, Shimizu H. Small-diameter porous poly( epsilon-caprolactone) films 
enhance adhesion and growth of human cultured epidermal keratinocyte and dermal 
fibroblast cells. Tissue Engineering 2007; 13:789-98. 
227. Salem AK, Stevens R, Pearson RG, Davies MC, Tendler SJB, Roberts CJ, Williams 
PM, Shakesheff KMI Interactions of 3T3 fibroblasts and endothelial cells with 
defined pore features. Journal of Biomedical Materials Research 2002;61 :212-7. 
228. Wegener J, Zink S, Rosen P, Galla HJ. Use of electrochemical impedance 
measurements to monitor ~-adrenergic stimulation of bovine aortic endothelial 
cells. Pflugers Archiv- European Journal of Physiology 1999;437:925-34. 
190 
229. Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization 1s the 
driving force for epithelial cell-cell adhesion. Cell 2000; 100:209-19. 
230. Fong H, Chun I, Reneker DH. Beaded nanofibers formed during electrospinning. 
Polymer 1999;40:4585-92. 
231. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical 
aspects. Archives of Ophthalmology 2003;12:547-57. 
232. Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor 
layer thinning over drusen in eyes with age-related macular degeneration imaged in 
vivo with spectral-domain optical coherence tomography. Ophthalmology 
2009; 116:488-96. 
233. Lutty G, Grunwald J, Majji AB, Uyama M, Yoneya S. Changes in the 
choriocapillaris and retinal pigment epithelium in age-related macular degeneration. 
Molecular Vision 1999;5:35. 
234. A vtar R, Tandon D. Mathematical modeling of intraretinal oxygen partial pressure. 
Tropical Journal of Pharmaceutical Research 2008;7:H1696-704. 
235. Chihara E, Nao-I N. Resorption of subretinal fluid by transepithelial flow of the 
retinal pigment epithelium. Graefe's Archive for Clinical and Experimental 
Ophthalmology 1985;223:202-4. 
236. Rob HD, Goldstick TK, Linsenmeier RA. Spatial vanat10n of the local tissue 
oxygen diffusion coefficient measured in situ in the cat retina and cornea. Advances 
in Experimental Medicine and Biology 1990;277: 127-36. 
237. Truskey GA, Yuan F, Katz DF. Transport phenomenon m biological systems. 
Upper Saddle River, NJ: Pearson Prentice Hall; 2004. 
238. Kuo AN, McNabb RP, Chiu SJ, El-Dairi MA, Farsiu S, Toth CA, Izatt JA. 
Correction of ocular shape in retinal optical coherence tomography and effect on 
current clinical measures. American Journal of Ophthalmology 2013;156:304-11. 
239. Roos MW. Theoretical estimation of retinal oxygenation during retinal artery 
occlusion. Physiological Measurement 2004;25: 1523-32. 
240. Johnson PT, Lewis GP, Talaga KC, Brown MN, Kappel PJ, Fisher SK, Anderson 
DH, Johnson LV. Drusen-associated degeneration in the retina. Investigative 
Ophthalmology & Visual Science 2003 ;44:4481-8. 
241. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an 
adjunct in the management of diabetic macular edema. American Journal of 
Ophthalmology 2004;137:675-82. 
191 
242. Panagiotoglou TD, Ganotakis ES, Kyminonis GD, Moschandreas JA, Fanti GN, 
Charisis SK, Malliaraki NE, Tsilimbaris MK. Atorvastatin for diabetic macular 
edema in patients with diabetes mellitus and elevated serum cholesterol. 
Ophthalmic Surgery, Lasers & Imaging 2010;41:316-22. 
243. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber 
TR. The Framingham Eye Study. I. Outline and major prevalence findings. 
American Journal of Epidemiology 1977;106: 17-32. 
244. Harriott LR. Limits of lithography. Proceedings of the IEEE 2001;89:366-74. 
245. Mastyugin V, McWhinnie E, Labow M, Buxton F. A quantitative high-throughput 
endothelial cell migration assay. Journal of Biomolecular Screening 2004;9:712-8 . 
192 
Education: 
11. VITA 
Kevin J. McHugh 
Telephone: (847) 373-7331 
E-mail: kjmchugh@bu.edu 
Mailing Address: 44 Cummington St., Boston, MA 02115 
Website: http: / /people.bu.edu/kjmchugh 
Born: 1987 
Boston University, Biomedical Engineering, Ph.D., May 2014 
Boston University, Biomedical Engineering, M.S., May 2012 
Case Western Reserve University, Biomedical Engineering, B.S.E., May 2009 
Professional Experience: 
2010- 2014 Graduate Research Assistant (M Saint-Geniez), Schepens Eye Research 
2011-2012 
2010- 2011 
2008-2009 
2007 
Institute, Harvard Medical School 
Graduate Teaching Fellow (AC Jackson), Boston University 
Draper Laboratory Fellow (SL Tao), Charles Stark Draper Laboratory 
Undergraduate Research Assistant (JM Anderson), Case Western Reserve 
University 
Summer Research Experience for Undergraduates (K Hecox), Medical 
College ofWisconsin 
2004- 2005 Mentorship (DJ Mogul), Biomedical Engineering, Illinois Institute of 
Technology 
Publications: 
Cao H, McHugh K, Chew SY, Anderson JM. The topographical effect of electrospun 
nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. Journal of 
Biomedical Materials Research Part A 2009;93: 1151-9. 
McHugh KJ, Tao SL, Saint-Geniez SL. A novel porous scaffold fabrication technique 
for epithelial and endothelial tissue engineering. Journal of Materials Science: 
Materials in Medicine 2013;24:1659-70. 
McHugh KJ, Saint-Geniez M, Tao SL. Topographical control of ocular cell types for 
tissue engineering. Journal of Biomedical Materials Research Part B: Applied 
Biomaterials 2013;101:1571-84. 
McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(£-caprolactone) scaffolds for retinal 
pigment epithelium transplantation. Investigative Ophthalmology & Visual Science 
2014;55: 1754-62. 
Pereira MJ, Sundback CA, Lang N, Cho WK, Pomerantseva I, Ouyang B, Tao SL, 
McHugh K, Mwizerwa 0, Vemula PK, Mochel MC, Carter DJ, Borenstein JT, 
Langer R, Ferreira LS, Karp JM, Masiakos PT. Combined surface micropatteming 
and reactive chemistry maximizes tissue adhesion with minimal inflammation. 
Advanced Healthcare Materials 2013. doi: 10.1 002/adhm.20 1300264. 
193 
Patents: 
McHugh KJ, Saint-Geniez M, Kim L. Predicting retinal degeneration based on three-
dimensional modeling of oxygen concentration. Provisional patent filed April 24, 
2013 . 
Oral Presentations: 
McHugh K, Hecox K. Finding correlations between brain and heart activity during 
epileptic seizures. Marquette University Research Experience for Undergraduates 
Symposium, Milwaukee, WI, August 2007. 
McHugh K, Anderson JM. The effects of surface porosity and nanofiber orientation on 
the foreign body reaction. Case Western Reserve University Biomedical Engineering 
Department Senior Project Exhibition I, Cleveland, OH, November 18, 2008. 
McHugh K, Anderson JM. Macrophage and foreign body giant cell adhesion on 
electrospun polycaprolactone scaffolds. Case Western Reserve University Biomedical 
Engineering Department Senior Project Exhibition II, Cleveland, OH, May 1, 2009. 
McHugh KJ, Kurihara T, Abend S, Redenti S, Young M, D'Amore PA, Tao S, Saint-
Geniez M. New poly(e-caprolactone) scaffolds for retinal pigment epithelium 
transplantation. Association for Research in Vision and Ophthalmology 2011 Annual 
Meeting, Fort Lauderdale, FL, May 1-5, 2011. 
McHugh KJ, Saint-Geniez M. A porous poly(£-caprolactone) tissue engineering scaffold 
for RPE transplantation. Schepens Eye Research Institute Ocular Regeneration Focus 
Group, Boston, MA, January 3, 2012. 
McHugh KJ, D'Amore PA, Tao SL, Saint-Geniez M. A porous poly(£-caprolactone) 
tissue engineering scaffold for RPE transplantation. Boston University Biomedical 
Engineering 8th Annual Graduate Research Symposium, Boston, MA, February 17, 
2012. 
McHugh KJ. Porous poly(£-caprolactone) tissue engineering scaffolds for retinal 
pigment epithelial transplantation in age-related macular degeneration. Prospectus 
(Master's) Thesis Defense, Boston University, May 3, 2012. 
McHugh KJ, Spencer C, D'Amore PA, Tao SL, Saint-Geniez M. A porous poly(£-
caprolactone) tissue engineering scaffold for RPE transplantation. Association for 
Research in Vision and Ophthalmology 2012 Annual Meeting, Fort Lauderdale, FL, 
May 6-10, 2012. 
McHugh KJ, Tao SL, Saint-Geniez M. A novel endothelial cell scaffold for small-
diameter vascular tissue engineering. Society for Biomaterials 2013 Annual Meeting 
& Exposition. Boston, MA, Aprill0-13, 2013. 
Poster Presentations: 
McHugh KJ, Hecox KE. Non-linear analysis of brain and cardiac dynamics in sudden 
unexplained death in epilepsy.2007 Biomedical Engineering Society Annual Fall 
Meeting. Los Angeles, CA, September 25-29, 2007. 
194 
Cao H, McHugh K, Anderson JM, Chew S. The topographical effect of electrospun 
nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. Biomaterials 
Asia 2009. Hong Kong, China, April 5-8, 2009. 
McHugh KJ, Teynor W A, Saint-Geniez M, Tao SL. A high-yield MEMS technique to 
fabricate microneedles for tissue engineering applications. National Institute of 
Biomedical Imaging and Bioengineering 2010 Training Grantees Meeting. Bethesda, 
MD, June 24-25, 2010. 
Ko CW, McHugh KJ, Yao J, Kurihara T, D'Amore PA, Saint-Geniez M, Young M, Tao 
SL. Nanopatterning of poly(e-caprolactone) thin film scaffold for retinal rescue. 
Fourth Military Vision Symposium on Ocular and Brain Injury: Current Concepts in 
Detection, Treatment, and Restoration. Boston, MA, September 26-29, 2010. 
McHugh K, Tao SL, D'Amore PA, Saint-Geniez M. New RPE transplantation scaffolds 
for retinal repair. Sixth Annual NIH Director' s Pioneer Award Symposium. Bethesda, 
MD, September 30- October 1, 2010. 
McHugh KJ, Saint-Geniez M, Tao SL. Template fabrication of a nanoporous 
polycaprolactone thin-film for retinal tissue engineering. Materials Research Society 
2010 Fall Meeting. November 29- December 3, 2010. 
McHugh KJ, Saint-Geniez M, Tao SL. Microfabrication of an artificial Bruch's 
membrane for the treatment of age-related macular degeneration. Society for 
Biomaterials Annual Meeting & Exposition. Orlando, FL, April13-16, 2011. 
McHugh KJ, Kurihara T, Abend S, Redenti S, Young M, D'Amore PA, Tao SL, Saint-
Geniez M. A novel poly( e-caprolactone) scaffold for retinal pigment epithelium 
transplantation. Annual Meeting of the Harvard Medical School Department of 
Ophthalmology. Boston, MA, June 17-19, 2011. 
McHugh KJ, Saint-Geniez M, Tao SL. A novel nanoporous poly(E-caprolactone) 
scaffold supports native-like retinal pigment epithelium. Biomedical Engineering 
Society 2011 Annual Meeting. Hartford, CT, October 12-15, 2011. 
McHugh KJ, Spencer CM, D'Amore PA, Tao SL, Saint-Geniez M. Enhanced retinal 
pigment epithelium maturation on a porous tissue engineering scaffold. 3rd Annual 
Translational Research Symposium. Boston University, Boston, MA, April26, 2012 
McHugh KJ, Spencer CM, D'Amore PA, Tao SL, Saint-Geniez M. Enhanced retinal 
pigment epithelium maturation on a porous tissue engineering scaffold. 
Massachusetts Eye & Ear Infirmary Ophthalmology Annual Meeting. Boston, MA, 
June 8-12, 2012. 
McHugh KJ, Spencer CM, Wang J, Tao SL, Saint-Geniez, M. Tissue engineering for the 
treatment of age-related macular degeneration. gth Annual NIH Director' s Pioneer 
Award Symposium. Bethesda, MD, September 13-14, 2012. 
McHugh KJ, Tao SL, Saint-Geniez M. A tissue engineering scaffold for epithelial tissue 
regeneration. 5th Military Vision Symposium on Ocular & Vision Injury. Boston, 
MA, September 18-20, 2012. 
McHugh KJ, Tao SL, Saint-Geniez M. Sub-retinal tissue engineering for the treatment 
of age-related macular degeneration. Biomedical Engineering Society 2012 Annual 
Meeting. Atlanta, GA, October 24-27, 2012. 
195 
McHugh KJ, Tao SL, Saint-Geniez M. A novel porous scaffold for epithelial and 
endothelial tissue engineering. 2013 Biomedical Engineering Society Cellular and 
Molecular Bioengineering Conference. Waimea, HI, January 2-5, 2013. 
McHugh KJ, Tao SL, Saint-Geniez M. Sub-retinal tissue engineering scaffold for age-
related macular degeneration. 2013 Biomedical Engineering Society Cellular and 
Molecular Bioengineering Conference. Waimea, HI, January 2-5, 2013 . 
Zhang MH, Khankhel AH, McHugh KJ, Saint-Geniez M. Pore-cast scaffold for vascular 
tissue engineering. 2013 391h Annual Northeast Bioengineering Conference. Syracuse, 
NY, April 5-7, 2013. 
Spencer C, Abend S, McHugh K, Saint-Geniez M. Effect of endothelial cells on RPE 
differentiation and matrix deposition. Experimental Biology 2013. Boston, MA, April 
20-24, 2013. 
McHugh KJ, Tao SL, Saint-Geniez M. A novel porous scaffold for epithelial and 
endothelial tissue engineering. Massachusetts General Hospital Research Fellows 
Poster Celebration. Boston, MA, May 22, 2013. 
McHugh KJ, Tao SL, Saint-Geniez M. A novel scaffold for vascular tissue engineering. 
Biomedical Engineering Society 2013 Annual Meeting. Seattle, W A, September 25-
28, 2013. 
McHugh K, Kwark L, Farsiu S, Kim LA, Saint-Geneiz M. Patient-specific modeling of 
retinal oxygen as a predictor of AMD progression. Association for Research in Vision 
and Ophthalmology 2014 Annual Meeting, Orlando, FL, May 4-8, 2014. 
Saint-Geniez M, Spencer C, Abend S, McHugh KJ. Synergistic interaction between 
endothelial cells and retinal pigment epithelium. Association for Research in Vision 
and Ophthalmology 2014 Annual Meeting, Orlando, FL, May 4-8,2014. 
Honors, Awards, & Fellowships: 
• Presidential Scholarship, Case Western Reserve University, 2005-2009 
• Dean's Honors, Case Western Reserve University, Fall2005, Spring 2009 
• Dean's High Honors, Case Western Reserve University, Spring 2006, Fall 2007, 
Spring 2008, Fall 2008 
• Graduated cum laude, Case Western Reserve University, 2009 
• National Science Foundation, Research Experience for Undergraduates (REU) at 
Marquette University, 2007 
• Biomedical Engineering Society Annual Fall Meeting Travel Grant, Marquette 
University Summer REU, 2007 
• Biomedical Engineering Society Annual Fall Meeting Travel Grant, Case Alumni 
Association, 2008 
• Translational Research in Biomaterials Institutional Research Training Grant, 
Boston University, 2009-2011 
• Association for Research in Vision and Ophthalmology Annual Meeting Travel 
Grant, National Eye Institute, 2012 
• Poster Award, 3rd Annual Translational Research Symposium, BU Clinical & 
Translational Science Institute, 2012 
• GEN TEN Award, Genetic Engineering and Biotechnology News, 2012 
196 
• Coulter College Travel Stipend, Wallace H. Coulter Foundation, 2012 
• Coulter College Project Award, 2nd Place, 2012 
• Biomedical Engineering Society Student Travel Award, BMES, 2012 
• Patient-specific modeling of oxygen distribution for predicting retinal 
degeneration. The Grimshaw Foundation, 2013 
• Biomedical Engineering Society Student Travel Award, BMES, 2013 
OTHER: 
• Boston University Student Association of Graduate Engineers 
o Member, 2009-11 
o Community Outreach Officer, 2011-2012 
o Vice President, 2012-2013 
o President, 2013-2014 
• Volunteer, West End House Boys and Girls Club, 2011-2014 
• Undergraduate Senior Project Mentor, 2012-2013 
• Undergraduate Mentor, Summer 2013 
197 
